ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.
Dr Anaita Udwadia-Hegde, Pediatric Neurologist, Mumbai, India. -Director of Neurosciences, SRCC Narayana Children’s Hospital & Honorary Consultant at the Jaslok Hospital & Research Centre & Wadia Children’s Hospital. -President of the Association of Child Neurology-India (AOCN-India)2021-2023. -Elected, Executive Board Member of the International Child Neurology Association, ICNA, 2018-2022, Lead of Education.
In the 4 years with ICNA, learnt alot regards the situation & needs of child neurology in different regions of the world. We have helped support with personnel, ideas, funds and or collaboration, national child neurology bodies and passionate professionals keen to improve the situation in their country.
Helped conceive the Global Regional Initiative Program -GRIP, a collaborative effort to upskill child neurology worldwide. Here ICNA with other international child neurology associations such as CNS, EPNS, etc plan to fund & support an upskilling regional project for 2 years.
The ICNA educational activities, inspite of COVID have been amazing. Numerous National associations have been endorsed by ICNA. Cross continent teaching programs and the ICNTN has been a run-away success.
As President of the AOCN-India, have created active verticals with a thrust on education, research, advocacy, outreach, finance, website and offbeat. Focus is to connect, empower, increase and enhance the child neurology fraternity in our country.
But my passion, is my work in rural Maharashtra. Founded the Rural Child Neurology Program, in 2010. Conduct camps quarterly. We treat, give holistic, multidisciplinary & nutritional care to over 800 children with neurological problems at each camp, & focus on parent education. During COVID, we were able to support the children with medication and virtual consults. I do believe that corrective measures in the critical first few years of a child’s development, have maximum benefits on mental and developmental growth
Having completed a term on the Executive board, I have had the opportunity to learn and see how the ICNA works in all regions of the world. As Lead of Education, ICNA, the pandemic made us move from conventional academic programs to the beauty of the virtual world. Change in educational methods, structure, platforms, has made us all closer, connected and made travel dispensable in the pursuit of education.
Dr. Hasan Tekgül was born in Gümülcine-Greece, in 1964. He migrated with his family to the west part of Turkey, Izmir, in 1974. Dr. H. Tekgül graduated from the University of Ege, Izmir, Turkey in 1986. Dr. Tekgül began his career in pediatrics in 1992, then as a pediatric neurologist in 1994, and as an associate professor in 1998. In 2000, he was awarded a grant by the Turkish Scientific Research Council, Research Fellowship at Harvard University. He studied neonatal neurology with Joseph Volpe and neonatal EEG with Gregory Holmes and Blaise Bourgeois between 2000-2002 at Children’s Hospital Boston.
Dr. Tekgül also spent three months in Cleveland Clinics, Ohio, for a three-month EEG course. He returned in 2002 to set up a pediatric clinical neurophysiology lab for the comprehensive diagnostic evaluation and treatment of children and adolescents with epilepsy at Ege University Hospital. Dr. Hasan Tekgül took up the position as Professor of Pediatric Neurology at the University of Ege, in 2003. His clinical sub-specialties are Neonatal Neurology, Developmental Neurology, Pediatric Epilepsy, and Pediatric Clinical Neurophysiology (EEG Monitoring, EMG, and Transcranial Magnetic Stimulation-TMS). He has designed and tested a reduced electrode EEG montage for neonatal EEG monitoring. He has also contributed to seminal research on biomarkers of epileptogenesis and neuronal plasticity in the developing brain with TMS. His current projects include genetic characterization of developmental epileptic encephalopathies, new EEG modalities for neonatal seizures in neonatal intensive care units.
Dr. Hasan Tekgül has 166 original research publications (103 in international journals and 63 national journals) and numerous book chapters. He has presented her research at international meetings but also supports global educational programs, with a particular focus on national EEG courses ( basic EEG: 12, and advanced EEG:11) and EMG courses.
Current Position:
Other Relevant Positions:
Conflict of Interest I have provided consulting services to UCB, Sanofi, Novartis, Nutricia, Abbot, and Nestle. I received lecture fees and professional travel accommodations from UCB, Sanofi, Novartis, Nutricia, Abbot, and Nestle.
ICNA is a golden synapsis between health professionals to advance knowledge, education, facilitation, and sharing resources in field of neuroscience and reach children across the world.
I have been a member of ICNA since 2005 and have attended ICNA meetings. I have worked over the past fifteen years to establish international collaborations. I have trained residents and fellows from Cyprus, Azerbaijan, and Iran.
I have attended four educational meetings as an ICNA speaker: Colombus, Sri Lanka (22-23 March 2014), Tebrise, Iran (13-15 Sep 2016), Cox-Bazar, Bangladesh (5-6 November, 20016), Chennai, India (Jan 2016).
I actively work in clinical and laboratory research on neonatal neurology, pediatric epilepsy, and pediatric clinical neurophysiology. I would like to share and contribute to the education of junior child neurologists. I can be actively involved in educational exchange programs, symposiums, workshops.
It would be an honor to be a member of the Executive Board of ICNA. If I have been nominated and elected to the EB of ICNA, I can contribute to international education activities and congresses.
Dr Rekha Mittal
Additional Director ( Pediatric Neurology)
Madhukar Rainbow Children’s Hospital, New Delhi – 110017
Ph: 9958870028, Email: drrekhamittal2008@gmail.com
Professional experience
1988 – 2010
Worked as Pediatrician and later Pediatric Neurologist in Armed Forces, India.
Completed two years in - service training (while in the Army) in Pediatric Neurology from All India Institute of Medical Sciences, Delhi , in 1998.
Subsequently, practiced Pediatric Neurology in diverse medical set ups in different cities across India – from basic medical centres to the advanced Army Hospital Research and Referral, New Delhi.
2010 - present
Worked in different superspeciality hospitals in New Delhi. Presently with the Madhukar Rainbow Children’s Hospital, New Delhi, where I also see children from different countries, including the middle east, Africa, and Asia, and have some insight into challenges in Pediatric Neurology in these countries.
Social work
Ran a charitable centre for 5 years, where Pediatric Neurology services were provided free of cost to children from economically weaker families.
Organisational experience
A. Association of Child Neurology (AOCN):
Was one of the seven founding members of the AOCN, and subsequently, Secretary and President of the AOCN.
Was secretary/chairperson in the organization of 3 National Conferences of the AOCN
Initiated /organized and was part of, many educational activities of the AOCN like Continuing Medical Education/ similar programs.
During the Covid pandemic, which happened when I was president of AOCN, academic activities were continued online, with masterclasses, short courses, lectures for Pediatric / Pediatric Neurology Residents, General Pediatricians and Pediatric Neurologists.
Convened 3 important consensus statements for India:
Social and Legal Aspects of Childhood Epilepsy
Diagnosis and Management of Febrile Seizures
Diagnosis and Management of West Syndrome
As President, I was successful in getting approval from the National Board of Examinations in Medical Sciences (Government of India), for Pediatric Neurology as a subject for awarding a degree in this subject ( equivalent DM )
I have experience in practice of Pediatric Neurology under diverse medical setups and populations, and also organisational experience and success in different activities at a National Level in India.
1. Pediatric Neurology UPSKILLING AT EVERY LEVEL : from the ground upwards to the sky is the limit, can be achieved; it is the key for resource development.
The ICNA is a prestigious world body to which Pediatric Neurologists the world over seek membership and follow. As such, the body already has a leadership role in multiple areas of education, practice, advocacy and encouraging and awarding research in Pediatric Neurology at different levels. However, a footprint into Pediatric Neurology practice at the grassroots level can be expanded, in best interest of children requiring Pediatric Neurology services.
In a majority of developing countries with limited resources, the pediatric neurology practice is mostly by General Pediatricians. The Zimbabwe story on the ICNA website ( https://icnapedia.org/icna-zimbabwe-appeal ) is not limited to Zimbabwe; it is still the story of most countries.
The way forward would be :
2. Development of ICNA consensus statements/ guidelines on common neurological disorders for practice at differing levels of healthcare.
3. Recognition of Pediatric Neurology services by individuals in this field, beyond research. This would encourage Humanism and innovation in practice of Pediatric Neurology.
Prof Shaheen Akhter
Professor of Paediatric Neurology
Dean, Faculty of Paediatrics Director, Institute of Paediatric Neurodisorder and Autism (IPNA)
Bangabandhu Sheikh Mujib Medical University (BSMMU)
Dhaka, Bangladesh
Email: shaheenk33@bsmmu.edu.bd
Prof Akhter is the Professor of Paediatric Neurology and Dean, Faculty of Paediatrics at Bangabandhu Sheikh Mujib Medical University (BSMMU), the only medical university in Bangladesh. She has been working for more than 22 years in Paediatric Neurology, Neurodevelopment, and Autism. She has taken an active role in developing and implementing the 'Paediatric Neurology and Neurodevelopment Residency Course' at BSMMU. She is actively engaged in patient management alongside clinical research and teaching commitments.
Prof Akhter is the Founder-Director of the Institute of Paediatric Neurodisorder and Autism (IPNA). IPNA is a pioneer institute that operates at the national level, providing comprehensive and tertiary-level services to children with neurodevelopmental disorders and autism. IPNA aims to consolidate research initiatives at the national and international level and organize national and international seminars and workshops to disseminate disability/autism-related knowledge and other essential skills to doctors, teachers, and parents. It also runs a model 'School for Children with Autism' by autism-expert teachers and their team, involving parents in managing children with disabilities. IPNA regularly organizes national and international training and seminars for paediatric neurologists, paediatricians, and other health professionals.
She is an active member of ICNA and, as IPNA head, she and her team had organized a two-day-long "ICNA Educational Meeting" at Cox's Bazar, Bangladesh, in 2016. The event hosted internationally reputed child neurology and child development scholars and focused on exchanging knowledge and best practices in Autism, Epilepsy, Movement Disorder, child development, CNS Infections, Cerebral Palsy Neurometabolism, and Neurodegenerative disorders.
Prof Akhter has also been working with the Bangladesh Non-communicable Disease Control Programme to develop tools for screening neurodevelopmental problems and ASD for community field workers in health care. Prof. Shaheen does not have any conflicts of interest to disclose.
During the pandemic, the ICNA’s continued role in creating a knowledge environment by providing education and training and engaging in research and advocacy was hugely beneficial for paediatric neurologists worldwide. We especially felt its positive impact in Bangladesh during the prolonged and continued lockdowns. I believe it is vital to build on these close connections and forge a deeper relationship based on learning and knowledge-sharing. I believe we can offer a unique perspective: of medical practitioners dealing with a vast number of healthcare seekers in low-resource settings.
More and more research is being conducted locally based on this context, especially since there are still certain infectious diseases that prevail in developing countries like Bangladesh, which struggle with providing care to a significant population with limited means. In Bangladesh, paediatric neurology is still a relatively new sub-specialty, but more and more doctors specialise in it. Integrating such understandings into a platform as huge as ICNA can enrich us in Bangladesh and bring diverse critical perspectives into the ICNA itself. Such representations can make crucial contributions to an ever-growing and increasingly diverse association in an ever globalizing and integrating world. Now more than ever, we need to improve systems to respond adeptly to the challenges children living with a neurologic condition face.
We need to work harder to create inclusive opportunities for all children and families to access and receive the quality of care they deserve. In this, each of us in the child neurology community has a role to play, and ICNA is already an integral actor in fulfilling this responsibility and disseminating scientific knowledge to empower regional healthcare delivery. I am committed to being a part of this journey and working to improve the lives of children with neurological disorders and neurodisability as a part of this worldwide neurology community.
Sheffali Gulati, FRCPCH (UK), FAMS, FIAP, FIMSA
Professor, Program Director, DM Pediatric Neurology Program
Faculty I/C, Centre of Excellence & Advanced Research for Childhood Neurodevelopmental Disorders
Chief, Child Neurology Division, Department of Pediatrics, AIIMS, New Delhi, India
INSAR (International Society for Autism Research) Global Senior Leader for India
Chairperson, Academy of Pediatric Neurology, Indian Academy of Pediatrics
President Elect, Association of Child Neurology, India
Executive Board Member, Indian Epilepsy Society
Co-Convenor, Paediatric Epilepsy Subsection, Indian Epilepsy Society
Founder Member, Association of Child Neurology
Professor Sheffali Gulati: trained/working at All India Institute of Medical Sciences, New Delhi. Part of the team which started first DM Pediatric Neurology Program in South Asia (2004), Program Director (2008-). Contributed towards establishing Pediatric Neurology programs across India/SAARC countries.
Over 25 years experience, has developed Pediatric Neurology in India as a specialty- academics, clinical care, patient empowerment, research, advocacy and public health domains. National/International awards(Over 25)- First India recipient, Sheila Wallace Award(ICNA)2014, National Award for Science & Technology communication 2021; Fellowship Award, McGill University 2006,ICNA 2010. Fellow, Royal College of Pediatrics and Child Health, UK; Fellow, National Academy of Medical Sciences/Indian Academy of Pediatrics/International Medical Science Academy.
Envisioned, conceptualized and heading Centre of Excellence and Advanced Research for Childhood Neurodevelopmental Disorders (2017-): high quality care, high end research, education hub(www.pedneuroaiims.org), National registry and National Child Neurology telehelpline/ consultation (24X7; toll free) .
Over 365 research publications (NEJM, JAMA pediatrics), Citations: 5094; h-Index 34; i10-index 125; Highest IF: 91.245, Maximum citations:316.Research projects leading to innovations/advocacy (NIH/Autism speaks/MRC,UK/ AIIMS-UCL): Neurodevelopmental disorders including Screening/Diagnostic Instruments(National programs; Mobile app PedneuroaiimsDiagnostics: google/ios) Drug refractory epilepsy including dietary therapies, Autism spectrum disorders, Cerebral palsy, SLD, Neuromuscular disorders/neurorehabilitation
Scientific associations International Society for Autism Research-Global Senior Leader (2021-); Association of Child Neurology, India- Founder member (2002); President elect (2023-2025); Academy of Paediatric Neurology, Indian Academy of Paediatrics- Chairperson (2021); National Convenor-Guidelines (2022), Indian Epilepsy Society(National body of ILAE): Co-convenor Paediatric section; Executive Board Member; Indian Academy of Neurology- Curriculum review / Guidelines development committee Member, Advisory board, ICNC 2018; Member, Advisory Board, ICNTN; Coordinator, Neurodevelopmental disorders module, organized “PediatricNeurogenomics” webinar series with ICNTN collaboration.
Has been instrumental in transforming care for children with neurodevelopmental disorders across India and her contributions in the field of epilepsy, autism and other neurodevelopmental disorders are unmatched CV summary: https://drive.google.com/file/d/12q3y8JIYWazVSCxrUc74rB60C4t7jWv9/view?usp=sharing
My vision for ICNA is for it to be a premier association for paediatric neurologists globally promoting the highest quality patient centered care for children with neurological disorders and neuro-disability and supporting the professional development of the members.
The association should focus on the trinity of clinical care, academics and research and to
Viraj Sanghi is a consultant paediatric neurologist at the SRCC Children’s Hospital and the KEM hospital and GS Medical College in Mumbai with a keen interest in paediatric stroke, neuromuscular disorders and palliative care.
He received his MBBS and MD degrees from Grant Medical College in Mumbai, India and subsequently received the Diplomate of the National Board in Neurology in 2002. He went on to obtain his fellowship in Paediatric Neurology from SickKids, Toronto. Recently he completed certification in Palliative care from Harvard Medical School, Boston.
Over the past 22 years he has been passionate about and closely involved in ethical and holistic care as well as rehabilitation of children and currently serves the Rehabilitation committee as well as the Ethics committees at the SRCC Children’s Hospital in Mumbai. He is also instrumental in establishing the Family Centred Care programme and setting up a paediatric Palliative Care programme at the hospital. He is an enthusiastic teacher and has conducted several education programmes for fellows, residents, neurologists, community paediatricians and other healthcare workers. Additionally, he has also uses his administrative skills to organize and serves as faculty in several Regional, National and International conferences including the ICNC 2018 which was held in Mumbai. As a Trustee of Neurology Foundation, a charitable organization based in Mumbai, he is involved in fund raising and philanthropic activities for the underprivileged sector of society. He is currently on the ICNA Executive Board and is committed to serving the organization to help achieve its mission and goals.
In his spare time, away from the hospital and his work, Viraj enjoys spending time with his wife and two daughters, adorable black Labrador, reading, working out and watching Netflix! He is an avid traveler and loves to explore different cultures and cuisines across the globe.
ICNA is a global community of individuals who share the philosophy of providing high quality neurological healthcare for children from all regions of the world. We come together on a common platform with the intent of decreasing the burden of disease. Towards this common goal we must strive to achieve the following:
Grow the paediatric neurology workforce, especially in resource limited regions, with an unwavering commitment to excellence in education. We must continue to provide cutting-edge academic programs that promote the intellectual and ethical growth of students, residents and fellows through in-person as well as online models of academic programmes.
Expand and support paediatric neuroscience Research and encourage and support young researchers in this regard.
Develop standardized protocols and clinical algorithms that can promote highest levels of care and yet be applicable to those with limited financial means.
Provide a network that allows for free exchange of ideas and communication towards the promotion of high quality patient care and better outcomes. This would include mentorship programmes for residents and neurologists in early stages of their careers to help foster a sense of support.
Attain financial growth and sustainability for the organisation and yet continue to provide low cost resources for those regions that need financial support.
Continue the development and promotion of JICNA and other educational activities already in place.
Advocate for patients and care givers with policymakers and form partnerships with other societies, the government and community.
8.Uphold the values, ethics and integrity of ICNA and integrate professional education with humanistic, scientific and social learning.
I remain committed to the core principles of ICNA and would be honoured to continue to serve the board.
Vrajesh Udani completed his medical training at the prestigious Grant Medical college Mumbai, India with honours. He trained in Child Neurology and Clinical Neurophysiology at the State University of New York, Brooklyn. After board certification he returned to Mumbai and set up one of the first Child Neurology services in India at the PD Hinduja National Hospital. A sabbatical year at the Miami Children’s Hospital enabled him to set up an active epilepsy surgery program. He further started an active teaching program at two public teaching institutions. Several child neurologists have trained under him in India.
His clinical and research interests have spanned several areas. He was part of the first international RCT studying the use of interferon in SSPE. He co-authored original clinical and genetic descriptions of MLC with subcortical cysts and PKAN in the Agrawal community in India. The link between infantile epilepsy and neonatal hypoglycemic brain injury was explored and has emerged as one of the commonest etiologies of drug-resistant epilepsy in the developing world. Long-term outcome studies in drug resistant epilepsy and autistic spectrum disorders have highlighted what happens in resource-poor setting. Recent research interests have been autoimmune encephalitis and MOG associated disorders.
He has published > 80 papers in peer-reviewed journals and 25 chapters in textbooks. He has served on expert consensus groups including the ILAE Pediatric Epilepsy Surgery task force and the ILAE Nosology Commission Syndrome Definitions.
He was the organizing chairperson of the International Child Neurology Congress in Mumbai in 2018 which was rated highly by most members. He is a member on the ICNA nominating committee for the last 4 years. He has served the Indian neurology community as President of the Association of Child Neurology-India and Chairman of the Pediatric Neurology subsection of the Indian Academy of Neurology.
He has lectured extensively in national and international meetings and given several prestigious orations.
A few initial thoughts about the state of world child neurology and what my goals would be if elected to the executive board
1) Though the burden of childhood neurological disease is high in the developing world, access to even basic child neurologic services is sorely lacking. This is primarily due to the lack of organized training in many parts of the world. The ICNA has been fairly successful in the continuing medical educational activities tried with regular physical and online teaching programs but a lot more needs to be done.
2) We probably have the highest numbers of rare disorders in child neurology. This makes it a challenge to study these diseases. We need international registries to be set up so to help increase our collective knowledge which would help our patients in the long run.
3) Access to advanced testing is a still a major hurdle in diagnosing rare disorders in many parts of the world due to cost / availability issues.
4) Finally novel therapies are rapidly gaining ground in different disorders. However, these are extraordinarily expensive and out of reach for most of the world. The ICNA is in a unique position in bridging these gaps with its reach across the world and its rapidly expanding membership.
I propose to help
1) Expand educational initiatives in parts of the world needing them most using not only world-renowned speakers but local experts as well
2) Establish registries to help study the epidemiology & natural history of rare disorders
3) Make available lists of where advanced genetic /immunologic tests can be done at reasonable rates
4) Use the good offices of ICNA to lobby the pharmaceutical industry to reduce costs and increase access to expensive medications
From the earliest stages of my career, I have been committed to improving access to appropriate neurologic care for children in resource-constrained regions. As a pediatric neurologist and epileptologist at Boston Children’s Hospital, I lead our department’s global health efforts, including trainee education focused on global perspectives of pediatric neurologic conditions and how to work effectively and ethically in limited resource regions. For over a decade, I have worked in Africa, currently spending over 4 months in the region annually focused on: (1) clinical neurology education and infrastructure development in Rwanda and Zambia, and (2) collaborative clinical research focused on early identification and management of children with epilepsy.
In Zambia, I have been deeply involved in training the first Zambian child neurologists, teaching neurology to pediatric residents and non-specialists across the country and promoting epilepsy advocacy through community health worker initiatives. Through the Human Resources for Health Program in Rwanda, I developed and implemented a child neurology curriculum for pediatric trainees, and continue to provide clinical, education, and research support for young pediatricians as a visiting consultant, with a focus on nurturing interest in our field as the country currently has no child neurologist. My current research is focused on identifying predictive factors for post-malaria epilepsy, with the goal of improving early identification of epilepsy in the highest risk children.
I am active in the global neurology community through several mechanisms that allow me to promote practice and policy change focused on health equity and access to care. I have served as an active consultant with the World Health Organization since 2015. I also serve on the Lancet Commission on Epilepsy; the International League Against Epilepsy’s Commission on Medical Therapies, including as Chair of the Task Force on Access to Medications; and most recently, joined the JICNA editorial board.
The ICNA’s focus on providing education and research opportunities for child neurologists globally with consideration of perspectives from all regions is central to my own career mission. Having seen the impact of child neurology exposure on places where subspecialty expertise is scarce, I have a strong understanding of the needs and potential for improvement in these regions. In Zambia, the field is exponentially growing since graduation of the first local neurologists; in Rwanda, there has been significant improvement in caring for children with neurologic needs with inclusion of neurology education in the pediatric curriculum.
My experiences have highlighted the importance of bidirectional educational exchanges. Should I be elected to the board, I would work to continue to promote such exchanges through several avenues: (1) increasing opportunities for child neurologists from LMIC to see advanced diagnostics and treatments available in resource-rich countries for both experience as well as drive vision for advancing care locally; (2) fostering partnerships with pediatric associations in countries without child neurologists to provide both deeply needed clinical expertise and exposure and training opportunities for local clinicians; (3) expanding opportunities for trainees from high resourced countries to gain direct experience on the impact of resource limitations on children with neurological diseases and to encourage the consideration of global perspectives in research and development of policy and practice parameters; and (4) promoting and advocating for increased investment in research exchanges between higher and lower resourced regions which demonstrate principles of strong and fair partnerships, including building sustainable clinical and research capacity on the ground.
By assuring that these global clinical and research initiatives are appropriately collaborative and respectful of local healthcare needs and priorities, we can continue toward the important goal of achieving equity in child health.
Biosketch
Dr Charuta Joshi is board certified in pediatric neurology in both Canada and the United States, clinical neurophysiology (Canada) and epilepsy (United States). She graduated medical school from Grant Medical College, Mumbai in 1995 with high honors. She did her pediatric neurology training in New York Presbyterian Hospital and clinical neurophysiology fellowship at Childrens Hospital Michigan. This was followed by seven years in Canada where she practiced pediatric neurology/ epilepsy at the University of Manitoba, Childrens Hospital Winnipeg before returning to the United States. She is presently a Professor in Pediatric Neurology at University of Texas Southwestern, School of Medicine, Childrens Medical Centre Dallas and holds the Dr Roy D. and Ragan S Distinguished Chair in Pediatric Epilepsy.
She is the Program Director of Advanced EEG and Epilepsy Research Fellowship. She has worked in resource rich as well as resource limited countries and is interested in global health, developmental and epileptic encephalopathies, surgical and non -surgical therapy (ketogenic diet, neuromodulation) of medically intractable epilepsies.
She spoke at ICNA in 2018 (Mumbai) as co-chair of a parallel symposium on infantile spasms. In 2020 (San Diego), she co-chaired a symposium on telemedicine and global heath. In 2022 (Antalya Turkey), she will chair a breakfast symposium on EMAS. She has been an invited speaker for the Epilepsy Colloquium (India 2020- converted to zoom due to COVID), Brain Hour at the McMaster University and at local, regional and national educational congresses.
Dr Joshi is passionate about teaching and has received several awards for teaching(medical student and resident level). She wishes to teach globally. She has participated in the ICNTN webinar and serves on the international affairs committee of the Child Neurology Society. She has started discussions with Dr Edward Kija regarding setting up a curriculum for teaching in Tanzania.
Vision
I finished medical training in Mumbai – Grant Medical College -batch of 1989 and am board certified in pediatric neurology (Canada and USA), clinical neurophysiology (Canada), and epilepsy (USA). My main interests are in global health, developmental and epileptic encephalopathies, surgical and non -surgical therapy (ketogenic diet, neuromodulation) of medically intractable epilepsies. I have seen the scope of medical practice in both resource rich and resource poor areas of the world. While there are factors that cannot be changed in how medicine is practiced, I feel that increasing knowledge has the power to change attitudes and finally change practice of whichever field one might be in.
My goal is to take another step in the right direction for the global population of children with epilepsy through greater participation in ICNA. This could be achieved through greater number of seminars/ lectures done online. The seminars could either be directed towards specialists or towards generalists and the hope is that case-based teaching will help the general care of epilepsy patients in areas where the ratio of the patient to doctor is very low. During COVID lockdown, I was bolstered by the educational content on websites like AES and ILAE and hope that I can contribute to enriching the same for ICNA.
I would like to run for the position of treasurer along with my application to the executive board because I believe that sitting at the same table will allow greater participation and would also allow me to use my time more wisely due to the advice received from other members of the board. My work as a treasurer will be geared to towards assuring that ICNA remains financially stable to allow further growth in its activities to promote care for children with neurological disabilities worldwide.
Vision
I have had the privilege of serving on the Executive Board of ICNA since 2018 representing North America. During this time, I have chaired the ICNA Research Committee, served on the Finance and Nominations committees as well as the Scientific Committees for the 2020 and 2022 ICNA Meetings. I have a keen interest in enhancing collaboration between members of the international child neurology community and have had the privilege of visiting child colleagues in many regions of the globe. This alliance has allowed me to gain valuable insight on global delivery of care to children with neurological disorders, as well as opportunities to enhance collaboration for education and research amongst child neurology providers. My goals for the ICNA:
The COVID pandemic has challenged our traditional models of care delivery as well as education and research collaboration. ICNA has responded to this challenge by building outstanding educational and research content on ICNApedia, with key input from our junior members (FLICNA), which is readily accessible online to all members. Our Research committee has created on-line content on how to do research and designed a Research Methodology course, to be offered to attendees of the upcoming ICNA meeting in Antalya. We anticipate this work will facilitate international collaboration in child neurology research.
I would be honored to continue to serve on the ICNA Board.
Biosketch
Dr. Hannah Glass, MDCM, MAS (https://profiles.ucsf.edu/hannah.glass) is a Professor of Neurology, Pediatrics, and Epidemiology & Biostatistics at the University of California, San Francisco, where she leads clinical, research, and education programs in Neonatal Neurology. She is the founding co-director of the Neurointensive Care Nursery (NICN), and Director of Neonatal Critical Care Services at the UCSF Benioff Children's Hospital, as well as the director of the Neonatal Neurology Fellowship Program. Dr. Glass leads a robust research program that has received funding from the NIH, Patient Centered Outcomes Research Institute, March of Dimes, Cerebral Palsy Alliance, and the Pediatric Epilepsy Research Foundation to conduct research that uses advanced imaging and brain monitoring to predict outcomes following newborn brain injury.
She is co-PI of the Neonatal Seizure Registry (https://neonatalseizureregistry.ucsf.edu/), a ninecenter collaborative that has studied diagnosis, treatment, and outcomes of seizures in more than 1000 newborns since 2012. Dr. Glass earned a medical degree at McGill University in Montreal, Canada, and completed pediatrics training, a child neurology residency, and chief residency at the University of Calgary. She trained in Neonatal Neurology and earned a master's degree in clinical research at UCSF. She lives with her husband, six-year-old son and nine-year-old dog in beautiful Lafayette, California. When not working, she enjoys reading, hiking, and travel.
I have been a member of the ICNA since 2004 and have participated actively in the ICNCs since then. I have had the privilege to serve on the ICNA Executive Board since 2014 and Chaired the Constitution and Bylaws Committee from 2014 – 2018. During that time, the ICNA has grown substantially and I have had the pleasure of participating in a number of educational programs in low- and middle-resource settings. This, to me, is the most important mission of the ICNA. The impact of the COVID-19 pandemic has been to limit the opportunities for in-person educational programs, but the use of technology has allowed us to reimagine how these programs can occur virtually.
My vision for the ICNA in the next 4 years is to capitalize on more widespread use of video technology to foster the expansion of the ICNA community in the areas of education, clinical consultation, and research. The historical priorities of providing opportunities in low- and middle-resource settings and to younger members of our profession are my priorities as well. As a member of the 2022-2026 Executive Board, I would leverage my prior experiences in these areas and work with my colleagues to develop and expand opportunities in the areas of education and research. In particular, working to develop a platform for consultation and sharing of expertise on children with complex movement disorders will be a priority aim.
Jorge Vidaurre MD, FAES, FACNS
Director, Pediatric Clinical Neurophysiology
Program Director EEG laboratory
Nationwide Children’s Hospital - The Ohio State University
Dr. Vidaurre currently serves as Director of the Pediatric Clinical Neurophysiology Program and EEG Laboratory at Nationwide Children's Hospital - The Ohio State University Medical Center. He is the Chair of “International Affairs Committee” for the Child Neurology Society (CNS), Chair for the “Education Task Force” from the International League Against Epilepsy (ILAE)” and “International Education Advisor” for the International Child Neurology Association (ICNA).
Dr. Vidaurre actively serves in multiple national and international societies. His activities include: Chair of the “Global Health, Special Interest Group (SIG)” at the American Epilepsy Society (AES), Regional leader for Latin America, from ILAE “Global Task Force” and member of the “Executive Board and Education Committee” at the Ibero-American Child Neurology Association (AINP). He participates in the “Professional Development Mentorship Program” at the American Clinical Neurophysiology Society (ACNS) and “Fellow-Mentor Program” from AES. He also served as member of the AES “Scientific Program Committee” and ACNS “International”, “Clinical Research Committee”.
Dr. Vidaurre is board certified in Neurology with Special Qualifications in Child Neurology, Clinical Neurophysiology and Epilepsy. He completed his neurology training at State University of New York (SUNY) and epilepsy training at Montefiore Medical Center, Albert Einstein College of Medicine. After finishing his fellowship, he returned to Latin America and worked in El Salvador for three years, before accepting his current position at Nationwide Children’s Hospital. As a member of the “ILAE North American Commission”, he collaborated in the implementation of epilepsy surgical programs in El Salvador and continues to work in this project.
Dr. Vidaurre is greatly involved in work related to international outreach collaborative programs in the field of pediatric neurology and epilepsy. He has extensive experience in the planning of educational and training programs in poor- resource regions, fostering collaborative efforts between multiple national and international societies. He works with local leaders in different regions including Latin America, Caribbean, Africa, and Asia. He has organized numerous local and regional international symposia in different countries and joined collaborative efforts directed at building infrastructure, such as, establishment of EEG laboratories, donations of EEG machines and training of EEG technicians in low -income countries. As chair of the ILAE Education Task Force, he is working on a practical, interactive, basic EEG curriculum to be used in resource limited countries.
Dr. Vidaurre is the recipient of the 2022 “Arnold P. Gold Foundation Humanism award” form CNS. He has authored and published multiple peer-reviewed journal articles and book chapters. His research interests and publications are in the field of pediatric epilepsy, epileptic encephalopathies, quality improvement in status epilepticus, and global health. He is an advisor for the international National Institute of Health (NIH) grant “Center without walls grant on antiepileptogenesis in traumatic brain injury”.
Future Vision
Encourage active participation of young leaders from different world regions, especially low-income countries, in the planning of educational programs directed to improve the practice of child neurology in poor-resource areas.
Support specific educational and training programs (These programs include local/regional symposia and training workshops) based on local need assessment.
Stimulating research that is of benefit for resource-limited region. This includes fostering programs directed to mentor and support young investigators, especially researchers working in low-medium income countries
Strengthen collaborative efforts between ICNA , CNS to increase the number of educational programs and develop long term- self-sustainable international outreach programs and facilitate collaborative efforts with other local, regional, and international societies, such as International League Against Epilepsy (ILAE).
Facilitate building of infrastructure needed in poor resource areas, throughout collaboration between societies, academic institutions and nonprofit organizations
Creation of new initiatives to support training of primary care providers, working in regions with limited or no access to properly trained child neurologist and creating practice guidelines, which are applicable to the specific regions and can facilitate neurological care.
Continue to build online resources which can be used by members seeking educational material and websites that facilitate communication between members and local leaders
Develop collaborations with large academic medical centers, involved in training of child neurologists in poor-resource regions by strengthening their infrastructure and providing support with ongoing programs.
Promote collaboration of academic centers in high income countries to support training in poor resource settings
Karen L. Skjei, M.D. was inspired to pursue a career in medicine after witnessing the impact of limited access to medical care during her 2 years in the U.S. Peace Corps in the Dominican Republic. She attended medical school at the University of California, San Francisco, followed by a pediatric neurology residency at the Mayo Clinic in Minnesota. She then completed a 2-year fellowship in Clinical Neurophysiology/Epilepsy at the Children's Hospital of Philadelphia. She is active in health disparities research and founded/leads the Health Equity Committee of the Pediatric Epilepsy Research Consortium.
After serving in academic leadership positions for 10 years, Dr. Skjei chose to combat health disparities directly by setting up the first pediatric epilepsy practice in El Paso, Texas, a city of 850,000 with a single pediatric neurologist. Internationally she has given lectures in English and Spanish at regional education conferences organized by ICNA, the American Epilepsy Society and the American Academy of Neurology in Ecuador, Paraguay, India and the Sudan. She has been editor of the ICNA Journal Watch since its inception in 2019 and now serves as editor of the Journal Watch section of JICNA. She has been an active participant in Executive Board meetings for the past 2 years.
Dr. Skjei is a fellow of the AES and has published more than a dozen peer-reviewed articles and book chapters. She’s won major awards throughout her career including the UCSF Chancellor’s Award for Public Service, the Mayo Brother’s Distinguished Fellows Award at Mayo, and the Tower Award for Outstanding Faculty at the University of Texas-Austin. She founded the Epilepsy Fellowship at the University of Texas and has garnered several teaching awards. Her passion has inspired many trainees to pursue pediatric neurology and pediatric epilepsy and she continues to mentor trainee from the undergraduate level through fellowship.
There are great disparities in Pediatric Neurology training and specialty care across the globe. Through its international reach, ICNA is positioned to ameliorate some of these disparities. I believe ICNA’s priorities in the coming years should include:
1) Improving our understanding of the needs of our membership. This can be accomplished through a biannual membership renewal survey which I suggested at the most recent Executive Board Meeting and which was approved by the Board.
2) Focusing our educational efforts on practice-changing discoveries. I have assisted in this through the educational lectures I have given in India, the Sudan, and Latin America, and through founding an organized ICNA Journal Watch, which has now been incorporated as a section in JICNA
3) Promoting international networking so that we can assist each other on an individual scale. This is accomplished through our biannual meetings and through sub-organizations such as FLICNA and the ICNA committees. I believe this can be aided by providing opportunities to a broader pool of interested members to be actively involved in ICNA committees, ICNApaedia and other ICNA activities. These members and their areas of interest and talent will be identified through the biannual membership survey.
4) Expanding the reach of our communal knowledge through virtual Pediatric Neurology training and other in-person and online educational opportunities.
Phillip L. Pearl, M.D. is Director of Epilepsy and Clinical Neurophysiology at Boston Children’s Hospital and William G. Lennox Chair and Professor of Neurology at Harvard Medical School. Dr. Pearl, originally from Baltimore, attended Johns Hopkins University and Peabody Conservatory of Music and University of Maryland School of Medicine. He took his residency at Baylor College of Medicine in Houston and fellowship at Boston Children’s Hospital. He was Division Chief of Neurology at Children’s National Medical Center, Director of Neurology Education Programs, and Professor of Neurology, Pediatrics, and Music at the George Washington University School of Medicine until returning to Boston in January 2014. Dr. Pearl also is a faculty member of the Music and Health Institute at the Berklee College of Music in Boston.
Dr. Pearl served on the Neurology RRC of the ACGME for six years and was a principal author of the revised program requirements for training in child neurology in the US as well as for the epilepsy fellowship. He has been a member of examination writing committees of the ABPN for 20 years and served as an oral board examiner over 20 times.
His major research interest is inherited metabolic epilepsies with specific focus on disorders of GABA metabolism. His book, Inherited Metabolic Epilepsies, had a second edition published in 2018. He is an editor of Swaiman’s Pediatric Neurology. Dr. Pearl is Past President of the Professors of Child Neurology and the immediate Past President of the Child Neurology Society. He has authored over 220 peer-reviewed manuscripts and over 150 chapters and reviews, written or edited five books including one translated into Chinese and another into Japanese, and produced two musical CDs, the first of which debuted at Georgetown’s Blues Alley and supports the care of indigent children in the capital city, Washington, D.C.
On one hand, it was jarring to have had the “pandemic presidency” of the Child Neurology Society (CNS). Having looked forward to leading the CNS into the long anticipated 2020 combined meeting with ICNA, and then our 50th Anniversary 2021 meeting, we were instead thrust with rapid fire and unprecedented needs, e.g. changing the standard of care for infantile spasms, assembling telemedicine toolkits, responding to crises in institutional racism.
On the other hand, what was inspiring above all was to work with Jo Wilmshurst and Pratibha Singhi in organizing the ICNA-CNS conference, a true albeit virtual success that required rapid implementation of a unique e- format. Furthermore, I developed more connections with international colleagues, with an especially important new group consisting of the presidents of child neurology societies across the globe. I have had meaningful international experiences previously, from working in Romanian orphanages during the 1990s, including establishing an epilepsy clinic in an orphanage in Siret, Romania and bringing children to the US for care before a moratorium was placed there on international adoptions, to wonderful visits and lecturing at conferences throughout Europe, Asia, the Middle East, and South America.
These international experiences, now facilitated by our new electronic means to meet and communicate, have been eye opening and enlightening. While I hope the input of the Child Neurology Society and my experiences will be helpful to ICNA, it is me that has truly benefitted from widening my horizons and working on behalf of pediatric neurology globally to enhance our discipline and improve conditions for all of our practitioners and investigators and, above all, our mutual patients and their families. The current pandemic only proves our interdependence. It would be a special pleasure and honor to join the ICNA board and continue to work on behalf of pediatric neurology worldwide.
Rajesh Ramachandran Nair, MD,FRCP, FRCPCH,FRCPC is an Associate Professor at McMaster University and the Director of the Comprehensive Pediatric Epilepsy Program (CPEP) at McMaster Children’s Hospital (MCH), Canada.
Dr Ramachandran Nair is the Co-Program Director of the International Child Neurology Teaching Network (ICNTN) of the ICNA. He initiated the ICNTN grandrounds in early 2021, providing the membership with the oppurtunity to interect with experts in child neurology worldwide. Dr Ramachandran Nair and team is develeoping a comprehensive learning module based certificate program in Pediatric Neurology. Dr. Ramachandran Nair leads the creation of the epilepsy module. His team will be presenting a symposium on ICNTN at the ICNC 2022, Turkey.
In 2020, Dr. Ramachandran Nair established the Canadian Epilepsy Teaching Network (CETN) the Canadian league Against Epilepsy (CLAE0.. In addition to monthly webinars CETN also started an EEG teaching course for neurology trainees. Dr. Ramachandran Nair started the weekly McMaster Pediatric Neurology Rounds “Brain Hour” in 2007, which are now attended (virtually) by an international audience. In 2012, he helped to develop the accredited EEG training program for EEG technologists. In 2017, he was awarded the McMaster Pediatric Neurology teaching award. Dr. Ramachandran Nair started the first epilepsy monitoring unit (EMU) at MCH in 2008, and developed CPEP in 2014. He was an active member of the Provincial Epilepsy Task Force.
Dr Ramachandran Nair was the co-Chair of the committee that drafted the Provincial Guidelines for the Management of Epilepsy. He was an invited member of the SUDEP Task Force of the AES, and a board member of the Canadian Association of Child Neurologists (3 years) He is a member of the scientific program committee of the AES. He is funded by the Ontario Brain Institute, Hamilton Health Sciences Foundation, Innovation Fund of the Academic Health Sciences by the Ministry of Health, and SUDEP Aware. To date he has authored over 50 peer reviewed journal articles, 4 book chapters and numerous conference abstracts. His publications on SUDEP communication with patients are widely cited by healthcare professionals, in conferences and in professional guidelines about SUDEP.
ICNA should continue to function as the primary global professional organization of child neurology clinicians that advocates and facilitates quality, comprehensive and optimal clinical care for children with neurological diseases worldwide at the right time and at the right place. This can be achieved through fruitful collaboration with regional child neurology professional organizations, global membership campaign, and working with child neurology patient advocacy groups. As the co-program director of ICNA’s Child Neurology Teaching Network (ICNTN), my major goal will be around education.
From the earliest stages of my career, I have been committed to improving access to appropriate neurologic care for children in resource-constrained regions. As a pediatric neurologist and epileptologist at Boston Children’s Hospital, I lead our department’s global health efforts, including trainee education focused on global perspectives of pediatric neurologic conditions and how to work effectively and ethically in limited resource regions. For over a decade, I have worked in Africa, currently spending over 4 months in the region annually focused on: (1) clinical neurology education and infrastructure development in Rwanda and Zambia, and (2) collaborative clinical research focused on early identification and management of children with epilepsy.
In Zambia, I have been deeply involved in training the first Zambian child neurologists, teaching neurology to pediatric residents and non-specialists across the country and promoting epilepsy advocacy through community health worker initiatives. Through the Human Resources for Health Program in Rwanda, I developed and implemented a child neurology curriculum for pediatric trainees, and continue to provide clinical, education, and research support for young pediatricians as a visiting consultant, with a focus on nurturing interest in our field as the country currently has no child neurologist. My current research is focused on identifying predictive factors for post-malaria epilepsy, with the goal of improving early identification of epilepsy in the highest risk children.
I am active in the global neurology community through several mechanisms that allow me to promote practice and policy change focused on health equity and access to care. I have served as an active consultant with the World Health Organization since 2015. I also serve on the Lancet Commission on Epilepsy; the International League Against Epilepsy’s Commission on Medical Therapies, including as Chair of the Task Force on Access to Medications; and most recently, joined the JICNA editorial board.
The ICNA’s focus on providing education and research opportunities for child neurologists globally with consideration of perspectives from all regions is central to my own career mission. Having seen the impact of child neurology exposure on places where subspecialty expertise is scarce, I have a strong understanding of the needs and potential for improvement in these regions. In Zambia, the field is exponentially growing since graduation of the first local neurologists; in Rwanda, there has been significant improvement in caring for children with neurologic needs with inclusion of neurology education in the pediatric curriculum.
My experiences have highlighted the importance of bidirectional educational exchanges. Should I be elected to the board, I would work to continue to promote such exchanges through several avenues: (1) increasing opportunities for child neurologists from LMIC to see advanced diagnostics and treatments available in resource-rich countries for both experience as well as drive vision for advancing care locally; (2) fostering partnerships with pediatric associations in countries without child neurologists to provide both deeply needed clinical expertise and exposure and training opportunities for local clinicians; (3) expanding opportunities for trainees from high resourced countries to gain direct experience on the impact of resource limitations on children with neurological diseases and to encourage the consideration of global perspectives in research and development of policy and practice parameters; and (4) promoting and advocating for increased investment in research exchanges between higher and lower resourced regions which demonstrate principles of strong and fair partnerships, including building sustainable clinical and research capacity on the ground.
By assuring that these global clinical and research initiatives are appropriately collaborative and respectful of local healthcare needs and priorities, we can continue toward the important goal of achieving equity in child health.
Biosketch
Dr Charuta Joshi is board certified in pediatric neurology in both Canada and the United States, clinical neurophysiology (Canada) and epilepsy (United States). She graduated medical school from Grant Medical College, Mumbai in 1995 with high honors. She did her pediatric neurology training in New York Presbyterian Hospital and clinical neurophysiology fellowship at Childrens Hospital Michigan. This was followed by seven years in Canada where she practiced pediatric neurology/ epilepsy at the University of Manitoba, Childrens Hospital Winnipeg before returning to the United States. She is presently a Professor in Pediatric Neurology at University of Texas Southwestern, School of Medicine, Childrens Medical Centre Dallas and holds the Dr Roy D. and Ragan S Distinguished Chair in Pediatric Epilepsy.
She is the Program Director of Advanced EEG and Epilepsy Research Fellowship. She has worked in resource rich as well as resource limited countries and is interested in global health, developmental and epileptic encephalopathies, surgical and non -surgical therapy (ketogenic diet, neuromodulation) of medically intractable epilepsies.
She spoke at ICNA in 2018 (Mumbai) as co-chair of a parallel symposium on infantile spasms. In 2020 (San Diego), she co-chaired a symposium on telemedicine and global heath. In 2022 (Antalya Turkey), she will chair a breakfast symposium on EMAS. She has been an invited speaker for the Epilepsy Colloquium (India 2020- converted to zoom due to COVID), Brain Hour at the McMaster University and at local, regional and national educational congresses.
Dr Joshi is passionate about teaching and has received several awards for teaching(medical student and resident level). She wishes to teach globally. She has participated in the ICNTN webinar and serves on the international affairs committee of the Child Neurology Society. She has started discussions with Dr Edward Kija regarding setting up a curriculum for teaching in Tanzania.
Vision
I finished medical training in Mumbai – Grant Medical College -batch of 1989 and am board certified in pediatric neurology (Canada and USA), clinical neurophysiology (Canada), and epilepsy (USA). My main interests are in global health, developmental and epileptic encephalopathies, surgical and non -surgical therapy (ketogenic diet, neuromodulation) of medically intractable epilepsies. I have seen the scope of medical practice in both resource rich and resource poor areas of the world. While there are factors that cannot be changed in how medicine is practiced, I feel that increasing knowledge has the power to change attitudes and finally change practice of whichever field one might be in.
My goal is to take another step in the right direction for the global population of children with epilepsy through greater participation in ICNA. This could be achieved through greater number of seminars/ lectures done online. The seminars could either be directed towards specialists or towards generalists and the hope is that case-based teaching will help the general care of epilepsy patients in areas where the ratio of the patient to doctor is very low. During COVID lockdown, I was bolstered by the educational content on websites like AES and ILAE and hope that I can contribute to enriching the same for ICNA.
I would like to run for the position of treasurer along with my application to the executive board because I believe that sitting at the same table will allow greater participation and would also allow me to use my time more wisely due to the advice received from other members of the board. My work as a treasurer will be geared to towards assuring that ICNA remains financially stable to allow further growth in its activities to promote care for children with neurological disabilities worldwide.
Vision
I have had the privilege of serving on the Executive Board of ICNA since 2018 representing North America. During this time, I have chaired the ICNA Research Committee, served on the Finance and Nominations committees as well as the Scientific Committees for the 2020 and 2022 ICNA Meetings. I have a keen interest in enhancing collaboration between members of the international child neurology community and have had the privilege of visiting child colleagues in many regions of the globe. This alliance has allowed me to gain valuable insight on global delivery of care to children with neurological disorders, as well as opportunities to enhance collaboration for education and research amongst child neurology providers. My goals for the ICNA:
The COVID pandemic has challenged our traditional models of care delivery as well as education and research collaboration. ICNA has responded to this challenge by building outstanding educational and research content on ICNApedia, with key input from our junior members (FLICNA), which is readily accessible online to all members. Our Research committee has created on-line content on how to do research and designed a Research Methodology course, to be offered to attendees of the upcoming ICNA meeting in Antalya. We anticipate this work will facilitate international collaboration in child neurology research.
I would be honored to continue to serve on the ICNA Board.
Biosketch
Dr. Hannah Glass, MDCM, MAS (https://profiles.ucsf.edu/hannah.glass) is a Professor of Neurology, Pediatrics, and Epidemiology & Biostatistics at the University of California, San Francisco, where she leads clinical, research, and education programs in Neonatal Neurology. She is the founding co-director of the Neurointensive Care Nursery (NICN), and Director of Neonatal Critical Care Services at the UCSF Benioff Children's Hospital, as well as the director of the Neonatal Neurology Fellowship Program. Dr. Glass leads a robust research program that has received funding from the NIH, Patient Centered Outcomes Research Institute, March of Dimes, Cerebral Palsy Alliance, and the Pediatric Epilepsy Research Foundation to conduct research that uses advanced imaging and brain monitoring to predict outcomes following newborn brain injury.
She is co-PI of the Neonatal Seizure Registry (https://neonatalseizureregistry.ucsf.edu/), a ninecenter collaborative that has studied diagnosis, treatment, and outcomes of seizures in more than 1000 newborns since 2012. Dr. Glass earned a medical degree at McGill University in Montreal, Canada, and completed pediatrics training, a child neurology residency, and chief residency at the University of Calgary. She trained in Neonatal Neurology and earned a master's degree in clinical research at UCSF. She lives with her husband, six-year-old son and nine-year-old dog in beautiful Lafayette, California. When not working, she enjoys reading, hiking, and travel.
I have been a member of the ICNA since 2004 and have participated actively in the ICNCs since then. I have had the privilege to serve on the ICNA Executive Board since 2014 and Chaired the Constitution and Bylaws Committee from 2014 – 2018. During that time, the ICNA has grown substantially and I have had the pleasure of participating in a number of educational programs in low- and middle-resource settings. This, to me, is the most important mission of the ICNA. The impact of the COVID-19 pandemic has been to limit the opportunities for in-person educational programs, but the use of technology has allowed us to reimagine how these programs can occur virtually.
My vision for the ICNA in the next 4 years is to capitalize on more widespread use of video technology to foster the expansion of the ICNA community in the areas of education, clinical consultation, and research. The historical priorities of providing opportunities in low- and middle-resource settings and to younger members of our profession are my priorities as well. As a member of the 2022-2026 Executive Board, I would leverage my prior experiences in these areas and work with my colleagues to develop and expand opportunities in the areas of education and research. In particular, working to develop a platform for consultation and sharing of expertise on children with complex movement disorders will be a priority aim.
Jorge Vidaurre MD, FAES, FACNS
Director, Pediatric Clinical Neurophysiology
Program Director EEG laboratory
Nationwide Children’s Hospital - The Ohio State University
Dr. Vidaurre currently serves as Director of the Pediatric Clinical Neurophysiology Program and EEG Laboratory at Nationwide Children's Hospital - The Ohio State University Medical Center. He is the Chair of “International Affairs Committee” for the Child Neurology Society (CNS), Chair for the “Education Task Force” from the International League Against Epilepsy (ILAE)” and “International Education Advisor” for the International Child Neurology Association (ICNA).
Dr. Vidaurre actively serves in multiple national and international societies. His activities include: Chair of the “Global Health, Special Interest Group (SIG)” at the American Epilepsy Society (AES), Regional leader for Latin America, from ILAE “Global Task Force” and member of the “Executive Board and Education Committee” at the Ibero-American Child Neurology Association (AINP). He participates in the “Professional Development Mentorship Program” at the American Clinical Neurophysiology Society (ACNS) and “Fellow-Mentor Program” from AES. He also served as member of the AES “Scientific Program Committee” and ACNS “International”, “Clinical Research Committee”.
Dr. Vidaurre is board certified in Neurology with Special Qualifications in Child Neurology, Clinical Neurophysiology and Epilepsy. He completed his neurology training at State University of New York (SUNY) and epilepsy training at Montefiore Medical Center, Albert Einstein College of Medicine. After finishing his fellowship, he returned to Latin America and worked in El Salvador for three years, before accepting his current position at Nationwide Children’s Hospital. As a member of the “ILAE North American Commission”, he collaborated in the implementation of epilepsy surgical programs in El Salvador and continues to work in this project.
Dr. Vidaurre is greatly involved in work related to international outreach collaborative programs in the field of pediatric neurology and epilepsy. He has extensive experience in the planning of educational and training programs in poor- resource regions, fostering collaborative efforts between multiple national and international societies. He works with local leaders in different regions including Latin America, Caribbean, Africa, and Asia. He has organized numerous local and regional international symposia in different countries and joined collaborative efforts directed at building infrastructure, such as, establishment of EEG laboratories, donations of EEG machines and training of EEG technicians in low -income countries. As chair of the ILAE Education Task Force, he is working on a practical, interactive, basic EEG curriculum to be used in resource limited countries.
Dr. Vidaurre is the recipient of the 2022 “Arnold P. Gold Foundation Humanism award” form CNS. He has authored and published multiple peer-reviewed journal articles and book chapters. His research interests and publications are in the field of pediatric epilepsy, epileptic encephalopathies, quality improvement in status epilepticus, and global health. He is an advisor for the international National Institute of Health (NIH) grant “Center without walls grant on antiepileptogenesis in traumatic brain injury”.
Future Vision
Encourage active participation of young leaders from different world regions, especially low-income countries, in the planning of educational programs directed to improve the practice of child neurology in poor-resource areas.
Support specific educational and training programs (These programs include local/regional symposia and training workshops) based on local need assessment.
Stimulating research that is of benefit for resource-limited region. This includes fostering programs directed to mentor and support young investigators, especially researchers working in low-medium income countries
Strengthen collaborative efforts between ICNA , CNS to increase the number of educational programs and develop long term- self-sustainable international outreach programs and facilitate collaborative efforts with other local, regional, and international societies, such as International League Against Epilepsy (ILAE).
Facilitate building of infrastructure needed in poor resource areas, throughout collaboration between societies, academic institutions and nonprofit organizations
Creation of new initiatives to support training of primary care providers, working in regions with limited or no access to properly trained child neurologist and creating practice guidelines, which are applicable to the specific regions and can facilitate neurological care.
Continue to build online resources which can be used by members seeking educational material and websites that facilitate communication between members and local leaders
Develop collaborations with large academic medical centers, involved in training of child neurologists in poor-resource regions by strengthening their infrastructure and providing support with ongoing programs.
Promote collaboration of academic centers in high income countries to support training in poor resource settings
Karen L. Skjei, M.D. was inspired to pursue a career in medicine after witnessing the impact of limited access to medical care during her 2 years in the U.S. Peace Corps in the Dominican Republic. She attended medical school at the University of California, San Francisco, followed by a pediatric neurology residency at the Mayo Clinic in Minnesota. She then completed a 2-year fellowship in Clinical Neurophysiology/Epilepsy at the Children's Hospital of Philadelphia. She is active in health disparities research and founded/leads the Health Equity Committee of the Pediatric Epilepsy Research Consortium.
After serving in academic leadership positions for 10 years, Dr. Skjei chose to combat health disparities directly by setting up the first pediatric epilepsy practice in El Paso, Texas, a city of 850,000 with a single pediatric neurologist. Internationally she has given lectures in English and Spanish at regional education conferences organized by ICNA, the American Epilepsy Society and the American Academy of Neurology in Ecuador, Paraguay, India and the Sudan. She has been editor of the ICNA Journal Watch since its inception in 2019 and now serves as editor of the Journal Watch section of JICNA. She has been an active participant in Executive Board meetings for the past 2 years.
Dr. Skjei is a fellow of the AES and has published more than a dozen peer-reviewed articles and book chapters. She’s won major awards throughout her career including the UCSF Chancellor’s Award for Public Service, the Mayo Brother’s Distinguished Fellows Award at Mayo, and the Tower Award for Outstanding Faculty at the University of Texas-Austin. She founded the Epilepsy Fellowship at the University of Texas and has garnered several teaching awards. Her passion has inspired many trainees to pursue pediatric neurology and pediatric epilepsy and she continues to mentor trainee from the undergraduate level through fellowship.
There are great disparities in Pediatric Neurology training and specialty care across the globe. Through its international reach, ICNA is positioned to ameliorate some of these disparities. I believe ICNA’s priorities in the coming years should include:
1) Improving our understanding of the needs of our membership. This can be accomplished through a biannual membership renewal survey which I suggested at the most recent Executive Board Meeting and which was approved by the Board.
2) Focusing our educational efforts on practice-changing discoveries. I have assisted in this through the educational lectures I have given in India, the Sudan, and Latin America, and through founding an organized ICNA Journal Watch, which has now been incorporated as a section in JICNA
3) Promoting international networking so that we can assist each other on an individual scale. This is accomplished through our biannual meetings and through sub-organizations such as FLICNA and the ICNA committees. I believe this can be aided by providing opportunities to a broader pool of interested members to be actively involved in ICNA committees, ICNApaedia and other ICNA activities. These members and their areas of interest and talent will be identified through the biannual membership survey.
4) Expanding the reach of our communal knowledge through virtual Pediatric Neurology training and other in-person and online educational opportunities.
Phillip L. Pearl, M.D. is Director of Epilepsy and Clinical Neurophysiology at Boston Children’s Hospital and William G. Lennox Chair and Professor of Neurology at Harvard Medical School. Dr. Pearl, originally from Baltimore, attended Johns Hopkins University and Peabody Conservatory of Music and University of Maryland School of Medicine. He took his residency at Baylor College of Medicine in Houston and fellowship at Boston Children’s Hospital. He was Division Chief of Neurology at Children’s National Medical Center, Director of Neurology Education Programs, and Professor of Neurology, Pediatrics, and Music at the George Washington University School of Medicine until returning to Boston in January 2014. Dr. Pearl also is a faculty member of the Music and Health Institute at the Berklee College of Music in Boston.
Dr. Pearl served on the Neurology RRC of the ACGME for six years and was a principal author of the revised program requirements for training in child neurology in the US as well as for the epilepsy fellowship. He has been a member of examination writing committees of the ABPN for 20 years and served as an oral board examiner over 20 times.
His major research interest is inherited metabolic epilepsies with specific focus on disorders of GABA metabolism. His book, Inherited Metabolic Epilepsies, had a second edition published in 2018. He is an editor of Swaiman’s Pediatric Neurology. Dr. Pearl is Past President of the Professors of Child Neurology and the immediate Past President of the Child Neurology Society. He has authored over 220 peer-reviewed manuscripts and over 150 chapters and reviews, written or edited five books including one translated into Chinese and another into Japanese, and produced two musical CDs, the first of which debuted at Georgetown’s Blues Alley and supports the care of indigent children in the capital city, Washington, D.C.
On one hand, it was jarring to have had the “pandemic presidency” of the Child Neurology Society (CNS). Having looked forward to leading the CNS into the long anticipated 2020 combined meeting with ICNA, and then our 50th Anniversary 2021 meeting, we were instead thrust with rapid fire and unprecedented needs, e.g. changing the standard of care for infantile spasms, assembling telemedicine toolkits, responding to crises in institutional racism.
On the other hand, what was inspiring above all was to work with Jo Wilmshurst and Pratibha Singhi in organizing the ICNA-CNS conference, a true albeit virtual success that required rapid implementation of a unique e- format. Furthermore, I developed more connections with international colleagues, with an especially important new group consisting of the presidents of child neurology societies across the globe. I have had meaningful international experiences previously, from working in Romanian orphanages during the 1990s, including establishing an epilepsy clinic in an orphanage in Siret, Romania and bringing children to the US for care before a moratorium was placed there on international adoptions, to wonderful visits and lecturing at conferences throughout Europe, Asia, the Middle East, and South America.
These international experiences, now facilitated by our new electronic means to meet and communicate, have been eye opening and enlightening. While I hope the input of the Child Neurology Society and my experiences will be helpful to ICNA, it is me that has truly benefitted from widening my horizons and working on behalf of pediatric neurology globally to enhance our discipline and improve conditions for all of our practitioners and investigators and, above all, our mutual patients and their families. The current pandemic only proves our interdependence. It would be a special pleasure and honor to join the ICNA board and continue to work on behalf of pediatric neurology worldwide.
Rajesh Ramachandran Nair, MD,FRCP, FRCPCH,FRCPC is an Associate Professor at McMaster University and the Director of the Comprehensive Pediatric Epilepsy Program (CPEP) at McMaster Children’s Hospital (MCH), Canada.
Dr Ramachandran Nair is the Co-Program Director of the International Child Neurology Teaching Network (ICNTN) of the ICNA. He initiated the ICNTN grandrounds in early 2021, providing the membership with the oppurtunity to interect with experts in child neurology worldwide. Dr Ramachandran Nair and team is develeoping a comprehensive learning module based certificate program in Pediatric Neurology. Dr. Ramachandran Nair leads the creation of the epilepsy module. His team will be presenting a symposium on ICNTN at the ICNC 2022, Turkey.
In 2020, Dr. Ramachandran Nair established the Canadian Epilepsy Teaching Network (CETN) the Canadian league Against Epilepsy (CLAE0.. In addition to monthly webinars CETN also started an EEG teaching course for neurology trainees. Dr. Ramachandran Nair started the weekly McMaster Pediatric Neurology Rounds “Brain Hour” in 2007, which are now attended (virtually) by an international audience. In 2012, he helped to develop the accredited EEG training program for EEG technologists. In 2017, he was awarded the McMaster Pediatric Neurology teaching award. Dr. Ramachandran Nair started the first epilepsy monitoring unit (EMU) at MCH in 2008, and developed CPEP in 2014. He was an active member of the Provincial Epilepsy Task Force.
Dr Ramachandran Nair was the co-Chair of the committee that drafted the Provincial Guidelines for the Management of Epilepsy. He was an invited member of the SUDEP Task Force of the AES, and a board member of the Canadian Association of Child Neurologists (3 years) He is a member of the scientific program committee of the AES. He is funded by the Ontario Brain Institute, Hamilton Health Sciences Foundation, Innovation Fund of the Academic Health Sciences by the Ministry of Health, and SUDEP Aware. To date he has authored over 50 peer reviewed journal articles, 4 book chapters and numerous conference abstracts. His publications on SUDEP communication with patients are widely cited by healthcare professionals, in conferences and in professional guidelines about SUDEP.
ICNA should continue to function as the primary global professional organization of child neurology clinicians that advocates and facilitates quality, comprehensive and optimal clinical care for children with neurological diseases worldwide at the right time and at the right place. This can be achieved through fruitful collaboration with regional child neurology professional organizations, global membership campaign, and working with child neurology patient advocacy groups. As the co-program director of ICNA’s Child Neurology Teaching Network (ICNTN), my major goal will be around education.
Dr. Ana Carolina Coan is Associated Professor of Child Neurology of the Department of Neurology of the Campinas University – Unicamp, Campinas, Brazil. Dr. Coan is author of over 71 peer-reviewed original articles and reviews. Since 2000, she developed her research at the Neuroimaging Laboratory at UNICAMP focusing at the use of structural and functional MRI for the identification of biomarkers associated epilepsies phenotypes. Her studies described the network of cerebral gray and white matter abnormalities in distinct phenotypes of epilepsies.
Dr. Coan also studied the use of multimodal neuroimaging to improve the noninvasive pre-surgical evaluation of individuals with pharmacoresistant epilepsies and how they can accelerate and diminish the costs of this evaluation. Her current research focuses on the association of clinical phenotypes and brain structural and functional abnormalities of different epileptic syndromes and their impact on brain development. At Unicamp, she is involved in teaching both undergraduates, residents and post-graduates. She supervised 9 master and doctoral thesis. She supervise the general child neurology and epilepsy outpatient clinics as well as the pediatric video-EEG and epilepsy surgery program of the Clinical Hospital of Unicamp. She has dedicated to translating and teaching PET (Pediatric Epilepsy Training) courses in Brazil.
Dr. Coan is an associated researcher of the Brazilian Institute of Neuroscience and Neurotechnlogy - BRAINN. She is currently the vice president of the Brazilian Society of Child Neurology (SBNI) and the representative of child neurology of the Education Commission of the Brazilian Academy of Neurology (ABN). She is also member of the Executive Board of the International Child Neurology Association (ICNA).
My vision is that ICNA should be a reference for worldwide education of pediatric neurologists as well as a society engaged in contributing to achieve high quality, efficient and humanistic health care services for children and adolescents according to the specific needs of each country. I believe I can contribute to maintain and expand the important work of ICNA worldwide. I believe ICNA should guarantee continuous worldwide education of pediatric neurologists according to the reality and needs of each different country. This educational approach was significantly expanded with the improvement of online contents in the last two years. I believe I can contribute to improve the access to the educational content for the Latin America and other countries of Portuguese languages.
The translation and teaching o PET (Paediatric Epilepsy Training) is an example of success in this area. By removing the language barrier, the PET course was accessible to different countries in the South America and Africa. A second important role of ICNA in my view is to contribute to advance research in different areas of child neurology. Through proposals such as the Connectome project ICNA can help to improve multicenter studies initiatives.
The Connectome project it could be expanded through partnerships and possible funding from national societies. As a professor of one of the most important Brazilian universities, I have access to government personal and it also puts me in contact with healthy professionals of the different facilities in Brazil. Being a university professor also facilitates my contact with international professionals. I have been working with different international consortiums of child epilepsy education, including an online Latin American course for primary physicians.
Dr Anaita Udwadia-Hegde, Pediatric Neurologist, Mumbai, India. -Director of Neurosciences, SRCC Narayana Children’s Hospital & Honorary Consultant at the Jaslok Hospital & Research Centre & Wadia Children’s Hospital. -President of the Association of Child Neurology-India (AOCN-India)2021-2023. -Elected, Executive Board Member of the International Child Neurology Association, ICNA, 2018-2022, Lead of Education.
In the 4 years with ICNA, learnt alot regards the situation & needs of child neurology in different regions of the world. We have helped support with personnel, ideas, funds and or collaboration, national child neurology bodies and passionate professionals keen to improve the situation in their country.
Helped conceive the Global Regional Initiative Program -GRIP, a collaborative effort to upskill child neurology worldwide. Here ICNA with other international child neurology associations such as CNS, EPNS, etc plan to fund & support an upskilling regional project for 2 years.
The ICNA educational activities, inspite of COVID have been amazing. Numerous National associations have been endorsed by ICNA. Cross continent teaching programs and the ICNTN has been a run-away success.
As President of the AOCN-India, have created active verticals with a thrust on education, research, advocacy, outreach, finance, website and offbeat. Focus is to connect, empower, increase and enhance the child neurology fraternity in our country.
But my passion, is my work in rural Maharashtra. Founded the Rural Child Neurology Program, in 2010. Conduct camps quarterly. We treat, give holistic, multidisciplinary & nutritional care to over 800 children with neurological problems at each camp, & focus on parent education. During COVID, we were able to support the children with medication and virtual consults. I do believe that corrective measures in the critical first few years of a child’s development, have maximum benefits on mental and developmental growth
Having completed a term on the Executive board, I have had the opportunity to learn and see how the ICNA works in all regions of the world. As Lead of Education, ICNA, the pandemic made us move from conventional academic programs to the beauty of the virtual world. Change in educational methods, structure, platforms, has made us all closer, connected and made travel dispensable in the pursuit of education.
Dr. Hasan Tekgül was born in Gümülcine-Greece, in 1964. He migrated with his family to the west part of Turkey, Izmir, in 1974. Dr. H. Tekgül graduated from the University of Ege, Izmir, Turkey in 1986. Dr. Tekgül began his career in pediatrics in 1992, then as a pediatric neurologist in 1994, and as an associate professor in 1998. In 2000, he was awarded a grant by the Turkish Scientific Research Council, Research Fellowship at Harvard University. He studied neonatal neurology with Joseph Volpe and neonatal EEG with Gregory Holmes and Blaise Bourgeois between 2000-2002 at Children’s Hospital Boston.
Dr. Tekgül also spent three months in Cleveland Clinics, Ohio, for a three-month EEG course. He returned in 2002 to set up a pediatric clinical neurophysiology lab for the comprehensive diagnostic evaluation and treatment of children and adolescents with epilepsy at Ege University Hospital. Dr. Hasan Tekgül took up the position as Professor of Pediatric Neurology at the University of Ege, in 2003. His clinical sub-specialties are Neonatal Neurology, Developmental Neurology, Pediatric Epilepsy, and Pediatric Clinical Neurophysiology (EEG Monitoring, EMG, and Transcranial Magnetic Stimulation-TMS). He has designed and tested a reduced electrode EEG montage for neonatal EEG monitoring. He has also contributed to seminal research on biomarkers of epileptogenesis and neuronal plasticity in the developing brain with TMS. His current projects include genetic characterization of developmental epileptic encephalopathies, new EEG modalities for neonatal seizures in neonatal intensive care units.
Dr. Hasan Tekgül has 166 original research publications (103 in international journals and 63 national journals) and numerous book chapters. He has presented her research at international meetings but also supports global educational programs, with a particular focus on national EEG courses ( basic EEG: 12, and advanced EEG:11) and EMG courses.
Current Position:
Other Relevant Positions:
Conflict of Interest I have provided consulting services to UCB, Sanofi, Novartis, Nutricia, Abbot, and Nestle. I received lecture fees and professional travel accommodations from UCB, Sanofi, Novartis, Nutricia, Abbot, and Nestle.
ICNA is a golden synapsis between health professionals to advance knowledge, education, facilitation, and sharing resources in field of neuroscience and reach children across the world.
I have been a member of ICNA since 2005 and have attended ICNA meetings. I have worked over the past fifteen years to establish international collaborations. I have trained residents and fellows from Cyprus, Azerbaijan, and Iran.
I have attended four educational meetings as an ICNA speaker: Colombus, Sri Lanka (22-23 March 2014), Tebrise, Iran (13-15 Sep 2016), Cox-Bazar, Bangladesh (5-6 November, 20016), Chennai, India (Jan 2016).
I actively work in clinical and laboratory research on neonatal neurology, pediatric epilepsy, and pediatric clinical neurophysiology. I would like to share and contribute to the education of junior child neurologists. I can be actively involved in educational exchange programs, symposiums, workshops.
It would be an honor to be a member of the Executive Board of ICNA. If I have been nominated and elected to the EB of ICNA, I can contribute to international education activities and congresses.
Dr Rekha Mittal Additional Director ( Pediatric Neurology)
Madhukar Rainbow Children’s Hospital, New Delhi – 110017
Ph: 9958870028, Email: drrekhamittal2008@gmail.com
Professional experience
1988: Completed two years in - service training (from the Army ) in Pediatric Neurology from All India Institute of Medical Sciences, Delhi , in 1998.
1988-2010 : Worked as Pediatrician and later Pediatric Neurologist in Armed Forces, India.
Subsequently, practiced Pediatric Neurology in diverse medical set ups in different cities across India – from basic medical centres to the advanced Army Hospital Research and Referral, New Delhi.
2010 - present: Worked in different superspeciality hospitals in New Delhi. Presently with the Madhukar Rainbow Children’s Hospital, New Delhi, where I also see children from different countries, including the middle east, Africa, and Asia, and have some insight into challenges in Pediatric Neurology in these countries.
Social work
Ran a charitable centre for 5 years, where Pediatric Neurology services were provided free of cost to children from economically weaker families.
Organisational experience
A. Association of Child Neurology (AOCN):
Was one of the seven founding members of the AOCN, and subsequently, Secretary and President of the AOCN.
Was secretary/chairperson in the organization of 3 National Conferences of the AOCN
Initiated /organized and was part of, many educational activities of the AOCN like Continuing Medical Education/ similar programs.
During the Covid pandemic, which happened when I was president of AOCN, academic activities were continued online, with masterclasses, short courses, lectures for Pediatric / Pediatric Neurology Residents, General Pediatricians and Pediatric Neurologists.
Convened 3 important consensus statements for India : • Social and Legal Aspects of Childhood Epilepsy • Diagnosis and Management of Febrile Seizures • Diagnosis and Management of West Syndrome
As President, I was successful in getting approval from the National Board of Examinations in Medical Sciences (Government of India), for Pediatric Neurology as a subject for awarding a degree in this subject ( equivalent DM )
I have experience in practice of Pediatric Neurology under diverse medical setups and populations, and also organisational experience and success in different activities at a National Level in India.
1. Pediatric Neurology UPSKILLING AT EVERY LEVEL : from the ground upwards to the sky is the limit, can be achieved; it is the key for resource development.
The ICNA is a prestigious world body to which Pediatric Neurologists the world over seek membership and follow. As such, the body already has a leadership role in multiple areas of education, practice, advocacy and encouraging and awarding research in Pediatric Neurology at different levels. However, a footprint into Pediatric Neurology practice at the grassroots level can be expanded, in best interest of children requiring Pediatric Neurology services.
In a majority of developing countries with limited resources, the pediatric neurology practice is mostly by General Pediatricians. The Zimbabwe story on the ICNA website ( https://icnapedia.org/icna-zimbabwe-appeal ) is not limited to Zimbabwe; it is still the story of most countries.
The way forward would be :
2. Development of ICNA consensus statements/ guidelines on common neurological disorders for practice at differing levels of healthcare.
3. Recognition of Pediatric Neurology services by individuals in this field, beyond research. This would encourage Humanism and innovation in practice of Pediatric Neurology.
Prof Akhter is the Professor of Paediatric Neurology and Dean, Faculty of Paediatrics at Bangabandhu Sheikh Mujib Medical University (BSMMU), the only medical university in Bangladesh. She has been working for more than 22 years in Paediatric Neurology, Neurodevelopment, and Autism. She has taken an active role in developing and implementing the 'Paediatric Neurology and Neurodevelopment Residency Course' at BSMMU. She is actively engaged in patient management alongside clinical research and teaching commitments.
Prof Akhter is the Founder-Director of the Institute of Paediatric Neurodisorder and Autism (IPNA). IPNA is a pioneer institute that operates at the national level, providing comprehensive and tertiary-level services to children with neurodevelopmental disorders and autism. IPNA aims to consolidate research initiatives at the national and international level and organize national and international seminars and workshops to disseminate disability/autism-related knowledge and other essential skills to doctors, teachers, and parents. It also runs a model 'School for Children with Autism' by autism-expert teachers and their team, involving parents in managing children with disabilities. IPNA regularly organizes national and international training and seminars for paediatric neurologists, paediatricians, and other health professionals.
She is an active member of ICNA and, as IPNA head, she and her team had organized a two-day-long "ICNA Educational Meeting" at Cox's Bazar, Bangladesh, in 2016. The event hosted internationally reputed child neurology and child development scholars and focused on exchanging knowledge and best practices in Autism, Epilepsy, Movement Disorder, child development, CNS Infections, Cerebral Palsy Neurometabolism, and Neurodegenerative disorders.
Prof Akhter has also been working with the Bangladesh Non-communicable Disease Control Programme to develop tools for screening neurodevelopmental problems and ASD for community field workers in health care. Prof. Shaheen does not have any conflicts of interest to disclose.
During the pandemic, the ICNA’s continued role in creating a knowledge environment by providing education and training and engaging in research and advocacy was hugely beneficial for paediatric neurologists worldwide. We especially felt its positive impact in Bangladesh during the prolonged and continued lockdowns. I believe it is vital to build on these close connections and forge a deeper relationship based on learning and knowledge-sharing. I believe we can offer a unique perspective: of medical practitioners dealing with a vast number of healthcare seekers in low-resource settings.
More and more research is being conducted locally based on this context, especially since there are still certain infectious diseases that prevail in developing countries like Bangladesh, which struggle with providing care to a significant population with limited means. In Bangladesh, paediatric neurology is still a relatively new sub-specialty, but more and more doctors specialise in it. Integrating such understandings into a platform as huge as ICNA can enrich us in Bangladesh and bring diverse critical perspectives into the ICNA itself. Such representations can make crucial contributions to an ever-growing and increasingly diverse association in an ever globalizing and integrating world. Now more than ever, we need to improve systems to respond adeptly to the challenges children living with a neurologic condition face.
We need to work harder to create inclusive opportunities for all children and families to access and receive the quality of care they deserve. In this, each of us in the child neurology community has a role to play, and ICNA is already an integral actor in fulfilling this responsibility and disseminating scientific knowledge to empower regional healthcare delivery. I am committed to being a part of this journey and working to improve the lives of children with neurological disorders and neurodisability as a part of this worldwide neurology community.
Professor Sheffali Gulati: trained/working at All India Institute of Medical Sciences, New Delhi. Part of the team which started first DM Pediatric Neurology Program in South Asia (2004), Program Director (2008-). Contributed towards establishing Pediatric Neurology programs across India/SAARC countries.
Over 25 years experience, has developed Pediatric Neurology in India as a specialty- academics, clinical care, patient empowerment, research, advocacy and public health domains. National/International awards(Over 25)- First India recipient, Sheila Wallace Award(ICNA)2014, National Award for Science & Technology communication 2021; Fellowship Award, McGill University 2006,ICNA 2010. Fellow, Royal College of Pediatrics and Child Health, UK; Fellow, National Academy of Medical Sciences/Indian Academy of Pediatrics/International Medical Science Academy.
Envisioned, conceptualized and heading Centre of Excellence and Advanced Research for Childhood Neurodevelopmental Disorders (2017-): high quality care, high end research, education hub(www.pedneuroaiims.org), National registry and National Child Neurology telehelpline/ consultation (24X7; toll free) .
Over 365 research publications (NEJM, JAMA pediatrics), Citations: 5094; h-Index 34; i10-index 125; Highest IF: 91.245, Maximum citations:316.Research projects leading to innovations/advocacy (NIH/Autism speaks/MRC,UK/ AIIMS-UCL): Neurodevelopmental disorders including Screening/Diagnostic Instruments(National programs; Mobile app PedneuroaiimsDiagnostics: google/ios) Drug refractory epilepsy including dietary therapies, Autism spectrum disorders, Cerebral palsy, SLD, Neuromuscular disorders/neurorehabilitation
Scientific associations International Society for Autism Research-Global Senior Leader (2021-); Association of Child Neurology, India- Founder member (2002); President elect (2023-2025); Academy of Paediatric Neurology, Indian Academy of Paediatrics- Chairperson (2021); National Convenor-Guidelines (2022), Indian Epilepsy Society(National body of ILAE): Co-convenor Paediatric section; Executive Board Member; Indian Academy of Neurology- Curriculum review / Guidelines development committee Member, Advisory board, ICNC 2018; Member, Advisory Board, ICNTN; Coordinator, Neurodevelopmental disorders module, organized “PediatricNeurogenomics” webinar series with ICNTN collaboration.
Has been instrumental in transforming care for children with neurodevelopmental disorders across India and her contributions in the field of epilepsy, autism and other neurodevelopmental disorders are unmatched CV summary: https://drive.google.com/file/d/12q3y8JIYWazVSCxrUc74rB60C4t7jWv9/view?usp=sharing
My vision for ICNA is for it to be a premier association for paediatric neurologists globally promoting the highest quality patient centered care for children with neurological disorders and neuro-disability and supporting the professional development of the members.
The association should focus on the trinity of clinical care, academics and research and to
Viraj Sanghi is a consultant paediatric neurologist at the SRCC Children’s Hospital and the KEM hospital and GS Medical College in Mumbai with a keen interest in paediatric stroke, neuromuscular disorders and palliative care.
He received his MBBS and MD degrees from Grant Medical College in Mumbai, India and subsequently received the Diplomate of the National Board in Neurology in 2002. He went on to obtain his fellowship in Paediatric Neurology from SickKids, Toronto. Recently he completed certification in Palliative care from Harvard Medical School, Boston.
Over the past 22 years he has been passionate about and closely involved in ethical and holistic care as well as rehabilitation of children and currently serves the Rehabilitation committee as well as the Ethics committees at the SRCC Children’s Hospital in Mumbai. He is also instrumental in establishing the Family Centred Care programme and setting up a paediatric Palliative Care programme at the hospital. He is an enthusiastic teacher and has conducted several education programmes for fellows, residents, neurologists, community paediatricians and other healthcare workers. Additionally, he has also uses his administrative skills to organize and serves as faculty in several Regional, National and International conferences including the ICNC 2018 which was held in Mumbai. As a Trustee of Neurology Foundation, a charitable organization based in Mumbai, he is involved in fund raising and philanthropic activities for the underprivileged sector of society. He is currently on the ICNA Executive Board and is committed to serving the organization to help achieve its mission and goals.
In his spare time, away from the hospital and his work, Viraj enjoys spending time with his wife and two daughters, adorable black Labrador, reading, working out and watching Netflix! He is an avid traveler and loves to explore different cultures and cuisines across the globe.
ICNA is a global community of individuals who share the philosophy of providing high quality neurological healthcare for children from all regions of the world. We come together on a common platform with the intent of decreasing the burden of disease. Towards this common goal we must strive to achieve the following:
Grow the paediatric neurology workforce, especially in resource limited regions, with an unwavering commitment to excellence in education. We must continue to provide cutting-edge academic programs that promote the intellectual and ethical growth of students, residents and fellows through in-person as well as online models of academic programmes.
Expand and support paediatric neuroscience Research and encourage and support young researchers in this regard.
Develop standardized protocols and clinical algorithms that can promote highest levels of care and yet be applicable to those with limited financial means.
Provide a network that allows for free exchange of ideas and communication towards the promotion of high quality patient care and better outcomes. This would include mentorship programmes for residents and neurologists in early stages of their careers to help foster a sense of support.
Attain financial growth and sustainability for the organisation and yet continue to provide low cost resources for those regions that need financial support.
Continue the development and promotion of JICNA and other educational activities already in place.
Advocate for patients and care givers with policymakers and form partnerships with other societies, the government and community.
8.Uphold the values, ethics and integrity of ICNA and integrate professional education with humanistic, scientific and social learning.
I remain committed to the core principles of ICNA and would be honoured to continue to serve the board.
Vrajesh Udani completed his medical training at the prestigious Grant Medical college Mumbai, India with honours. He trained in Child Neurology and Clinical Neurophysiology at the State University of New York, Brooklyn. After board certification he returned to Mumbai and set up one of the first Child Neurology services in India at the PD Hinduja National Hospital. A sabbatical year at the Miami Children’s Hospital enabled him to set up an active epilepsy surgery program. He further started an active teaching program at two public teaching institutions. Several child neurologists have trained under him in India.
His clinical and research interests have spanned several areas. He was part of the first international RCT studying the use of interferon in SSPE. He co-authored original clinical and genetic descriptions of MLC with subcortical cysts and PKAN in the Agrawal community in India. The link between infantile epilepsy and neonatal hypoglycemic brain injury was explored and has emerged as one of the commonest etiologies of drug-resistant epilepsy in the developing world. Long-term outcome studies in drug resistant epilepsy and autistic spectrum disorders have highlighted what happens in resource-poor setting. Recent research interests have been autoimmune encephalitis and MOG associated disorders.
He has published > 80 papers in peer-reviewed journals and 25 chapters in textbooks. He has served on expert consensus groups including the ILAE Pediatric Epilepsy Surgery task force and the ILAE Nosology Commission Syndrome Definitions.
He was the organizing chairperson of the International Child Neurology Congress in Mumbai in 2018 which was rated highly by most members. He is a member on the ICNA nominating committee for the last 4 years. He has served the Indian neurology community as President of the Association of Child Neurology-India and Chairman of the Pediatric Neurology subsection of the Indian Academy of Neurology.
He has lectured extensively in national and international meetings and given several prestigious orations.
A few initial thoughts about the state of world child neurology and what my goals would be if elected to the executive board
1) Though the burden of childhood neurological disease is high in the developing world, access to even basic child neurologic services is sorely lacking. This is primarily due to the lack of organized training in many parts of the world. The ICNA has been fairly successful in the continuing medical educational activities tried with regular physical and online teaching programs but a lot more needs to be done.
2) We probably have the highest numbers of rare disorders in child neurology. This makes it a challenge to study these diseases. We need international registries to be set up so to help increase our collective knowledge which would help our patients in the long run.
3) Access to advanced testing is a still a major hurdle in diagnosing rare disorders in many parts of the world due to cost / availability issues.
4) Finally novel therapies are rapidly gaining ground in different disorders. However, these are extraordinarily expensive and out of reach for most of the world. The ICNA is in a unique position in bridging these gaps with its reach across the world and its rapidly expanding membership.
I propose to help
1) Expand educational initiatives in parts of the world needing them most using not only world-renowned speakers but local experts as well
2) Establish registries to help study the epidemiology & natural history of rare disorders
3) Make available lists of where advanced genetic /immunologic tests can be done at reasonable rates
4) Use the good offices of ICNA to lobby the pharmaceutical industry to reduce costs and increase access to expensive medications
257 Childhood Frontal Lobe Epilepsies: Etiology, Classification, and EEG Findings
Salih Akbaş, Ebru Arhan, Irem Yildirim, Aslı Akyol, Gokhan Kurt, Murat Ucar, Lütfiye Ozlem Atay, Ümit Ozgur Akdemir, Nazlı Balcan Karaca, Esra Serdaroğlu, Ercan Demir, Tugba Hırfanoglu
651 Evaluation of Childhood Epilepsies with Frontal Paroxysm
Meryem Ozdemir, Elif Karatoprak, Hatice Gulhan Sozen, Kutluhan Yılmaz
248 Hand Postures and Localization Value in Patients at Video EEG Monitorization
Deniz Menderes, Esra Serdaroglu, Ayse Serdaroglu, Tugba Hirfanoglu, Ebru Arhan
379 Ictal Nose Wiping in Frontal-Onset Absence Epilepsy; A case report
FATMA KUSGOZ, IRMAK ERDOGAN, NIHAL OLGAC DUNDAR, PINAR GENCPINAR
113 Opercular syndrome due to Herpes Encephalitis
Sevgi Yimenicioglu, Nur Badak, Vural Fidan, Arzu Ekici
293 Electro-clinical spectrum of Absence epilepsy: A case series from India
Romit Jain, Ramesh Konanki, Sagar Sukapatla, Dashratha Ramiah, Lokesh Lingappa
617 Evaluation of periodic slow head nodding seizure
Eiji Nakagawa
683 Pathogenesis of nodding syndrome; Preliminary findings
Richard Idro, Maria Pia Giannocaro, Angela Vincent
614 Vermian dysplasia and lipoma in a child with headache and epileptic seizure
Senay Demir, Semra Saygi
442 Intractable epilepsy due to cerebellar ganglioneural hamartoma: Evidence for seizures originating from cerebellum
Sanem Yilmaz, Cemile Busra Olculu, Aylin Oral, Erdem Simsek, Omer Kitis, Seda Kanmaz, Zeynep Burak, Hepsen Mine Serin, Gul Aktan, Hasan Tekgul, Sarenur Gokben, Burcak Bilginer
132 The Diagnostic Utility of the Video EEG at a Tertiary Care Center of North India: A Retrospective Study
Rahul Sinha, Sonali Singh, Ashish Upadhyay, Gautam Kamila
550 Cases with Seizures During Routine Video Electroencephalography: Clinical and Electroencephalographic Characteristics
Aysen Gok, Cagatay Gunay, Duygu Aykol, Mehmet can Yesilmen, Semra Hız Kurul, Uluc Yis
714 Home-EEG long term monitoring versus in house long term EEG monitoring
Yael Michaeli yossef, ANDREEA NISSENKORN
129 Do Hyponatremia and Anemia in Simple Febrile Convulsions Affect Reccurence in The First 24 Hours?
ASIYE KESKIN BASASLAN, HUSEYIN TAN, ELIF YILDIRIM
585 Answer to seizures: The pediatric Covid-19 infection
Mehpare SARI YANARTAS, Sait ACIK, Ozlem YAYICI KOKEN, Senay HASPOLAT
64 Seroprevalence of Anti- N-methyl-D-aspartate receptor antibodies in children with seizures of unknown cause
Mohammed Abdulrasol Abdulamer, Nebal Waill Saadi , Batool Ali Ghalib Yassin , Imad Al Jumaili
603 Maturation of the auditory evoke potentials with age: data from a pilot study
Jithangi Wanigasinghe, Chris Pirrung, Isuru Weerasinghe, Isurunee Samarasinghe, Piyadasa Kodituwakku, James Cavanagh, John Phillips
758 Next generation whole exome sequencing in the genetic diagnosis of developmental and epileptic encephalopathy
Kun-Long Hung, Su-Jin Hsu, Lee-Chin Wang, Jyh-Feng Lu
629 Predicting seizure recurrence risk in pediatric epilepsy patients who are seizure free and stopped Anti-Epileptic Drugs
BRAHMINI KORRAI, VRAJESH UDANI, Neelu Desai
466 Risk Factors for Seizure Recurrence After Initial Withdrawal of Anti-Seizure Medication in Childhood Epilepsy
Nicholas Odero, Katherine Oyieke, Samson Gwer, Pauline Samia
90 Predisposing factors to childhood Epilepsy at the Federal Medical Centre Umuahia Nigeria
Amarachukwu Okafor, Ihuoma Ukpabi, Roseann Chidomere, Ojinnaka Ngozi
305 DRUG RESISTANT EPILEPSY AND ASSOCIATED FACTORS AMONG CHILDREN WITH EPILEPSIES IN TANZANIA, A CROSS SECTIONAL STUDY
Obrey Urio, Helga Naburi, EDWARD KIJA
522 The effect of anti-epileptic treatment selection on prognosis in traumatic brain injury
Mehmet Oguz Demiroglu, Atilla Ersen, Yigithan Guzin, PINAR GENÇPINAR, NİHAL OLGAÇ DÜNDAR
770 Clinical profile and short term seizure outcome in children with Genetic Generalized Epilepsies
Kavita Srivastava, Saahil Savaskar, Sneha Mahajan, Surekha Rajadhyaksha
686 Epilepsy prevalence and trends in antiepileptic medication use among children in Turkey between 2015-2020
Irmak Simsek, Dilek Yapar, Tuğba Hirfanoğlu, Esra Serdaroğlu, Ercan Demir, Ebru Arhan
222 Leuprolide Acetate Induced Non-convulsive Status Epilepticus: Case Report
Merve Öztürk, Ömer Karaca, Defne Alikılıç, Adnan Deniz, Mesut Güngör, Bülent Kara
321 OUTCOME OF REFRACTORY STATUS EPILEPTICUS IN CHILDREN
Javeria Raza, Tipu Sultan, Areeba Wasim, Zia Rehman
666 Childhood status epilepticus in children of 1-12 years of age SQUH: demographics and outcome of treatment
Amna Al Futaisi, Shihab Al Mawaali
641 Novel treatment approach to NORSE (new onset refractory status epilepticus) in children: Skipping the pharmacological coma
Harshkumar Patel
743 Clinical spectrum, treatment response and outcomes in children with Febrile Infection Related Epilepsy Syndrome (FIRES) : A case series from India
Ramya Bandi, Lokesh Lingappa, Vivek Jain, Ravi Sharma, Ramesh Konanki
410 Can the gut microbiota be a guide in the diagnosis and treatment of childhood epilepsy?
Sevim Türay, Şengül Cangür, Gözde Kahraman, Eda Kayabaşı, Ömer Faruk Çetiner, Burak Aydın, Cihadiye Elif Öztürk
572 Posterior Ocular Structure Parameters by Optical Coherence Tomography Angiography in Pediatric Epilepsy patients
Pembe Gültutan, Pınar Nalçacıoğlu Memiş , Deniz Yılmaz, Mehmet İçöz, Ayşegül Neşe Çıtak Kurt
650 Increased Post-Seizure ACTH Peak May Have a Role in the Benign Characteristics of Febrile Seizures
Elif Özcan, Sevim Şahin, Pınar Özkan Kart, Nihal Yıldız, Serap Özer Yaman, Ali Cansu
589 The effect of antiepileptic drugs on ischemia modified albumin, myeloperoxidase and catalase levels in children with idiopathic epilepsy
Ayse Yasemin Celik, Deniz Yılmaz, Ayse Kartal, Salim Neselioğlu, Aysegül Nese Cıtak Kurt, Ozcan Erel
754 Assessment of the knowledge level of physicians regarding the management of acute seizures in children and adolescents
Müge Ayanoğlu, Sercan Öztürk, Ayşe Tosun
101 Arthrogryposis multiplex congenita and SCN1A mutations: Another reported case and treatment guidance
Alyssa Robison, Charlotte Hollman
237 FOXG1 gene related epileptic diskinetic encephalopathy
Yasemin Özkale, Özgür Kütük , İlknur Erol
417 Missense variants in RHOBTB2 in a patient with developmental and epileptic encephalopathy and paroxysmal movement disorder
HYO JEONG KIM
562 SPTAN1 related epileptic encephalopathy- a case study
Hazem Eltoukhy, Vivek Kalra
456 Very rare novel DHDDS mutation of infant with severe mental-motor retardation, resistant epilepsy, movement disorder
Hande Gazeteci Tekin, Pınar Edem
741 STXBP1 as a Novel Gene for Sleep-Related Hypermotor Epilepsy: A Video-EEG Documented Case Report
Esra Ülgen Temel, Ayşe Serdaroğlu, Ebru Arhan
752 Whole Exome Sequencing Results of 101 Epilepsy-Related Patients
Mustafa Hakan Demirbaş, Emriye Ferda Perçin, Gülsüm Kayhan, Ebru Arhan
766 Pyridoxine Dependent Epilepsy with ALDH7A1 Mutation: Clinical Spectrum and Outcome in A Multicenter Study Cohort From Turkey
Leman Tekin Orgun, İlknur Erol, Seda Kanmaz, Şeyda Beşen, Cengiz Havalı, Habibe Koç Uçar, Canan Yıldırım, Erdem Şimşek, Pakize Karaoğlu, Türkan Uygur Şahin, Ayşe Aksoy, Faruk İncecik, Gülen Gül Mert, Gül Demet Kaya, Mehbare Özkan, Pınar Özkan, Senem Ayça, Tuğçe Uzunhan, Fatma Derya Bulut, Elif Perihan Öncel, Sevcan Tuğ Bozdoğan, Sanem Keskin, Hasan Tekgül
79 CHEDDA syndrome associated with epileptic encephalopathy and hand stereotypies
İlknur EROL , Yasemin ÖZKALE, Atıl BİŞGİN
135 New two findings in idiopathic generalized epilepsy-15 (EIG-15); happy demeanor and gait disturbance: a case report
ELIF YILDIRIM, HUSEYIN TAN, FILIZ KESKIN
142 Early infantile epileptic encephalopathy (Ohtahara Syndrome): A case report with STXBP1 mutation
Senem Ayca, Elif Nur Subay
180 Prevalence Proportion and Clinical Spectrum of Genetic Epilepsy in Children of Bangladesh: A Hospital Based Study
Naznin Ruby, Iffat Shamsad, Shaheen Akhter
338 CDKL5 Mutation-Associated Epileptic Encephalopathy Case
Canan Üstün, Mutluay Arslan, Ali Öztuna, Ayşe Nur Coşkun, Özgen Hür, Bülent Ünay
342 A Case of Dup15q Syndrome Presenting with WEST Syndrome
Canan Üstün, Mutluay Arslan, Ayşe Nur Coşkun, Özgen Hür, Bülent Ünay
348 Case report: Potassium sodium-activated channel subfamily T member 1 gene mutation related epilepsy.
Nuriye Ayca Gul, Emek Uyur Yalcın, Nilufer Eldes Hacıfazlioglu, Derya Guder, Bilgihan Bikmazer
399 A rare presentation characterized by epileptic spasms in ALDH7A1, pyridox(am)ine-5’-phosphate oxidase (PNPO), and PLPBP deficiency
Xianru Jiao, Pan Gong, Yue Niu, Yuehua Zhang, Zhixian Yang
404 Focal cortical dysplasia type II related to a new pathogenic gene-RAB6B
Xiao Li, Kai Gao, Qingzhu Liu, Ye Wu, Lixin Cai, Yuwu Jiang
216 A case with developmental delay, resistant epilepsy and invuluntary movements diagnosed as SCN8A mutation
Emine Tekin, Betül Diler Durgut
231 Clinical predictors of positive genetic investigation of the developmental and epileptic encephalopathies
Maria Benevides, Helena Tadiello de Moraes, Diana Marcela Mejía Granados, Luciana Cardoso Bonadia, Letícia Sauma, Maria Augusta Montenegro, Iscia Lopes-Cendes, Ana Carolina Coan
258 Epileptic Encephalopathy Secondary to Homozygous TBC1 Domain-Containing Kinase (TBCK) Mutation in Four Patients of Puerto Rican Descent
Johanna De Luca-Ramirez, Sofia Rosado-Fernandez, Orlando Torres
285 Intractable epilepsy with Rahman Syndrome
Nefise Arıbaş Öz, Esra Gürkaş, Zeynep Selen Karalök, Ahmet Cevadet Ceylan
332 Two Cases of ACTL6B Mutation-Associated Epileptic Encephalopathy
Canan Üstün, Mutluay Arslan, Deniz Torun, Ayşe Nur Coşkun, Özgen Hür, Bülent Ünay
521 A Rare Cause of Epilepsy In A Child: Mosaic Ring Chromosome 21
Ayşe Yasemin Çelik, Hamit Özyürek, Gulsum Kayhan, Mehmet Ali Ergün, Deniz Yılmaz
420 Features of a male with MACF1 mutation suffered from West syndrome：a case report and literature review
Linjie Jiang, Jun Hu
457 A Rare Cause of Developmental Epileptic Encephalopathy; UBA5 Gene Mutation
merve hilal dolu, pakize cennetoğlu, ihsan kafadar
628 Clinical Evaluation of Childhood Rare Genetic Epilepsies; Multicentric collaboration study
Yİğithan Güzin, Pakize Karaoğlu, Bülent Ünay, Ayşe Tosun , Dilek Çavuşoğlu , Hande Gazeteci Tekin, Ayşe Nur Coşkun, Seçil Oktay, İlknur Cankurt, Semra Hız Kurul, Gülten Öztürk, Ebru Arhan, Selvinaz Edizer, Mutluay Arslan, Müge Ayanoğlu, Ayşen GÖK, Dilsad Türkdogan , Uluç Yiş, Tuba Hirfanoğlu , Serdar Pekuz, Olcay Ünver, Ünsal Yılmaz, Aycan Ünalp
681 Novel ANKRD11 gene mutation in an individual with a phenotype of KBG syndrome presenting like West syndrome
ASLI KÜBRA ATASEVER, Sibğatullah Ali ORAK, ÇİSİL ÇERÇİ KUBUR, Muzaffer POLAT
706 Clinical features of KCNQ2 mutation in a Romanian family
Florinela Gisela Rotaru, Daniela Dorina Vasile, Raluca Ioana Teleanu
672 Epileptic encephalopathy, visual impairment and developmental retardation: CDKL5 deficiency disorder
Betül Kılıç, Esra Özpınar, Yasemin Topçu, Mehmet Palaz, Kürşad Aydın
67 Polymicrogyria and epilepsy with continuous spike-wave during sleep in pediatric patients
Sviatlana Kulikova, Sergei Likhachev, Inna Kozyreva, Micle Talabaev
155 Self-Limited Epilepsy with Autonomic Seizures (SeLEAS): A Case series
Ashna Kumar, Suvasini Sharma, Aakanksha Anand
160 Neurodevelopmental outcomes and clinical utility of genetic testing in a cohort of Australian families with self-limited (familial) epilepsy (neonatal/infantile onset)
Emily Innes, Suzanne Nevin, Rebecca Macintosh, Fleur Le Marne, Richard Webster, Sinthu Vivekanandarajah, Rani Sachdev, Annie Bye
182 The fate of spikes in self-limited epilepsy with centrotemporal spikes: Are clinical and baseline EEG features effective?
Çağatay Günay, Gamze Sarıkaya Uzan, Özlem Özsoy, Semra Hız Kurul, Uluç Yiş
223 Immune mechanism in Benign Epilepsy with Centrotempral Spikes
Zhijie Zhang, Jing Wu, Danfeng Xu, Di Lian, Shengnan Zhao, Dandan Zhang, Ling Li
356 Clinical and electroencephalographic characteristics of childhood epilepsy with centrotemporal spikes for antiseizure medications: monotherapy versus dualtherapy in a multicenter cohort study
Beril Dilber, Esra SERDAROĞLU, Seda KANMAZ , betül kılıç, rojan ipek, deniz kargın menderes, ebru petek arhan, ayşe serdaroğlu, çetin okuyaz, kürşad aydın, hasan tekgül, ali cansu
362 Continuous spikes and waves during sleep (CSWS): A Descriptive Clinical-epidemiological Profile from India
Aakanksha Anand, Suvasini Sharma
475 Electrical status epilepticus during sleep: A study of 67 patients
Sibel Oz Yildiz, Ceren Günbey, Kader Karlı Oğuz, Gökçen Konuşkan, Göknur Haliloğlu, Dilek Yalnızoğlu
557 Heart Rate Variability in Childhood Benign Rolandic Epilepsy
Özge Tanıdır Artan, Serhat Koca, Gökçe Kaş, Deniz Yılmaz, Esra Gürkaş, Ayşegül Neşe Çıtak Kurt
665 Research of autoimmunity clues in electrical status epilepticus (ESES) during sleep
Turgay Cokyaman, Gül Demet Kaya Özçora, Emine Tekin, Gürkan Gürbüz, Huriye Cetin
201 Assessing risk for relapse among children with infantile spasms using the BASED score
Lin Wan, Guang Yang
204 Challenges of determination in date of onset of infantile spasms: A tertiary health center’s experience
Aristides Hadjinicolaou, Christina Briscoe Abath, Avantika Singh, Stephanie Donatelli, Christopher Yuskaitis, Chellamani Harini
261 Treatments and Seizure Outcome of 327 Patients with Infantile Spasms: A Retrospective Analysis
Yinjie Ling, Peifang Jiang
303 Idiopathic Hemiconvulsion Hemiplegia Epilepsy (IHHE) in an 8 yr old boy
Mahesh Kamate, Bhavana Koppad, Virupaxi Hattiholi
400 The clinical features and long-term follow-up of vitamin B6-responsive infantile spasms in a Chinese cohort
Xianru Jiao, Pan Gong, Yue Niu, Zhao Xu, Ye Wu, Yuehua Zhang, Zhixian Yang
407 Electro-clinic features and outcome in children with “pure” epilepsy with myoclonic atonic seizures (EMAS)
Hasan Tekgul, Hepsen Mine Serin, Muzaffer Polat, Gül Aktan, Ayşe Tosun, Sarenur Gökben
648 Genotypic and phenotypigenotypic and phenotypic spectrum of children with genetic West syndrome from Northern India
Balamurugan Nagarajan, Priyanka Madaan, Anupriya Kaur, Arushi Gahlot Saini, Renu Suthar, Lokesh Saini, Sameer Vyas, Naveen Sankhyan, Jitendra Kumar Sahu
697 Can vaccine-proximate seizures in Dravet syndrome be prevented?
Ingrid Scheffer, Lucy Deng, Nicholas Wood, Georgina Lewis, Abigail Cheung, Anita Campbell, Ushma Wadia, Krist Ewe, Margie Danchin
744 The Role of Genetic Factors in Electroclinic and Therapeutic Effectiveness in Children with Dravet Syndrome: A Multi-Center Cohort Study
PİNAR OZKAN KART, Esra Serdaroglu, Nihal Yildiz, Seda Kanmaz, Ozlem Ersoy, Pinar Gencpinar, Cetin Okuyaz, Nihal Olgac Dundar, Senay Haspolat, Hasan Tekgul, Ayse Serdaroglu, Ali Cansu
315 The Impact of Epilepsy on Sleep Characteristics in Epileptic Adolescents and their Caregivers
İpek Dokurel Cetin, Birsen Senturk, Sezen Kose, Gul Aktan, Seda Kanmaz, Mine Serin, Sanem Yılmaz, Sarenur Gokben, Hasan Tekgul
440 Genetic spectrum of Developmental and Epileptic Encephalopathies
Madhavi Shelke, Varsha vaidya, suvarna Magar, Shirish Bhartiya, Sandip Saraf
450 Quality Improvement Project to ameliorate the provision of mental health support to our children with epilepsy
Sharmila Manivannan, Usha Rajalingam, Philip AMATO GAUCI, Nicki Astle , Nadira Maharaj, Una Frederick, Martin Smith
598 Health Economic Analysis of Psychology Adding Value Epilepsy Screening (PAVES) - a Screening and Intervention Programme for the Epilepsy Clinic
Zara Hamill, Sarah Whittaker, Kirsten Verity, Jennifer Hislop, Jay Shetty, Ailsa McLellan
612 Application of a Recently Proposed Semiological Classification to Psychogenic Nonepileptic Seizures in Children
Hakan Ercelebi, Pinar Ozbudak, Tugba Hirfanoglu, Ayse Serderoglu, Ebru Arhan
675 An overview of drug-resistant epilepsies based on advances in genetics: a cohort study
Betül Kılıç, Esra Özpınar, Yasemin Topçu, İsmail Kaytan, Akif Ayaz, Kürşad Aydın
695 Evaluation of Health Related Quality of Life in children with epilepsy using quality of life in childhood epilepsy questionnaire (QOLCE - 55)
Benjamin M. Sagayaraj, Venkatesan Srinath Melpakkam, Lal D V, Manasa Thangella
705 Evaluation of seizure semiology, genetic, magnetic resonance imaging and electroencephalogram findings in children with Rett syndrome: A multicenter retrospective study
Nihal Yıldız, Esra Serdaroglu, Pinar Ozkan Kart, Seyda Besen, Seda Kanmaz, Dilara Ece Toprak, Betul Kilic, Ozlem Ersoy, Pinar Gençpinar, Baris Ekici, Nihal Olgaç Dündar, Çetin Okuyaz, Ayse Serdaroglu, Kursat Bora Carman, Coskun Yarar, Burak Tatli, Ilknur Erol, Kursad Aydin, Hasan Tekgul, Ali Cansu
739 Developmental Epileptic Encephalopathies in A National Cohort Study (Turkish EPISTEP -1): A Step-based Approachment for Etiologic Diagnosis
Seda Kanmaz, Yavuz Atas, Hulya Kayilioglu, Cemile Busra Olculu, Pınar Ozkan Kart, Nihal Yildiz, Betul Kilic, Esra Ozpinar, Yasemin Topcu, Aysenur Coskun, Mutluay Arslan, Deniz Sünnetci Akkoyunlu, Naci Cine, Gamze Sarikaya Uzan , Cagatay Gunay , Duygu Aykol , Ozlem Ersoy, Meltem Cobanogulları Direk , Mustafa Komur , Hatice Hilal Kırkgoz, Pakize Karaoglu, Ipek Burcu Parlak Ibis , Cisil Cerci Kubur, Sibgatullah Ali Orak, Secil Oktay, Muge Ayanoglu, Mirac Yildirim, Omer Bektas, Esra Serdaroglu, Sema Bozkaya Yilmaz, Ilknur Cankurt, Tugba Hirfanoglu, Ayten Gulec, Mehmet Canpolat , Huseyin Per , Ebru Arhan, Pinar Gencpinar, Nihal Olgac Dundar, Serap Teber, Hepsen Mine Serin, Sanem Yilmaz, Ayse Tosun, Muzaffer Polat, Unsal Yilmaz, Aycan Unalp, Bulent Kara, Cetin Okuyaz, Uluc Yis, Semra Hiz, Gul Aktan, Sarenur Gokben, Bulent Unay, Ali Cansu, Kursad Aydin, Hasan Tekgul
52 Sirolimus in Tuberous Sclerosis Complex prior to epilepsy: evidence from a registry-based real-world study
Yan-Wen Shen, Yang-Yang Wang, Meng-Na Zhang, Yong Xu, Qian Lu, Wen He, Hui-Min Chen, Li-Ying Liu, Ling-Yu Pang, Qiu-Hong Wang, Shuo Dun, Yu-Feng Li, Jing Gao, Fang Han, Li-Ping Zou
92 A Case of Carbamazepine Responsive Neonatal Epilepsy Secondary to PACS2 Gene mutation
Pawan Kashyape, Abdulla Alawadhi, Nikhil Pawar, Samar Almuntaser
119 Pyridoxine in Management of Super-Refractory Status Epilepticus: A Case Report
Denis Richard Shatima, Naja'atu Hamza, Rumaysah Shehu Malami
144 Efficacy and Safety of Cannabidiol Dose Adjustment in Patients with Lennox-Gastaut Syndrome in a Phase 3 Trial and Open-label Extension
Timothy B Saurer, Elaine C Wirrell, Ashley Schreiber, Robert T Wechsler
161 The efficacy of Everolimus onTSC associated drug resistant epilepsy
Mohammad Barzegar, Bia Poorshiri, Sina Raeisi
191 Efficacy and tolerability of adjunctive perampanel in pediatric patients (aged 4–12 years) with inadequately controlled focal-onset seizures
Si-jia Chu, Ji-hong Tang
209 Levetiracetam Monotherapy For The Treatment Of Febrile and Febrile Induced Seizures
Gamze Sarıkaya Uzan, Cem Paketçi, Semra Hız Kurul, Uluç Yiş
296 Reversible Leigh’s-like brain abnormalities with Vigabatrin: A Case Series
Surbhi Gupta, Ramesh Konanki, Nihaal Reddy, Lokesh Lingappa
735 Evaluation of Efficacy and Tolerability of Lacosamide in Children with Drug-Resistant Epilepsy: A Multicenter Cohort Study
Pinar Ozkan Kart, Esra Serdaroglu, Nihal Yildiz, Mehpare Sari, Suleyman Sahin, Gursel Sen Sen, Pakize Karaoglu, Pinar Gencpinar, Betul Kilic, Selcan Ozturk, Elif Perihan Oncel, Celil Yilmaz, Arife Derda Yucel Sen, Ozlem Ersoy, Cetin Okuyaz, Kursat Bora Carman Carman, Muzaffer Polat, Ilknur Erol, Kursad Aydin Aydin, Hüseyin Per, Nihal Olgac Dundar, Aycan Unalp, Hasan Tekgul, Bülent Unay, Serap Teber, Senay Haspolat, Ayse Serdaroglu, Ali Cansu
774 Effect of antiseizure medications on calcium profile, thyroid profile and bone mineral density in children
Kavita Srivastava, Saahil Savaskar, Sneha Mahajan
339 Effectiveness of zonisamide in childhood refractory epilepsy
Mahmut Aslan, Serdal Gungor
355 The Effect Of Levetiracetam Therapy On Electrocardiography Parameters
Hilal Aydin, Oguzhan Korkut
366 Comparison of corti̇costeroi̇ds versus clobazam treatment of epi̇lepti̇c encephalopathy wi̇th electri̇cal status epi̇lepti̇cus for electroclinical remission
ilknur cankurt, Tuğba Hirfanoğlu, Recep Kamil Kılıç, Esra Serdaroğlu, Ercan Demir, Ayşe Serdaroğlu, Ebru Arhan
381 VIRAP - new randomized, double-blind, preventive study (vigabatrin vs sirolimus) on prevention of epilepsy in TSC
Sergiusz Jozwiak, Katarzyna Kotulska
398 Relationship Between Valproic Acid, Hepatosteatosis and Serum Betatrophin Levels
Huriye Cetin, Turgay Cokyaman, Senay Bengin Ertem, Hilal Sehitoglu
495 Permampenel in Refractory Epilepsy - Investigator initiated study
Lokesh LIngappa, SRIKANTH DURISHETTI
498 Topiramate alters the erythrocyte osmotic fragility and whole blood viscosity
Ayşe Meltem Sevgili, Pelin Aslan, Sevtap Kılınç, Zeynep Yığman, Hamit Özyürek
535 Rufinamide Experience in Childhood Epilepsy from a Tertiary Center, Turkey
Mehmet Fatih Butun, Mehpare Sari Yanartas, Sakir Genc, Sait Acik, Ozgur Duman, Ozlem Yayici Koken, Senay Haspolat
536 Clobazam Experience in Childhood Epilepsy from a Tertiary Center, Turkey
Sait Acik, Mehmet Fatih Butun, Sakir genc, Mehpare Sari yanartas, Ozgur Duman, Ozlem Yayici Koken, Senay Haspolat
587 Lacosamide Experience in Childhood Epilepsy from a Tertiary Center, Turkey
Mehpare SARI YANARTAS, Sakir GENC, Mehmet Fatih BUTUN, Sait ACIK, Ozgur Duman, Ozlem YAYICI KOKEN, Senay HASPOLAT
333 The ketogenic diet for Dravet syndrome: a multi-center retrospective study
Mei Yu, Hua Li, Dan Sun, Dan Li, Jianmin Zhong, Qiang Gu, Shaoping Huang, Rong Luo, Dengna Zhu, Baoqiang Yuan, Baomin Li, Nong Xiao, Yucai Chen, Yuqin Zhang, Jurong Wei, Yuwu Jiang, Jianxiang Liao, Jiong Qin
542 Children with Tuberous Sclerosis Complex (TSC) on Ketogenic diet therapies: Outcome of a retrospective cohort
Sheffali Gulati, Anuja Agarwala, Vishal Sondhi, Vaishakh Anand, Ankit Kumar Meena, Kanak Lata Gupta, Aakash M
560 Efficacy of Ketogenic Diet therapies in Lennox Gastaut Syndrome: A Prospective Cohort Study
Sheffali Gulati, Anuja Agarwala, Vishal Sondhi, Vaishakh Anand, Ankit Kumar Meena, Kanak Lata Gupta, Gautam Kamila, Prashant Jauhari, Biswaroop Chakrabarty
573 Effect of concurrent anti-seizure medications on the efficacy of the ketogenic diet in children with epilepsy
Suvasini Sharma, Amir Aschner, Nadia Kabir, Elizabeth Donner
627 Management of Valproat Monotherapy in Adolescent Girls with Epilepsy; Evaluation of Predictive Factors of Seizure Recurrens
Edibe Pembegul Yildiz, Fulya Kurekci, Mehmet Akif Kılıç, Rıdvan Avci,, Osman Kipoğlu, Hülya Maras Genc, Mine Caliskan
632 Ketogenic diet treatment success in our two patients with epilepsy of infancy with migrating focal seizures
Betül Kılıç, Esra Özpınar, Mehmet Palaz, Yasemin Topçu, Kürşad Aydın
635 Modified Atkins Diet for the Treatment of Refractory Epilepsy in Children: A Pilot Study from Indonesia
Setyo Handryastuti, Achmad Rafli, Irawan Mangunatmadja, Amanda Soebadi, Yoga Devaera, Cut Nurul Hafifah, Lora Sri Nofi, Ariek Ratnawati, Suci Fitrianti
637 Kidney Stone Formation İn Children Receiving Ketogenic Diet Therapy
Yiğithan Güzin, Ünsal Yılmaz, Nida Dinçel, Fatma Devrim, Aycan Ünalp
727 Efficiency of Rufinamide as add-on Treatment of Drug Resistant Generalized and Focal Epilepsies: One center
yasemin topcu, Esra Ozpinar, mehmet palaz, betul kilic, kursad aydin
196 Dynamic changes of cytoskeleton in epileptic mice
xuemei wu
263 Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD); 2 different clinical outcome
Hale Atalay Celik, Zeynelabidin Ozturk, Yasemin Tascı Yıldız, Rahsan Gocmen, Deniz Yuksel
308 Comparison of 3D Printing Techniques with Patient-Specific Models for Epilepsy Surgery
Ishaan Kumar, Abhi Khapuria, Chip Bobbert, Muhammad Shahzad Zafar, Bilal Berke Ayvaz
316 Is There a Relation Between Hippocampal Measurements and Childhood Idiopathic Generalized Epilepsy?
Hilal Altas, Özge Dedeoğlu, Manolya Panpallı, Başak Gülleroğlu, Seçil Ekşioğlu, Neşe Çıtak Kurt
327 Pre-surgery phase 1 evaluation results and contribution to surgery in pediatric patients with drug-resistant epilepsy
İlknur Cankurt, Tuğba Hirfanoğlu, Recep Kamil Kılıç, Esra Serdaroğlu, Ercan Demir, Ayşe Serdaroğlu, Ebru Arhan
367 Serum and Hippocampus Thiol / Disulfide Balance in the Hyperthermic Febrile Seizure Model in Rats
Alper Oğlakçioğlu, Nesrin Ceylan, Leyla Aydin, Salim Neşeli̇oğlu, Aysegul Nese Citak Kurt
600 Real-time cortical excitability in children with DRE and ESES and its correlation with treatment response: A TMS based comparative study
Prashant Jauhari, Rahul Sinha, Gautam Kamila, Ankit Meena, Suman Jain, Biswaroop Chakrabarty, Ravindra Mohan Pandey, Sheffali Gulati
649 Non-dominant hemisphere is more excitable compared to dominant hemisphere
Gautam Kamila, Prashant Jauhari, Suman Jain, Biswaroop Chakrabarty, R M Pandey, Sheffali Gulati
199 An Observational Study to Assess Inter-observer agreement for neonatal EEG Interpretation
Vrushabh Gavali, Shilpa Kulkarni, Anaita Udwadia Hegde
283 NEONATAL EEG: IMPORTANCE AND UTILITY IN DIFFERANTIAL DIAGNOSIS and PROGNOSIS
Recep Kamil Kilic, Ebru Arhan, Ilknur Cankurt, Esra Serdaroglu, Ercan Demir, Tugba Hirfanoglu
326 Neonatal Amplitude Integrated EEG (aEEG): Contribution to Clinical, Etiologic, and Prognosis
ilknur cankurt, Ebru Arhan, Recep Kamil Kılıç, Esra Serdaroğlu, Ercan Demir, Tuğba Hirfanoğlu
418 Neonatal-onset epilepsy: Clinico-etiological spectrum and developmental outcomes
Prasanthi Aripirala, Lokesh Lingappa, Ramesh Konanki
486 Clinical, electrophysiological, and neuroimaging predictors for antiseizure medication in infants with neonatal clinical seizures
İpek Dokurel Cetin, Seda Kanmaz, Hasan Tekgul
499 Levetiracetam as mono-and polytherapy in the treatment of neonatal-onset seizures
Fatma Kusgoz, Gunce Basarir, Defne Engur, Nihal Olgac Dundar, Pinar Gencpinar
613 A new scoring model for outcomes in neonates with seizures: ENEOSS (Ege Neonatal Seizure Scoring Model)
Seda Kanmaz, Demet Terek, Ozge Altun Koroglu, Sanem Yılmaz, Mehmet Yalaz, Mete Akisu, Hasan Tekgul
621 The clinical value of amplitude-integrated EEG for neonatal seizures: comparison of short-term (6-12 hours) and long-term (24-48 hours) monitoring
Hasan Tekgul, Mehmet Yalaz, Ayfer Arduc Akcay, Seda Kanmaz, Demet Terek, Ozge Altun Koroglu, Sanem Yılmaz, Gul Aktan, Mete Akisu, Nilgun Kultursay
734 The adaptability of health care professionals to the new neonatal seizure classification : ILAE-2020
Feyza Sakin, Seda Kanmaz, Sanem Yilmaz, Pinar Gencpinar, Muzaffer Polat, Demet Terek, Ozge Altun Koroglu, Sebnem Calkavur, Mehmet Yalaz, Mete Akisu, Hasan Tekgul
229 Is Screening of Congenital CMV Infection in Saliva by RT-PCR Feasible?
Ayla Günlemez, Fetiye Kolaylı, Eda Yazıcı, Ali Duranoğlu, Bülent Kara
373 THE RELATİONSHİP BETWEEN FİRST TRİMESTER MATERNAL SERUM PAPP-A LEVEL AND POSTNATAL NEUROLOGİCAL DEVELOPMENT LEVEL
Recep Kamil Kilic, Tugba Hirfanoglu, Deniz Menderes, Esra Serdaroglu, Cem Terece, Mehmet Zeki Taner, Ayse Serdaroglu, Ercan Demir, Ebru Arhan
433 A prospective observational study to determine difference in motor developmental outcomes & effect of early intervention in Full Term vs. Late Preterm neonates using INFANIB.
Vrushabh Gavali, Shilpa Kulkarni, Prasoon Bansal
476 Neonatal Spinal Cord Injury: Not To be Missed
Thomas Smith, Dipak Ram
538 Investigation of Risk Factors in Neural Tube Defects in Newborns
Nuşabe Abdullayeva, Demet Terek , Mahmut Çelik , Özge Altun Köroğlu, Mehmet Yalaz , Mete Akisu, Nilgün Kültürsay , İsmail Mete İtil
564 General Movement Assessment for predicting the neurodevelopmental outcomes in cohort of infants exposed to severe hyperbilirubinemia and hypoxic ischaemic encephalopathy respectively in the neonatal period
lokesh Saini, chandana bhagwat, rudresh naik, praveen kumar, naveen sankhyan, arushi gehlot saini, kanya mukhopadhyaya, rajni sharma, christa einspieler, prabhjot malhi
620 A multimodal prognostic evaluation of preterm and term infants with neonatal encephalopathy in a prospective follow-up study
Seda Kanmaz, Ozge Altun Koroglu, Mahir Tanriverdi, Demet Terek, Gul Aktan, Mehmet Yalaz, Nilgun Kultursay, Mete Akisu, Hasan Tekgul
738 To study the most efficacious drug combination for drug resistant NHBI cases.
Prajakta Ghatage, Vrajesh Udani
89 Pediatric Moya Moya Disease: Clinical and Radio-Angiographic characteristics- A study from a Tertiary care center in Bangladesh
Kanij Fatema, MD Mizanur Rahman, Shaheen Akhter, MD Monir Hossain
116 A Pictorial Review of Paediatric Histiocytic Disorders in the Head and Neck
Robert Hendeson, Rahul Lakshmanan
121 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN PEDIATRICS
Ángeles Schteinschnaider, Rocio Elizabeth Alamo, Romina Nélida Dominguez, Martin Carnevale, Paulina Yañez, Pablo Jorrat
195 Risk factors and prognosis of spinal cord injury without radiological abnormality in children in China
xuemei wu
317 Clinico-Etiological Spectrum of Children with Bilateral Basal ganglia lesions: An Observational Study from A Tertiary Care Centre
Dasaratha Ramaiah Jinka, Lokesh Lingappa, Ramesh Konanki, Nihaal Reddy
559 CLINICAL PROFILE OF CONGENITAL MALFORMATIONS OF NERVOUS SYSTEM - IS IT STILL AN ICEBERG???
sindhura P, shiji chalipat, vishwanath kulkarni
584 Ante-natal and post-natal factors affecting the rate of growth of corpus callosum in preterm infants: a retrospective study
Dhanalakshmi Angappan, Miguel Morales, Damayanti Raja Murali, Prabhu Parimi
736 Brain computed tomography still plays a critical role in the diagnosis of Aicardi-Goutières syndrome
Kürşad Aydın, Betül Kılıç, İlknur Erol, Esra Özpınar, Elif Perihan Öncel, Yasemin Topçu, Akif Ayaz, Mehmet Palaz
764 clinical and radiological profile of focal cortical dysplasia in children
shikha jain, sangeetha yoganathan, karthik muthusamy
767 Two cases with Pontine Tegmental Cap Dysplasia: a rare hindbrain anomaly which may be misdiagnosed as Moebius Sequence
Hülya Maraş Genç, Sevinç Kalın, Büşra Kutlubay, Cemile Pehlivanoğlu
225 Congenital tonic pupil - what's behind?
Sandra Patricia Toelle, Anthia Papazoglou, Raimund Kottke, Christina Gehrt-Kahlert
351 Cerebral microstructural changes in children suffering from hemolytic uremic syndrome
Eva Bültmann, Antonia Zapf, Hans Joachim Mussgnug, Heinrich Lanfermann, Nele Kanzelmeyer, Hans Hartmann
447 Basal ganglia germinoma in an adolescent: A case report
Anish Ainapure, Shilpa Kulkarni, Foram Gala, Shubham Kaudinya
470 Posterior reversible encephalopathy syndrome in children with malignances
Natalia Bronina, Inna Schederkina, Evgenia Seliverstova, Maria Natrusova, Evgeny Burtsev, Kirill Kirgizov, Gleb Bronin
485 A Common Neurologic Symptom Leads To A More Serious Oncologic Diagnosis!
Reza Shervin Badv, Zahra Rezaei, Leili Koochakzadeh, Farzad Kopmani, Mahmoud Mohammadi
504 Neurological manifestations of lympho-haematopoietic malignancies
Shubham Kaudinya, Shilpa Kulkarni, Sonam Kothari, Anish Ainapure
545 Clinical characteristics of 50 cases of cerebral cystic necrosis in children
Lijuan Fan, Rong Luo, Xiaolu Chen
717 Intracranial haemorrhage in two infant siblings: hereditary or acquired?
Ramudu Rongalli, Arjun Kurup, K Uday Bhanu, Biju M John, Vishal Sondhi, Sachendra Badal
724 Intracranial cysts in pediatric age group: Incidental or developmental?
Burçin Şanlıdağ, Mehmet Alp Dirik, Eray Dirik
728 Posterior reversible encephalopathy syndrome (PRES) without radiological correlate : Is it possible?
Apoorv Saxena, KMSK Krishna, Sarvesh Kohli, Satyranjan Das, K Uday Bhanu, Biju M John, Vishal Sondhi, Sachendra Badal
412 Variation in neuroimaging and outcomes in patients with SWS type III
Aristides Hadjinicolaou, Aisling Quinlan, Sanjay Prabhu, Anna Pinto
551 Effects of maternal and early-life anaemia on child brain development: a South African birth cohort study
Catherine Wedderburn, Jessica Ringshaw, Kirsten Donald, Shantanu Joshi, Sivenesi Subramoney, Jean-Paul Fouche, Jacob Stadler, Whitney Barnett, Andrea Rehman, Nadia Hoffman, Annerine Roos, Katherine Narr, Heather Zar, Dan Stein
591 Autosomal recessive NOTCH3-related leukodystrophy in two siblings and review of the literature
Fatema Al Amrani, Khalid Al Thihli , Amna Al Futaisi
615 Posterior periventricular extensive diffusion restriction in a 17 years old boy after cardiopulmonary resuscitation
Senay Demir , Halil Ibrahim Suner , Semra Saygi
671 A case with an epidermoid cyst in the cerebellopontine angle presenting with hemifacial spasm
Asli Kübra Atasever, Çi̇si̇l Çerçi̇ Kubur, Sibğatullah Ali Orak, Muzaffer Polat
721 Paroxysmal sympathetic hyperactivity in a child with High Grade Glioma post resection surgery.
Sarvesh Kohli, Apoorv Saxena, Subir Dey, Sudip Sengupta, TVSVGK Tilak, Biju M John, Vishal Sondhi, Sachendra Badal
732 Mirror movements in children: Case series
kiran Sanalli, Sweta Mukherjee, K Uday Bhanu, VISHAL SONDHI, Sachendra Badal
733 Keep an aye on lumpy bumpy head: a case series highlighting spectrum of presentation in craniosynostosis
Marya Hameed, Syed Maaz Tariq, Ameet Kumar Jesrani, Hina Hanif, Kanwal Laique, Syed Shariqullah, Ashraf Amir Ali
177 Primary headache with onset in childhood and adolescence: natural history and prognostic factors in a Portuguese population
Juliana da Silva Cardoso, Carolina Curto, Paula Manuel Vieira, Joanna Ashworth, Teresa Temudo, Inês Carrilhho
181 Recurrent Painful Ophthalmoplegic Neuropathy: Report of the Two New Pediatric Cases
Çağatay Günay, Pınar Edem, Semra Hız Kurul, Elif Yaşar, Uluç Yiş
206 A case of first pediatric pseudotumor cerebri syndrome secondary to superior sagittal sinus thrombosis associated with SARS-CoV-2
Mehmet Can Yeşilmen, Çağatay Günay, Gamze Uzan Sarıkaya, Özlem Özsoy, Semra Hız Kurul, Elif Yaşar, Uluç Yiş
234 Efficacy of Agents Used in the Prevention of Migraine in Children
Serap Bi̇lge
253 Neurological face of familial mediterranean fever
Polat Cengiz Bektas, Asli Kavas Tufan, Nuran Cetin, Coskun Yarar, Kursat Bora Carman
269 ASSESSMENT OF CHILDHOOD HEADACHES: A SINGLE CENTER EXPERIENCE
müge baykan, osman büyükşen, nihal olgaç dündar, yiğithan güzin, pınar gençpınar
277 Evaluation of the risk factors, functionalities, life qualities of the patients with the diagnosis of pediatric acute arterial ischemic stroke
Fatih Mehmet Akif Özdemi̇r, Ülkühan Öztoprak, Ali Fettah, Utku Arman Örün, Mustafa Kiliç, Fatma Gül Sarikaya, Betül Deri̇nkuyu, Deniz Yuksel
558 Vascular Endothelial Dysfunction, Cognition and Stroke in Early Life Study (VECSELS)
Maria Vu, Kirstin Walker, Amanda Robertson, Trish Domi, Liza Pulcine, Robyn Westmacott, Nomazulu Dlamini
625 Pseudotumor cerebri in childhood: a new vision to clinical spectrum and predictors for visual outcome
Cemile Busra Olculu, Seda Kanmaz, Ilayda Korkmaz, Yavuz Atas, Cenk Eraslan, Elif Demirkilinc Biler, Hepsen Mine Serin, Sanem Yilmaz, Omer Kitis, Onder Uretmen, Cem Calli, Gul Aktan, Sarenur Gokben, Hasan Tekgul
278 Unilateral internal carotid artery and middle cerebral artery thrombosis in a pediatric patient with mildly symptomatic COVID-19: Case report and literature review
Gülnur Esenülkü, Sevim Şahin, Şükrü Oğuz, Eser Bulut, Beril Dilber, Pınar Özkan Kart, Osman Yeşilbaş
286 «Risk factors of the stroke in early age children»
Shaanvar Shamansurov, Shakhlo Saidazizova , Ziyodakhon Abduyaminova
304 Stroke secondary to thoracic outlet syndrome, treated successfully with thrombolytics and thrombectomy in a teenager: a case report
Dhanalakshmi Angappan, Artur Riddle, Jenny Wilson
336 Clinical Evaluation Of The Vestibular Functions In Pediatric Patients With Migraine And Probable Vestibular Migraine Of Childhood
Ela Cömert, Nesrin Şenbil, Buğra Şimşek, Elif Çetinkaya
449 THE COURSE OF PEDIATRIC HEADACHES DURING COVID-19 PANDEMIC
Secil Doga Tunc, Mehmet Gunduzalp, Ayse Yasemin Celik , Hamit Ozyurek, Ozlem Yayici Koken, Esra Gurkas, Aydan Degerliyurt, Aysegul Nese Citak Kurt
455 AN ATYPİCAL CASE OF POST VARİCELLA STROKE İN A CHİLD ASSOCİATED WİTH HYPERHOMOCYSTEİNEMİA AND MTHFR A1298C MUTATİON
Sedef Terzioğlu Öztürk, Nursel Yurttutan, Mehmet Turan, Mehmet Ali Ekenel, Cengiz Dilber
472 CLINICAL PROFILE OF HEADACHE AMONG CHILDREN ATTENDING EMERGENCY DEPARTMENT AT ALEXANDRIA UNIVERSITY CHILDREN'S HOSPITAL
HANAN AZOUZ, Marwa Abd Elmaksoud, Wafaa Muhammad
496 Ambulatory blood pressure monitoring in children diagnosed with primary headache
Asiye Bolca, Secil Arslansoyu Camlar, Cemaliye Basaran, Gokcen Erfidan, Gunce Basarir, Pinar Gencpinar, Demet Alaygut, Fatma Mutlubas, Nihal Olgac Dundar, Belde Kasap Demir
539 Sleep-related difficulties and decreased sleep quality among adolescents with idiopathic intracranial hypertension
Itay Tokatly, Riva Tauman, Noam Senderowich, Raviv Markovitz , Anat Bachar-Zipori , Ainat Klein, Aviva Fattal-Valevski, Moran Hausman-Kedem
567 POSTERIOR CIRCULATION ARTERIAL ISCHEMIC STROKE IN CHILDREN
PAYAL SHAH, SHILPA KULKARNI, FORAM GALA, KONIKA BANSAL, KOMAL ZANAK
386 Anterior spinal artery syndrome due to fibrocartilaginous embolism – case report and treatment options
Christian Menke, Ivonne Wieland, Sabine Illsinger, Eva Bültmann, Hans Hartmann
473 Pediatric Bow Hunter Syndrome, a case report.
Ángeles Schteinschnaider, Romina Nélida Dominguez, María Sol Voyame , Isaura Gonzalez, Martín Carnevale, Paulina Yañez, Romina Goñi
474 The Case of a 15-year-old Adolescent with Cerebral and Pulmonary Fat Embolism Syndrome without Dermatologic Involvement
Sevcan İpek, Cengiz Dilber, Can Acıpayam, Sedef Terzioğlu Öztürk, Betül Kızıldağ, Nursel Yurttutan
577 A Child with Cerebral Venous Thrombosis Secondary to COVID 19 Infection Successfully Treated with Thrombectomy
Zeynep Gökçe Gayretli̇ Aydin, Eli̇f Acar Arslan, Hasan Di̇nç
601 The Prevalence of Adenoid Hypertrophy in Brain MRI Examination in Children with Headache in the Pediatric Neurology Outpatient Clinic
Semra Saygi, Çi̇ğdem Yalçin
663 A retrospective study of central nervous system vasculitis patients
Sarolta Dobner, Zoltán Liptai, Léna Szabó, Tamás Constantin, Edit Varga, Benke Péter, Barsi Péter, Mária Anna Hudák
718 Does the presence of Friedman criteria always spesific for pseudotumor cerebri?
Gülnur ESENÜLKÜ, İlker Eyüpoğlu, Tülay Kamaşak, Hasan Emral, Sevim Şahin, Elif Acar Arslan, Beril Dilber, Pınar Özkan Kart, Nihal Yıldız, Ali Cansu
737 A rare dual pathology: Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy
Aysen Gok, Dondu Ulker Ustebay, Semra Hız Kurul, Uluc Yis
756 Mineralising angiopathy presenting as stroke
Shikha Jain, Meenakshi Girish
57 Relationship Between the Level of Gross Motor Function and Magnetic Resonance Imaging Findings in Children with Cerebral Palsy in a Tertiary Care Hospital
Sanjida Ahmed, Shaheen Akhter, Gopen Kumar Kundu
68 Establishment of High-Risk Infant Follow up Clinic for Implementation of Early Diagnosis of Cerebral Palsy Guidelines
Khaled Ashour, tarek omar, Basma ElMohandes
134 Clinical characteristic of oropharyngeal dysphagia and swallowing safety in children with dystonia: a preliminary report
Muserrefe Nur Keles, Esra Serdaroglu
250 Clinical and electophysiological evaluation of autonomic dysfunction in children with spastic cerebral palsy
Hanan Azouz, Ali Abdelmohsen, Hayam Abdelghany
270 General Movements Assessment in Term Newborns with Moderate Hyperbilirubinemia
Deniz Erdem Fırat, Nargiz Aliyeva, Defne Engur, Nihal Olgac Dundar, Pinar Gencpinar
312 Wasting Syndrome is a predictor of early death in Spastic Cerebral Palsy
Wahed Wahed
471 EVALUATION OF MOTOR AND SENSORY FUNCTIONS AND PSYCHOLOGICAL PROPERTIES IN CHILDREN WITH HEMIPARETIC CEREBRAL PALSY BETWEEN THE AGES OF 6 AND 16 YEARS
Yilmaz Satirer, Deniz YUKSEL
549 A Retrospective Case Series of Indian Children With Homozygous RNASEH2B Mutations Presenting As ‘Cerebral Palsy’ Mimic
Rahul Badheka, Drushi Patel, Sanjiv Mehta, Nitish Vora, Lokesh Lingappa, Siddharth Shah
690 Assessment of Nutritional Status, Resuscitation Modalities of Malnutrition, and Enteral Feeding Products for Children with Neurological Disorders
Burce Emine Dortkardesler, Seda Kanmaz, Ozlem Yilmaz, Gursel Sen, Yavuz Atas, Cemile Busra Olculu, Tugce Ince, Dilara Ece Toprak, Hepsen Mine Serin, Sanem Keskin Yilmaz, Gul Aktan, Sarenur Gokben, Hediye Reyhan, Dogan Barut, Miray Karakoyun, Funda Cetin, Nuri Zafer Kurugol, Sema Aydogdu, Hasan Tekgul
58 Association of Functional Ability with Nutritional status among Children with Cerebral Palsy
Razia Sultana, Ariful Islam, Naila Zaman
77 Health-related quality of life of children with cerebral palsy at a tertiary hospital in Nigeria
Naja'atu Hamza, Denis Richard Shatima, Mariya Mukhtar Yola, Jane Oowo Anyiam
85 An unusual cause of torticollis in childhood
Indrasish Ray Chaudhuri, Prabhas Prasun Giri, Goutam Goswami, Rohit Kapoor
359 Hippotherapy in children with cerebral palsy
Kursat Bora Carman, Ibrahim Serdar Kaçar, Enis Kazim Sezgin, Cafer Yildirim, Sukru Torun, Mina Akbay, Coskun Yarar, Arife Derda Yucel Sen, Mehtap Turkmenoglu, Ugur Bilge
459 Features of epilepsy drug therapy in children with cerebral palsy
Madina Taghiyeva, Aytan Mammadbayli
493 Gabapentin: Efficacy and tolerability as adjuvant therapy for dystonic cerebral palsy
Suhani Shah, Vishal Patel, Radhika Agarwal, Nishant Rathod, Anaita Udwadia Hegde
537 Erythropoietin for Hypoxic-Ischemic Encephalopathy: A Follow up Study in New Taipei City, Taiwan
Zhao-Qing Lin, Yung-Ting Kuo
693 Relationship between MRI patterns and refractory epilepsy in children with cerebral palsy: Cross-sectional study from a tertiary center
Mehmet Akif Kılıç, Fulya Kürekci, Edibe Pembegül Yıldız
746 To determine the prevalence of comorbidities among children with cerebral palsy (CP) and risk-factors predictive of different comorbidities.
Ruchika Jha, Maya Vishwanath, Ankita Dilip Gambhirao, Arjun Kurup, Sachendra Badal, Sarvesh Kohli, Parvathi Parappil, Biju M John, Krishna Moorthy Adhikari, Vishal Sondhi
185 A pediatric case of reversible splenial lesion syndrome associated with SARS-CoV-2: Case report
Ari̇fe Derda Yücel Şen, Kürşat Bora Çarman, Coşkun Yarar
423 Post COVID anti-NMDAR Encephalitis in an adolescent girl
Javeria Alvi, Tipu Sultan, Muhammad Sultan
487 Profile of Neurological manifestations of Covid 19 in a Pediatric hospital in Delhi
Rekha Mittal, Chandrasekhar Singha, Prashant Choudhary, Ankur Ohri
530 Changes in the patient number of viral infections and febrile seizure before and after the COVID-19 pandemic
Jae Min Park, Young Jun Ko, Soo Ahn Chae
547 A Comparative Study On The Risk Of Seizure In Children During The Delta And The Omicron variants of SARS-COV-2 Infection
Varghese Abraham
548 A Rare Neurological Manifestation of Coronavirus Disease 2019 (COVID-19) in a Single Reference Center: Ramsay Hunt Syndrome
Çiğdem Genç Sel, Osman Karslı
602 COVID-19-associated Retrobulbar Neuritis In A Child
Semra Saygi, Oğuzhan Ali Oruz
610 MOG antibody- associated encephalitis secondary to Covid 19
Gülcan Akyüz
626 Post-COVID-19 related neurological features in a pediatric population
Salma Zouari Mallouli, Imen Ben Kraiem, Wafa Bouchaala, Olfa Jallouli, Sihem Ben Nsir, Fatma Kamoun Feki, Chahnez Charfi Triki
740 A case of acute ophthalmoplegia presenting after multisystem inflammatory syndrome in children (MIS-C)
Yavuz Sayar, Ömer Bektaş, Miraç Yıldırım, Çiğdem İlter Uçar, Serap Teber
133 Chronic meningitis mimicking idiopathic intracranial hypertension: a surprising diagnosis
Huseyin Tan, Elif Yildirim, Filiz Keskin
372 Reactivation of HSV-1 Encephalitis in an Infant Within One-Month of Completing Acyclovir Treatment: A Case Study
Andrew Hey, Jaime Shoup, Vinay Puri
415 12-Year Surveillance Results of Acute Flask Paralysis Cases in Southeast Turkey and the Effect of Refugee Movements on Surveillance Results
Nezir Özgün, Gülnaz Kubat, Birgül Turan, Mert Özgün, İzzettin Toktaş, Gülay Korukluoğlu
529 Clinico-etiological profile of Acute Encephalitic syndrome from Northern India
Sheffali Gulati, Gautam Kamila, Rama Chaudhry, Lalit Dhar, KM. AARZOO Sirohi, Aakash M, Rishi Sharma, Immaculata Xess, Hitender Gautam, Bimal Das, Bijay Ranjan Mirdha, Pradeep Chaturvedi, Ahmadulla Shariff, javed Ahsan Quadri, Sudip kumar Datta, Thirumurthy Velpandian, seema Kapoor, Uma Kumar, Prashant Jauhari, Biswaroop Chakrabarty
540 Neuro-tuberculosis in COVID: Our experience
Shreya Gandhi, Suhani Shah, Sumeet Pawar, Puja Mehta, Viraj Sanghi, Anaita Hegde
655 Covid-19 related ADEM and longitudinal extensive transverse myelitis with acute adenovirus co-infection in a nine-year-old child
Recep Kamil Kilic, Ebru Arhan, İlknur Cankurt, Esra Serdaroglu, Emine Akkuzu, Ebru Azapagasi, Mutlu Uysal Yazici, Ercan Demir, Tugba Hirfanoglu
659 The Enabling Inclusion (EI) App: A story from Rural South India about COVID-19 and digital techno
Franzina Coutinho, Dinesh Krishna, Marie Brien, gauri. saxena, Paramakalyani Rajeshwaran, Navamani V
669 Health coaching and COVID-19: Parent reports from India
Franzina Coutinho, Vrajesh Udani, Neelu Desai, gauri. saxena, Rashmi Dixit
691 Serious neurological complication associated with COVID 19 and MISC: Do we need to be more vigilant?
Renu Suthar, Chandana Bhagwat, Suresh Kumar, Arnab Ghosh, Arun Bansal, Mini Singh, Naveen Sankhyan
685 A case of posttransplant acute limbic encephalitis associated with human herpesvirus-6
Yavuz Sayar, Çiğdem İlter Uçar, Ömer Bektaş, Miraç Yıldırım, Serap Teber
306 Acute Cerebellit: Is it always benign?
Pembe Gültutan, Aylin Babuççu, Şükriye Yılmaz, Aslınur Özkaya Parlakay, Aydan Değerliyurt, Hamit Özyürek
434 Paroxysmal sympathetic hyperactivity in Pediatric Tuberculous meningitis: A New association
Sonali Singh, Prashant Jauhari, Rahul Sinha, Gautam Kamila, Agam Jain, Sakshi Ojha, Mohana Sundaram S.M, Atin Kumar, Biswaroop Chakrabarty, Sheffali Gulati
461 Variations in clinical presentation, neuroimaging and electroencephalographic patterns of subacute sclerosing panencephalitis
Areeba Wasim, Tipu Sultan, Zia Ur Rehman Rehman
525 The first case of Streptococcus intermedius brain abscess with hemophagocyic histiocytosis
Jia Zhang, Jing Gan, Xiaolu Chen
607 Subacute Sclerosing Panencephalitis in Children: A Case Series in Dr. Cipto Mangunkusumo Tertiary General Hospital, Jakarta, Indonesia
Irawan Mangunatmadja, Setyo Handryastuti, Amanda Soebadi, Achmad Rafli, Arnesya Pramadyani, Tiara Ayu Murti, Vini Jamarin
624 Global burden of measles: A registry of neurological complications
Ibrahim Oncel, Ruzica Kravljanac, Altynshash Jaxybayeva, Sophia Bakhtadze, Jo Wilmshurst, Elaine Wirrell, Banu Anlar
694 Clinical analysis of 26 children with recurrent bacterial meningitis
Lian-feng Chen, Wen-lin Wu, Wen-Xiong Chen
722 The Rare Central Nervous System Findings in Pediatric SARS-COV-2 Patients
Olgay Bildik, Gunce Basarir, Fatma Kusgoz, Fatma Ceren Sarioğlu, Pinar Gencpinar, Nihal Olgac Dundar
56 Identification of candidate genetic susceptibility variants in the carnitine (Cn) transporter and carnitine biosynthesis gene families in Autism Spectrum Disorder: A novel precision medicine target
Ingrid Tein, Anne-Marie Lamhonwah, Mehdi Zarrei, Evdokia Anagnostou, Stephen Scherer
70 Effect of oxidative stress and Glutathione on telomere length in a population of Egyptian autistic children
Nagwa meguid, Mohamed Taha, Adel Hashish, Ayat Abdaltawab
108 Acoustic alterations of ultrasonic vocalization in the autism model mice (duplication of 15 q11-13) upon maternal isolation
Hiromi Wada
175 Epileptiform discharges and epilepsy in non-syndromic ASD patients. Pre, peri, post-natal risk factors for epilepsy.
Adelina Glangher, Magdalena Budisteanu, Florentina Ionela Linca
325 Association Between Sleep Problems and Perinatal Factors and Maternal Psychopathology in Toddlers at Risk for Autism
Bilgihan Bikmazer, Alperen Bikmazer, Esra Altinbilek, Beyza Fetanet Gürel, Fulya Bakır, Vahdet Gormez
541 Parental age, socioeconomic status and parity related with the clinical phenotypes in children with autism spectrum disorder
Wen-Xiong Chen, Xian Liu, Zhi-Fang Huang
568 The Spectrum of Co-morbidities in children with ASD (Autism Spectrum Disorder): a retrospective study
Sheffali Gulati, Shobha Sharma, Kakali Purkayastha, Gautam Kamila, Arvinder Singh, Sayoni Chowdhury, Ankit Meena, Sonali Singh, Juhi Gupta, Sanjeeda Khan, Arunangshu Bhattacharya, Anushka Rathi
580 Biomarkers in children with Autism: A case control Study
Sheffali Gulati, Chinthana L, Gautam Kamila, Thirumurthy Velpandian, Seema Kapoor, Vinod Scaria, Shobha Sharma, Kakali Purkayastha, Sanjeeda Khan, Prashant Jauhari, Biswaroop Chakrabarty, Prateek Kumar Panda, Sudip Kumar Datta, Pradeep Kumar Chaturvedi, R. M. Pandey
609 Macrocephaly/autism syndrome exhibits neuroradiological abnormalities including Arnold-Chiari syndrome type I: Clinico-radiological spectrum of a PTEN-opathy
Tuğçe Aksu Uzunhan, Bülent Kara, Adnan Deniz , Biray Ertürk, Kürşad Aydın, Pınar Öz, Mehpare Özkan, Betül Kılıç, Deniz Sünnetçi Akkoyunlu
643 Neurological Evaluation and Electroencephalographic Findings in Children with Autism Diagnosis
Elif Didinmez Taşkırdı, Nihal Olgaç Dündar, Pınar Gençpınar, Osman Büyükşen, Gonca Özyurt
137 Performance of Physiotherapy Through Early Stimulation in High Risk Babies. Experience Report on the Insertion of this Elective Internship Program for Physiotherapy Students
Regina Turolla de Souza, Telma Dagmar Oberg, Airton Jose Martins
186 New ways of treatment for childhood autism: are we moving in the right direction?
Taras Voloshyn
295 Evaluation of Psychomotor, Behavioral and Sensory Development in Hypoxic Ischemic Encephalopathy Patients
Selin Akyüz Oktay, Kıvılcım Gücüyener, Azime Şebnem Soysal Acar
377 Broad Autism Phenotype Questionnaire— Translation and Validation in a South Indian language followed by pilot study
Soumya Sundaram, P Sandhya , Betsy Baby , Raviprasad Varma, Shobha Meera
588 Our cases with hypoxic ischemic encephalopathy in which we applied hypothermia
Mehmet Ateş, Demet Terek , Seda Kanmaz , Özge Altun Köroğlu, Sanem Keskin Yılmaz , Mehmet Yalaz , Mete Akisu, Hasan Tekgül
652 Autonomic Nervous System Function Changes during Arousals in Children with Primary Nocturnal Enuresis
Ayşe Kaçar Bayram, Süleyman Sunkak, Sevde Daşdelen, Funda Baştuğ
710 The Determinants of Quality of Life in Rett Syndrome: A Cross-sectional Study
Ilay Caliskan, Ayfer Arduc Akcay
771 A Protocol for Evaluation and Treatment of Children with Autistic/Psychotic Regression
Naama Yosha-Orpaz, Orit Hadar, Tally Lerman-Sagie
123 OVERCOMING ADVERSITIES TO PROMOTE EARLY BRAIN DEVELOPMENT IN CHILDREN - A STUDY FROM RURAL INDIA
Nandita Chattopadhyay
224 Phenotypic and genotypic expansion of TRAPPC12-related disorder
Dhanya Lakshmi Narayanan, Purvi Majethia, Lakshmi Priya Rao, Michelle do Rosario, Yatheesha BL, Suvasini Sharma , Shahyan Siddiqui, Girisha Katta, Anju Shukla
275 Clinical characteristics of children with neurodevelopmental delay and pathogenic copy number variations who underwent microarray analysis
Hülya Maraş Genç, Yasemin Kendir Demirkol, Hande Beklen, Büşra Kutlubay, Hatice Gülhan Sözen, Özlem Akgün Doğan
401 Diagnostic yield of Whole Exome and Whole Genome Sequencing in pediatric neurological disorders. A UAE Tertiary hospital experience
Bushra Alattas, Majid Aziz
436 Clinical utility of next generation sequencing in neurodevelopmental disorders —experience from a tertiary care centre
Karthika Ajit Valaparambil, Soumya Sundaram, Ramshekar Menon
462 TRAPPC9-related intellectual disability: report of two new cases
F. Müjgan Sonmez, EYYÜP ÜÇTEPE, Ahmet Yeşilyurt
512 A Novel Candidate Gene For Neurodevelopmental Disorders: JKAMP
Enise Avci Durmusalioglu, Esra Isik, Muzaffer Polat, Ebru Canda, Tahir Atik
569 Application of advanced molecular technologies in revealing the etiology of intellectual disability – clarification or more questions
Elena Sukarova-Angelovska, Slavica Trajkova, Dragica Nestoroska, Natalija Angelkova, Aneta Demerdzieva, Lejla Kazanoska-Muaremoska
579 Neuroimaging for children with Neurodevelopmental Disorders (NDDs) in the African Population
Aleya Remtulla, Emma Eastman, Deepika Goolab, Este Sauerman, Raphaela Itzikowitz , Brigitte Melly , Charles Newton, Amina Abubakar, Elise Robinson, Kirsten A Donald
482 Developmental trends and changes in children: Comparing assessment data of Japanese children from 1983 and 2020
Hideyo Goma, Yui Zen
780 Pathological, probably pathological or of uncertain significance copy number variant in a population of patients with neurodevelopmental disorders with epidemiological representation.
Francisco Carratalá-Marco, Andrea Huertas-Viudes, Lorena Pastor-Ferrandiz, Patricia Andreo-Lillo, Maite Carratalá-Marco
242 PURA Syndrome: A Specific Phenotype
Ömer Karaca, Merve Öztürk, Defne Alikılıç, Adnan Deniz, Mesut Güngör, Bülent Kara
274 Response Inhibition in Children with Different Subtypes/Presentations of Attention deficit hyperactivity disorder: a Near-infrared Spectroscopy Study
Yike Zhu, Siqi Liu, Fan Zhang, Yongying Ren, Tingyu Zhang, jing sun, Xin Wang, Lin Wang, Jian Yang
302 Broad spectrum micronutrient supplementation in the management of ADHD: a clinical trial and systematic review
Maureen Njoroge, Samson Gwer
329 Exploration of serum B vitamin levels in children with ADHD and their correlation with clinical symptoms
Fan Zhang, Min Zhang, Yike Zhu, Siqi Liu, Yongying Ren, Xin Wang, Lin Wang, Jian Yang
460 Study of computerized cognitive training technique for treatment of children with attention deficit hyperactivity disorder. A new treatment modality experience.
Hussein AbdelDayem, Salma AbdelDayem
507 Spectrum of co-morbidities and psychopathology in children with Attention-deficit hyperactivity disorder (ADHD): A retrospective study
Sheffali Gulati, Shobha Sharma, Kakali Purkayastha, Gautam Kamila, Arvinder Singh, Sayoni Chowdhury, Puneet Chaudhary, Shivam Pandey
534 The spectrum of specific learning disability and associated co-morbidities in children at a tertiary care center: A retrospective study.
Sheffali Gulati, Shobha Sharma, Kakali Purkayastha, Shivam Pandey, Sayoni Chowdhury, Sachendra Badal, Sanjeeda Khan, Gautam Kamila, Ankit Meena
657 Study to determine sensory processing dysfunction in children with attention deficit hyperactivity disorder
Saurodip Maity, Neelu Desai, Vrajesh Udani
725 Neurocognitive Functions and Behavior Outcome of Preschool-Age Children with a History of Febrile Convulsions
Nuran Gozpinar, Bilgihan Bikmazer, Oguzhan Koyuncu, Aygun Hüseynova, Ferit Durankus, Elif Yuksel Karatoprak, Emek Uyur Yalcin, Nilufer Eldes Hacifazlioglu, Alperen Bikmazer, Vahdet Gormez
729 Co-morbid psychiatric disorders in patients with arachnoid cyst: A case series
Yeliz Engindereli, Burçin Şanlıdağ, Mehmet Alp Dirik, Eray Dirik
61 High-efficacy treatment for aggressive pediatric Multiple Sclerosis
Maria Shumilina
65 Neuromyelitis Optica Spectrum Disorder in a sample of children: Experience of Children Welfare Teaching Hospital, Baghdad
Hayder Kadhim Jabbar, Nebal Waill Saadi
183 Optic Neuritis in CD59 Deficiency: An Extremely Rare Presentation
Çağatay Günay, Elvan Yardım, Elif Yaşar, Semra Hız Kurul, Gamze Sarıkaya Uzan, Taylan Öztürk, Aylin Yaman, Uluç Yiş
188 Evaluation of the Risk Factors for Developing Demyelinating Disease after Optic Neuritis in Children: A Single Center Experience
Mustafa Börekçi, Sevim Şahin, Nihal Yıldız, Mehmet Kola, Ali Cansu
255 Clinical efficacy and safety of intrathecal methotrexate in the treatment of Balo’s concentric sclerosis: a case report
Deniz YUKSEL, Hale Celik, Ozge Kucur, Kader Oguz
478 Devic's neuromyelitis optica (NMO) or a pediatric onset multiple sclerosis (MS)? A case report
Seyfeddine Baouia
563 Successful management of Pediatric-onset Multiple sclerosis with Ocrelizumab
Nisreen Bader , Khurshid Khan, Amal Sherif, Aman Sohal
639 Optic Neuritis And Pseudotumor Cerebri Co-Existence İn A Patient With A Recent COVID-19 Infection
Semra Saygi, Şenay Demi̇r, Astan Ibayev
687 Effects of Oleuropein on Systemic Lipopolysaccharide-Induced Neuroinflammation in Rats
Sevim Şahin, Gülnur Esenülkü, Elif Şahin, Gülin Renda, Seren Gülşen Gürgen, Nihal Yıldız, Pınar Özkan Kart, Ahmet Alver, İsmail Abidin, Ali Cansu
751 Two Pediatric Cases of Initial Manifestation of Multiple Sclerosis After Immunization with the Pfizer-BioNTech COVID 19 Vaccine
Özben Akıncı Göktaş, Cansu Öztürk
120 FLAMES (FLAIR Hyperintense Lesions in Anti-Myelin Oligodendrocyte Glycoprotein-associated Encephalitis with Seizures), a case report.
Ángeles Schteinschnaider , María Gala González, Romina Nélida Dominguez, Paulina Yañez, Mario Massaro
138 Myelin oligodendrocyte glycoprotein antibody-associated disorder due to COVID 19 infection: a child case report
Huseyin Tan, Elif Yildirim, Filiz Keskin
266 Evaluation of Prognostic Factors in Pediatric Transverse Myelitis: A Multicenter Cohort Study
Sevim Şahin, Gülen Gül Mert, Muhittin Bodur, Pınar Özkan Kart, Özlem Hergüner, İbrahim Öncel, Hasan Tekgül, Deniz Yüksel, Nihal Olgaç Dündar, Aycan Ünalp, Edibe Pembegül Yıldız, Mesut Güngör, Meltem Çobanoğulları Direk, İlknur Erol, Hüseyin Tan, Habibe Koç, Ayşe Tosun, A. Derda Yücel Şen, Banu Anlar, Turkish Pediatric Transverse Myelitis Study Group .
289 A Rare Complication of COVID-19 in a Pediatric Patient; Acute Transverse Myelitis
Nefise Arıbaş Öz, Esra Gürkaş, Nesrin Ceylan, Meryem Hilal Altaş, Ayla Akca Cağlar, Aslınur Özkaya Parlakay
394 Acute transverse myelitis related to BNT162b2 vaccine in a teenage girl
Cengiz Dilber, Sedef Terzioğlu Öztürk, Hande Dilber, Şeyma Demiray, Nursel Yurttutan, Sadık Yurttutan, Şükrü Güngör
396 Human Herpes Virüs-7 Enfeksiyonu Sonrası Gelişen Subakut Sklerozan Panensefalit Olgusu
Ezgi Günce Nural Kirci, Oğuzhan Seri̇n, Özge Balci, Tutku Taşkinoğlu, Arzu Yilmaz, Fatma Müjgan Sönmez
464 GAD antibody-spectrum disorders: case report
Maria Shumilina
481 Clinico-radiological spectrum of MOG antibody associated disorder (MOGAD) in Pediatric population.
Konika Bansal, Shilpa Kulkarni, Payal Shah, Komal Zanak
509 Rising surge of subacute sclerosing panencephalitis in pandemic era
Shubham Kaudinya, Shilpa Kulkarni, Vrushab Gavali , Anish Ainapure
611 A very young gi̇rl li̇mbi̇c encephali̇ti̇s wi̇th LGI1 anti̇bodi̇es
Gülcan Akyüz, Gülten Öztürk, Olcay Ünver, Dilşad Türkdoğan
103 Prevalence and outcomes of autoimmune encephalitis in a tertiary hospital in Baguio city, Philippines
Jaidi Sagay
156 Acute necrotizing encephalopathy (ANE) is a feature of dengue virus encephalitis
Sophie Barron, Tong Hong Yeo, Terrence Thomas
221 Efficacy of Rituximab Treatment in Rasmussen’s Encephalitis
Merve Öztürk, Ömer Karaca, Defne Alikılıç, Adnan Deniz, Mesut Güngör, Bülent Kara
352 Paediatric anti-gamma aminobutyric acid-B receptor encephalitis with benign prognosis
Liu Liu, Yeping Wang, Feng Gao
510 Clinical profile of autoimmune encephalitis in Western India
Shubham Kaudinya, Shilpa Kulkarni, Konika Bansal
633 Anti-NMDA receptor encephalitis in children – tale of ten years at a tertiary care center
Gautam Kamila, Richa Tiwari, Sheffali Gulati, Ankit Kumar Meena, Puneet Choudhary, Rahul Sinha, Prashant Jauhari, Biswaroop Chakrabarty
701 Acute disseminated encephalomyelitis (ADEM) in children: a multicenter retrospective study
Seda Kanmaz, Sanem Yilmaz, Nihal Olgac Dündar, Ayse Aksoy, Mehmet Canpolat, Huseyin Per, Ilknur Erol, Hakan Gumus, Yasemin Ozkale, Selcan Ozturk, Dilara Ece Toprak, Ibrahim Oncel, Murat Ozkale, Elif Nurdan Mansur, Hepsen Mine Serin, Gulsen Ersoz, Seyda Besen, Gulen Gul Mert, Ayten Gulec, Sevim Sahin, Cemile Busra Olculu, Ayberk Selek, Serdar Pekuz, Gunce Basarir, Cagatay Gunay, Leman Tekin Orgun, Didem Bİcer, Zehra Filiz Kahraman, Deniz Yuksel, Meral Karadag, Erdem Simsek, Aycan Unalp , Nihal Yildiz, Meltem Cobanogullari Direk , Uluc Yis, Huseyin Tan, Cengiz Havali , Aydan Degerliyurt , Mesut Gungor , Ozlem Herguner , Elif Perihan Oncel , Olcay Unver , Hale Atalay Celik, Bilge Ozgor, Ali Cansu , Asli Kubra Atasever , Ayse Tosun, Olcay Gungor, Cetin Okuyaz, Selvinaz Edizer , Semra Hız , Esra Sarıgecili, Gokcen Oz Tuncer , Pinar Gencpinar, Unsal Yilmaz, Hasan Tekgul, Banu Anlar
704 Anti-Hu associated encephalitis as the initial presentation of neuroblastoma
Seda Kanmaz, Sanem Yilmaz, Eda Ataseven, Dilara Ece Toprak, Tugce Ince, Hepsen Mine Serin, Mehmet Kantar, Hasan Tekgul
772 Anti-NMDA receptor encephalitis after Human Bocavirus infection
Hale Atalay Celik, Ergin Atasoy, Bahadır Konuskan, Zeynelabidin Ozturk, Deniz Yuksel
51 Subcutaneous immunoglobulin in anti-HMGCR myopathy with children for long-term maintenance
Dilek Cavusoglu, Beril Talim, Haluk Topaloglu
62 Congenital myotonic dystrophy: a retrospective study of a single center
Duygu Yılmaz, Gökçe Eser, Haluk Topaloglu
71 CLINICAL SPECTRUM OF THE LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2E (LGMD2E)
Gokce Eser, Ayse Karaduman, Duygu Yılmaz, Haluk Topaloglu
95 Muscle cramps may be a clue for GFPT1 gene related congenital myasthenic syndrome
Özlem Yayıcı Köken, Gökçen Öz Tunçer, Büşranur Çavdarlı, Ahmet Cevdet Ceylan, Ayşe Aksoy, Haluk Topaloğlu
128 Continuous Glucose Monitoring in Obese/Overweight Children and Adolescents with Neurological Manifestations: A Single Reference Center Experience
Çiğdem Genç Sel, Ayça Törel Ergür, Tuğçe Ataseven Emeksiz
288 Pediatric Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study from Türkiye
Gamze Sarıkaya Uzan, Deniz Yüksel, Erhan Aksoy, Ülkühan Öztoprak, Mehmet Canpolat, Selcan Öztürk, Çelebi Yıldırım, Ayten Güleç, Hüseyin Per, Hakan Gümüş, Çetin Okuyaz, Meltem Çobanoğulları Direk, Mustafa Kömür, Aycan Ünalp, Ünsal Yılmaz, Ömer Bektaş, Serap Teber, Nargiz Aliyeva, Nihal Olgaç Dündar, Pınar Gençpınar, Esra Gürkaş, Sanem Keskin Yılmaz, Seda Kanmaz, Hasan Tekgül, Ayşe Aksoy, Gökçen Öz Tuncer, Elif Acar Arslan, Ayşe Tosun, Müge Ayanoğlu, Muhittin Bodur, Bülent Ünay, Semra Hız Kurul, Uluç Yiş
322 Guillain–Barre Syndrome due to COVID 19 in a child with acute lymphoblastic leukemia: a case report
Huseyin Tan, Elif Yildirim, Mustafa Ozay
413 Paraneoplastic polyneuropathy associated with inflammatory myofibroblastic tumor in a pediatric patient
Adnan Deniz, Defne Alikılıç, Merve Öztürk, Ömer Karaca, Mesut Güngör, Ugur Demirsoy, Bülent Kara
608 The Utility of Prognostic Models in Pediatric Guillain Barre Syndrome : A Regional Cohort Study-EGE
Yavuz Ataş, Seda Kanmaz, Cemile Büşra Ölçülü, Tugce Ince, Ozlem Yılmaz, Dilara Ece Toprak, Gürsel Şen, Sanem Yılmaz, Hasan Tekgul
664 A rare manifestation of pediatric CIDP: hypoglossal nerve involvement
Nurşah Yeniay Süt, Ömer Bektaş, Miraç Yıldırım, Ayşe Tuğba Kartal, Serap Teber
126 HIRAYAMA DISEASE: ABOUT TWO CASES
Angeles Schteinschnaider, Francina Belen Lombardi, Solange Gril, Romina Nelida Dominguez, Isaura Gonzalez, Paulina Yañez, Eliana Julian, Martin Carnevale
416 Shear wave elastography in patients with spinal muscular atrophy type 2-3
Burcin Nazli Karacabey, Zuhal Bayramoglu, Orhan Coskun, Zeynep Nur Akyol Sari, Melis Ulak Ozkan, Edibe Pembegul Yildiz, Mine Caliskan
500 Funccional testing and rehabilitation of spinal muscular atrophy patients
Biljana Mitrevska, Valentina Koevska, Natalija Angelkova, Ljelja Muaremoska Kanzoska
533 Nusinersen safety and effects in children with spinal muscular atrophy: a single center experience
Xiaomei Zhu, Chaoping Hu, Hui Li, Shuizhen Zhou, Wenhui Li, Yi Wang
647 Spinal Muscular Atrophy - Emerging therapies: Experience from a tertiary care hospital
Sheffali Gulati, Madhulika Kabra, Rahul Sinha, Sonali Singh, Sayoni Roy Chowdhury, Arvinder Wander, Ankit Kumar Meena, Puneet Choudhary, Richa Tiwari, Rishi Sharma, Sakshi Ojha, Pawan Ghanghoria, Aakash M, Gautam Kamila, Anuja Agarwala, Kanak Lata Gupta, Vipsa Gupta, Shivani Tripathi, Vinod Dahiya
757 Evaluation Of Pediatric Cases With Gullian Barre Syndrome: A National Multicenter Study
Mehmet Canpolat, Selcan Öztürk, Hakan Gumus, Erhan Aksoy, Şeyda Besen, Aycan Ünalp, Nihal Olgaç Dündar, Sevim Şahin, Sermin Özcan, Cem Paketçi, Abdullah Canbal, Faruk İncecik, Seda Kanmaz, Aydan Değerliyurt, Arife Derda Yücel Şen, Çelebi Yıldırım, Ergin Atasay, İlknur Erol, Ünsal Yılmaz, Mesut Güngör, Sibgatullah Ali Orak, Hüseyin Tan, Pınar Gençpınar, Elif Acar Arslan, Gülten Öztürk, Gamze Sarıkaya Uzan, Burcu Calışkan, Hepsen Mine Serin, Didem Ardıçlı, Ömer Bektaş, Ayşe Tosun, Müjgan Arslan, Coşkun Yarar, Adnan Deniz, Hülya İnce, Meltem Cobanogulları Direk, Gökçen Öz Tuncer, Muhittin Bodur, Ayten Gülec, Ülkühan Öztoprak, Leman Tekin Orgun, Yiğithan Guzin, Çisil Çerçi Kubur, Fatma Hancı, Dilek Cavuşoglu, Deniz Yüksel, Hüseyin Per, Turkish Pediatric Guillain Barre Study Group Collaboration
760 Cardiac impairment in Duchenne Muscular Dystrophy: A single-center retrospective experience
Didem Ardicli, Rohat Oztepeli, Nilgun Isiksalan Ozbulbul, Aysegul Nese Citak Kurt, Ibrahim Ilker Citak Kurt
777 PRIDOSTIGMIN TREATMENT IN X-LINKED MYOTBULAR MYOPATHY
Salih Akbaş, Recep Kamil Kilic, Kıvılcım Gücüyener, Esra Serdaroğlu, Ercan Demir
102 Paraneoplastic Guillain-Barre Syndrome: A case report and call for modified diagnostic criteria
Alyssa Robison, Alex Card, Sumeet Bhatia
228 Preconceptional diagnosis for giant axonal neuropathy before wedding engagement decision
Nouha Bouayed Abdelmoula
260 Isolated unilateral Palatal Palsy- a postinfectious inflammatory mononeuritis of the pharyngeal branch of the vagal nerve
Darshan Das , Areena Vincent
271 Congenital Myasthenia Syndrome: Correlation between clinical features and genetics from North India
Renu Suthar, Naveen Sankhyan, Yashovardhan Kaushal, Arushi G Saini, Pratibha Singhi
443 Charcot-Marie-Tooth Disease, So Which Type?
Ayşe Nur Coşkun, Canan Üstün, Özgen Hür, Mutluay Arslan, Deniz Torun, Bülent Ünay
645 Facial Nerve Venous Malformation Presenting As Bell's Palsy
SEMRA SAYGI, ZAFER ALTUN, HALUK YAVUZ
634 Two Cases With Typical GBS And Rare GBS Variant Associated With Covid-19
Sibğatullah Ali ORAK, Cisil ÇERÇİ KUBUR, Aslı Kübra ATASEVER, Muzeffer POLAT
654 PERONEAL NERVE PALSY DUE TO OSTEOCHONDROMA OF THE FİBULAR HEAD: A RARE CAUSE OF FOOT DROP
Recep Kamil Kilic, Salih Akbas, Akif Muhtar Ozturk, Ercan Demir
775 Four Different Types of Cases with Charcot-Marie-Tooth Axonal Involvement
Rojan İpek
162 Updated demographics and safety data from patients with nonsense mutation Duchenne muscular dystrophy receiving ataluren in the STRIDE Registry
Francesco Muntoni, Filippo Buccella, Isabelle Desguerre, Janbernd Kirschner, Eugenio Mercuri, Andrés Nascimento Osorio, Már Tulinius, Shelley Johnson, Christian Werner, Joel Jiang, James Li, Panayiota Trifillis
163 Comparison of timed function test results in nmDMD patients receiving ataluren: STRIDE Registry vs phase 3 clinical trial
Eugenio Mercuri, Francesco Muntoni, Már Tulinius, Filippo Buccella, Isabelle Desguerre, Janbernd Kirschner, Andrés Nascimento Osorio, Shelley Johnson, Christian Werner, Joel Jiang, James Li, Panayiota Trifillis
164 Comparing the change in 6-minute walk distance in nmDMD patients receiving ataluren: STRIDE Registry compared with phase 3 clinical trial
Francesco Muntoni, Már Tulinius, Filippo Buccella, Isabelle Desguerre, Janbernd Kirschner, Andrés Nascimento Osorio, Shelley Johnson, Christian Werner, Joel Jiang, James Li, Panayiota Trifillis, Eugenio Mercuri
165 Age at loss of ambulation in STRIDE Registry and CINRG Natural History Study patients with DMD: a matched cohort analysis
Eugenio Mercuri, Francesco Muntoni, Filippo Buccella, Isabelle Desguerre, Janbernd Kirschner, Andrés Nascimento Osorio, Már Tulinius, Shelley Johnson, Christian Werner, Joel Jiang, James Li, Panayiota Trifillis, Craig. M. McDonald
169 Pulmonary function in Duchenne muscular dystrophy patients from the STRIDE Registry and CINRG Natural History Study: a matched cohort analysis
Már Tulinius, Filippo Buccella, Isabelle Desguerre, Janbernd Kirschner, Eugenio Mercuri, Francesco Muntoni, Andrés Nascimento Osorio, Shelley Johnson, Christian Werner, Joel Jiang, James Li, Panayiota Trifillis, Craig. M. McDonald
170 Comparison of North Star Ambulatory Assessment score change in nmDMD patients receiving ataluren: STRIDE Registry vs phase 3 clinical trial
Francesco Muntoni, Már Tulinius, Filippo Buccella, Isabelle Desguerre, Janbernd Kirschner, Andrés Nascimento Osorio, Shelley Johnson, Christian Werner, Joel Jiang, James Li, Panayiota Trifillis, Eugenio Mercuri
184 COVID-19 Vaccine Hesitancy Among Neuromuscular Disorder Children and Adolescents
Michael Kwan Leung Yu, Wilfred Hing Sang Wong, Amy Suen, Jaime S Rosa Duque, Sophelia Hoi Shan Chan
262 Impact of COVID-19 pandemic on healthcare utilitsation and psychosocial well-being of children with neuromuscular disorder
Michael Kwan Leung Yu, Winnie Wan Yee Tso, Ka Man Yip, Wilfred Hing Sang Wong, Oscar Kuen Fong Yiu, Godfrey Chi Fung Chan, Patrick Ip, Sophelia Hoi Shan Chan
571 Interobserver Reliability of the Turkish Translation of Timed Tests in Duchenne Muscular Dystrophy
Eli̇f Acar Arslan, Arzu Erden
653 Three years follow up of 6-minute walk test and North Star Ambulatory Assessment in 30 ambulant DMD boys since the beginning of steroid treatment
Natalija Angelkova, Olivera Lekovska, Elena Sukarova-Angelovska, Biljana Mitrevska, Ljelja Muaremoska Kanzoska
213 Clinical Features Beyond Myopathy: Three Calpainopathy Patients with CAPN3 Mutation
Defne Alikılıç, Merve Öztürk, Adnan Deniz, Ömer Karaca, Mesut Güngör, Bülent Kara
226 Myotonia congenita associated to multiple sclerosis in a Tunisian family
Nouha Bouayed Abdelmoula
280 Compliance with riboflavin treatment in a patient with late-diagnosed Brovn-Vialetto-Van Laere syndrome
selahattin katar, Ahmet Yaramış
281 Riboflavin treatment in 3 cases with ETFDH gene mutation
selahattin katar, Ahmet Yaramış, Meral Bülbül Öztoprak
282 Clinical And Genetic Spectrum of Myotonia Congenita in Turkish Children
Gokcen Oz Tuncer, Aslıhan Sanrı, Seren Aydın , Ozlem Hergüner, Nezir Ozgün, Mustafa Kömür, Dilara Füsun İçağasıoğlu, Rabia Tütüncü Toker, Sanem Yılmaz, Elif Acar Arslan , Mesut Güngör , Gültekin Kutluk, Şeyda Beşen, Gülen Gül Mert, Burçin Gönüllü Polat, Ayşe Aksoy
405 Ketogenic diet for 134 cases of SCN1A related drug-resistant epilepsy
Yu Fang, Man Wang, Hua Li, Jianmin Zhong, Juan Wang, Xiuxia Wang, Ciliu Zhang, Jiwen Wang, Fang Yuan, Lifen Duan, Suli He, Rong Luo, Dan Sun, Zhe Tao, Dong Wang, Hua Wang, Zhifeng Wu, Guang Yang, Hongwei Zhang, Guo Zheng, Jianping Zhu, Zhihong Zhuo, Jianxiang Liao
438 A rare cause of hypotonia, arthrogryposis, and early-onset scoliosis: Autosomal recessive PIEZO2-associated neuromuscular disease
Didem Ardicli, Aydan Degerliyurt, Ahmet Cevdet Ceylan
590 MLIP-associated myopathy; report of a patient and review of the literature
Fatema Al Amrani, Khalid Al Thihli, Almundher Al-Maawali
776 Clinical Spectrum of Voltage-gated Sodium Channelopaties; One-center Experience
HALE Atalay CELİK, Abdullah Sezer, Ulkuhan Oztoprak, Erhan Aksoy, Deniz Yuksel
140 A Novel Founder Mutation in the SGCB Gene Causes Severe Form of Limb Girdle Muscular Dystrophy (LGMD) 2E in Sathwara Community
Siddharth Shah, Alpesh Patel, Shivshankar Chettiar
279 A Multicenter Retrospective Study in Turkish Children with Myotonic Dystrophy Type 1
Gokcen Oz Tuncer, Aslıhan Sanrı, Gülbahar Kurt Bayır, Ilknur Erol, Merve Oztürk, Hasan Tekgül, Özlem Hergüner, Gültekin Kutluk, Dilek Cavusoglu, Hande Gazeteci Tekin, Mustafa Kömür, Ayse Aksoy
307 Diagnostics, clinical and genetic characteristics of Duchenne muscular dystrophy in Kazakhstan
Bakhytkul Myrzaliyeva, Marzhan Lepessova
310 Clinical Experience of gene replacement therapy in children with Spinal Muscular Atrophy: A single center retrospective study of 25 children
NIDHEESH CHENCHERI, Haitham Elbashir , Gail Alexander
360 LİMBE GİRDLE MUSCULAR DYSTROPHY WİTH A MUTATİON İN THE CAVEOLİN-3 (CAV-3) GENE
Derya Guder, Nilufer Eldes Hacifazlioglu, Emek Uyur Yalcin, Bilgihan Bikmazer, nuriye ayca gul
371 GENETIC LANDSCAPE OF CONGENITAL MUSCULAR DYSTROPHIES(CMD) FROM CENTRAL AEGEAN PART OF TURKEY
Didem Soydemir, Berk Özyılmaz, Ipek Polat, Pinar Edem, Gamze Sarıkaya Uzan, Figen Baydan, Semra Hiz Kurul, Sebahattin Çirak, Uluc Yis
409 Uniparental disomy unmasks a homozygous mutation of POMGNT1 in a case of muscle-eye-brain disease
Yi-Dan Liu, Dan-Dan Tan, Dan-Yu Song, Hui Xiong
424 A rare phenotype of congenital muscular dystrophy: 'Muscular dystrophy-dystroglycanopathy type B,1'
Özgen Hür, Canan Üstün, Ayşe Nur Coşkun, Mutluay Arslan, Deniz Torun, Bülent Ünay
566 Gamma-sarcoglycanopathy (LGMDR5): clinical and genetic study of a pediatric Tunisian cohort
Thouraya Ben Younes, Zouhour MILADI, Hedia Klaa, Hanene Benrhouma, Aida Rouissi, Madiha Trabelsi, Ichraf Kraoua, Ilhem Ben Youssef-Turki
640 A case of Emery Dreifuss Muscular Dystrophy with SYNE1 and SYNE2 mutations and white matter involvement
Senem Ayça, Zeynep Okay, Berker Okay, Kamil Şahin
193 Cli̇ni̇cal characteri̇sti̇cs of cases wi̇th spi̇nal muscular atrophy
Ari̇fe Derda Yücel Şen, Cefa Ni̇l Arslan Karademi̇r, Emre Kaplan, Ersi̇n Yüksel, Coşkun Yarar, Kürşat Bora Çarman
249 Onasemnogene abeparvovec for Spinal Muscular Atrophy: Experience from one center in the United Arab Emirates
Vivek Mundada, Rania Abusamra, Omendra Narayan, Anand Gorva, Deepak Mullasery
301 Setting up of a standard of care for children with spinal muscular atrophy at a tertiary care center in North Kerala: South India
Smilu Mohanlal, Aarthi Balaji, Pramod Sudarshan, Mahendra verma, Vinitha Vijayaraghavan, Satish Kumar, Manjula Anand, Suresh Kumar, Sneha Shaji
370 Safety, tolerability and efficacy of widely available nusinersen program in children with Spinal Muscular Atrophy.
Katarzyna Kotulska, Maria Mazurkiewicz-Bełdzińska, Anna Kostera-Pruszczyk
432 Bone Health in Children with Spinal Muscular Atrophy
Joanna Yuet-ling Tung, Sophelia Hoi-Shan Chan
444 Spinal muscular atrophy with lower extremity-predominant (SMA-LED)
Surbhi Gupta, Ramesh Konanki, Lokesh Lingappa
518 The impact of Nusinersen treatment on scoliosis progression in patients with Spinal Muscular Atrophy
Hoi Ning Hayley Ip, Sophelia Hoi Shan Chan, Kenny Yat Hong Kwan
546 Spinal Muscular Atrophy with Two SMN2 Copies and Preserved Deep Tendon Reflexes: An Extremely Rare Case
Eli̇f Acar Arslan, Arzu Erden, Ni̇hal Yildiz, Pinar Özkan Kart, Nurhayat Korkmaz
561 The effect of Nusinersen and starting age on the improvement of motor performance in Spinal Muscular Atrophy (SMA): Preliminary results
Arzu Erden, Eli̇f Acar Arslan, Murat Emi̇rzeoglu, Nurhayat Korkmaz, Ni̇hal Yildiz, Pinar Özkan Kart
80 A case of CAV3 caveolinopathy / channelopathy with familial absence epilepsy and distal myoneuronopathy extending the clinical spectrum
İlknur Erol, Elif Perihan Öncel, Şeyda Beşen, Leman Tekin Orgun, Atıl Bişgin
81 The first Turkish case with early-juvenile-onset recessive distal titinopathy and the first case with prominent neurogenic involvement
İlknur Erol, Elif Perihan Öncel, Şeyda Beşen, Leman Tekin , Sevcan Tuğ Bozdoğan
82 First Turkish case with MICU1 mutation-related myopathy and extrapyramidal findings
Elif Perihan ÖNCEL, İlknur Erol , Şeyda Beşen, Leman Tekin Orgun, İbrahim Boğa , Atıl Bişgin
210 The Co-existence of Phenylketonuria and Myasthenia Gravis: A CaseReport
Bita Poorshiri, Mohammad Barzegar, Sina Raeisi, Mohammadreza Afghan
241 Clinical features of pediatric acute rhabdomyolysis
Yeliz Kutat, Serkan Kirik
527 Electromyography in Pediatric Population, A Single Center Experience
Duygu Aykol, Dondu Ulker Ustebay, Cagatay Gunay, Aysen Gok, Onder Karakaya, Semra Hiz Kurul, Uluc Yis
483 Clinical case of acromicric dysplasia syndrome (ACMICD-syndrome)
Zhuldyz Nukebayeva, Ainur Bekitayeva , Marzhan Lepessova , Alma Issabekova
682 A case of TUBGCP2-associated tubulinopathy with a novel missense variant
Yavuz Sayar, Miraç Yıldırım, Ömer Bektaş, Çiğdem İlter Uçar, Serap Teber
59 Improvement of Hand Hygiene Practices among the Healthcare Workers in a Neonatal Intensive Care Unit
ABDULLAHEL AMAAN, Sanjoy Dey
157 Linear scleroderma as one of the manifestations of collagenosis
Sarafroz Fayzullaeva, Nilufar Ziyamukhamedova
311 Prematurity and Postnatal Neurological Sequelae
Wahed
401 Diagnostic yield of Whole Exome and Whole Genome Sequencing in pediatric neurological disorders. A UAE Tertiary hospital experience
Bushra Alattas, Majid Aziz
448 Identification of a novel variant of the CDKl5 gene associated with atypical Rett Syndrome
Arijit Chattopadhyay, Dipanjana Datta, Asimayan Nandi
489 Efficacy, safety and tolerability of Gabapentin as monotherapy for dystonic cerebral palsy
Suhani Shah, Vishal Patel, Radhika Agarwal, Nishant Rathod, Anaita Udwadia Hegde
526 Vici syndrome: Experience at tertiary care center
Amal Kentab
661 ERCC5 novel missense mutation causing developmental delay and spasticity
Saleel Ramesh Chandratre
674 Clinical evolution in patients with autosomal recessive limb-girdle muscular dystrophy (LGMDR5): A Tunisian cohort
wafa bouchaala, sirine Frikha, Sihem Ben Ncir , Salma Zouari, Olfa Jallouli, Fatma kamoun, Faiza Fakhfakh, Chahnez Triki
97 Dancing eyes and lazy gut in an infant with developmental delay
Ashna Kumar, Suvasini Sharma
203 Social deficits and cerebellar degeneration in Purkinje cell Scn8a knockout mice
Xiaofan Yang
211 Clinical and genetic profiles of grey matter heterotopia – report of 28 patients
Magdalena Budisteanu, Sorina Mihaela Papuc, Catrinel Iliescu, Carmen Burloiu, Oana Tarta-Arsene, Diana Barca, Cristina Motoescu, Carmen Sandu, Alice Dica, Cristina Anghelescu, Adelina Glangher, Dana Craiu, Aurora Arghir
227 Sensorineural impairment in maternally inherited diabetes mellitus and deafness (MIDD) disorder
Nouha Bouayed Abdelmoula
297 Evaluation of clinical, laboratory, and imaging findings of patients with the diagnosis of Pontocerebellar Hypoplasia: A multicenter national study
Dilek Cavusoglu, Gulten Ozturk, Dilsad Turkdogan, Semra Hiz Kurul, Uluc Yis, Mustafa Komur, Faruk Incecik, Olcay Unver, Cengiz Dilber, Gulen Gul Mert, Cagatay Gunay, Gamze Sarikaya Uzan, Ozlem Ersoy, Serdar Mermer, Gokcen Oz Tuncer, Olcay Gungor, Gul Demet Kaya Ozcora, Ugur Gumus, Ozlem Sezer, Gokhan Ozan Cetin, Turkan Sahin, Arzu Yilmaz, Gurkan Gurbuz, Ahmet Cevdet Ceylan, Serdar Ceylaner, Joseph G Gleeson, Dilara Fusun Icagasioglu, F. Mujgan Sonmez
335 An Aicardi-Goutieres Syndrome 2 Case
Canan Üstün, Mutluay Arslan, Ali Öztuna, Ayşe Nur Coşkun, Özgen Hür, Bülent Ünay
350 Pontocerebellar Hypoplasia Associated With TTC 1 Mutation: Case Series
Gamze Sarıkaya Uzan, Ece Sönmezler, Semra Hız Kurul, Çağatay Günay, Yavuz Oktay, Rita Horvath, Hanns Lochmüller, Uluç Yiş, Ahmet Yaramış
358 Infantile Neuroaxonal Dystrophy; A Rare Or Underdiagnosed Disease?
Zahra Rezaei, Mahmoud Reza Ashrafi, Morteza Heidari, Ali Reza Tavasoli, Ali Zare Dehnavi, Maryam Rasulinezhad
374 Progressive encephalopathy due to SLC1A4 mutations in two non Ashkenazi Brazilian siblings.
Sergio Rosemberg, Dirce Takako, Fernando Arita
53 SLC25A12 as a new candidate for febrile seizures: a case-control association study
Yan-Wen Shen, Xiu-Yu Shi, Hua-Cheng Zheng, Li-Ping Zou
171 Evaluation of the etiology of epilepsy and/or developmental delay in children with next generation sequencing: A single center experience
Handan Kava, Yasemin Alanay, Ahmet Yesilyurt, Ugur Isik
197 Identification of 1q21.1 Microduplication in a family
Tingting Huang, Haifeng Xu, Shangyu Wang, Guo Zheng, Gang Zhang
380 Xp22.33-p11.4 Duplication and 46, X+mar gonadal dysgenesis in a Patient with Epilepsy, Dysmorphisms, Hypotonia and Intellectual Disability, A case report
Fatma Kusgoz, Nihal Olgac Dundar, Olgay Bildik, Berk Ozyilmaz, Melis Kose, Pinar Gencpinar
453 Duplication 9 p Syndrome; Case Report
müge baykan, NİHAL OLGAÇ DÜNDAR, Berk Özyılmaz , fatma kuşgöz, pınar gençpınar
616 Bi-allelic POLR3A null variants cause autosomal recessive leukodystrophy, hypomyelinating, 7
JiYoon Han, Hyo Jeong Kim, Jee Min Kim
622 Complete Penetrance but Different Phenotypes in a Korean Family with Maternal Interstitial Duplication at 15q11.2-q13.1: A Case Report
Jee Min Kim, Ji Yoon Han
696 EXPANDING PHENOTYPIC DIVERSITY OF PRUNE1 RELATED DISORDERS: AN EXPERIENCE OF FOUR CASES IN A TERTIARY CENTER
Didem Soydemir, Cagatay Gunay, Sanem Yılmaz , Mert Karakaya, Sebahattin Cirak, Brunhilde Wirth, Hasan Tekgul, Semra Hiz Kurul, Reza Maroofian , Uluc Yis
720 National Based, Retrospective Study on the Evaluation of Clinical, Laboratory, and Imaging Research of Angelman Syndrome- Turkey's Multicenter Study
Hakan Gümüş, Ayten Güleç , Mehmet Canpolat, Betül Kılıç, Özlem Yılmaz, Yasemin Topçu, Seda Kanmaz, Adnan Deniz, Ünal Akça, Gülten Öztürk, Muhammed Bahadır Samur, Peren Perk Yücel, Dilara Füsun İçağasıoğlu, Aydan Değerliyurt, Mesut Güngör, Hülya İnce, Pinar Ozkan, Kürşad Aydın, Sanem Yılmaz, Hasan Tekgül, Selcan Öztürk, Bülent Kara, Burcu Karakayalı, Gülen Gül Mert, Nihal Olgaç Dündar Dündar, Çisil Çerci Kubur, Sedef Terzioglu Öztürk, Pinar Gençpinar, Aslıhan Kıraz, Murat Erdoğan, Munis Dündar, Hüseyin Per, Turkish Pediatric Angelman Syndrome Study Group
762 National Based, Retrospective Study on the Evaluation of Clinical, Laboratory, and Imaging Research of Tuberous Sclerosis Cases
Hüseyin Per, Mehmet Canpolat, Ayten Güleç, Esra Serdaroğlu, Yavuz Ataş, İlknur Erol, Aydan Değerliyurt, Betül Kılıç, Meltem Çobanoğullları Direk, Gökçen Öz Tunçer, Selcan Öztürk, Kürşat Bora Çarman, Ebru Arhan, Seda Kanmaz, Yasemin Ozkale, Meryem Hilal Altaş, Emek Uyur Yalçın, Uluç Yiş, Serdal Güngör, Dilşad Türkdoğan, Ali Cansu, Bülent Ünay, Yasemin Topçu, Türkan Uygur Şahin, Nihal Olgaç Dündar, Aslihan Akdamar Kayar, Şeyda Besen, Ömer Karaca, Sevinç Keskin Keçecioğlu, Tuğba Hirfanoğlu, Hepsen Mine Serin, Kürşad Aydın, Gülbahar Kurt Bayır, Coşkun Yarar, Sibğatullah Ali Orak, Nilufer Eldeş Hacıhafızoglu, Ayşe Semra Hız, Bilge Özgör, Burcu Karakayalı, Nihal Yıldız, Çisil Çerçi, Hülya İnce, Rojan İpek, Dilek Çavuşoğlu, Canan Üstün, Çetin Okuyaz, Ayşegül Danış, Hakan Gümüş, Ayşe Serdaroğlu, Turkish Tuberous Sclerosis Study Group
146 Genetics and clinical phenotypes of epilepsy associated with Dup15q syndrome
Miaomiao Cheng, Ying Yang, Xueyang Niu, Yi Chen, Quanzhen Tan, Wenwei Liu, Xiaoling Yang, Zhixian Yang, Yuehua Zhang
202 Phenotype of heterozygous variants of dehydrodolichol diphosphate synthase
Xianru Jiao, Yinan Xue, Sai Yang, Pan Gong, Yue Niu, Qi Wang, Hui Yang, Hui Xiong, Yuehua Zhang, Zhixian Yang
214 Analysis of clinical features and genetic variants among patients with SLC6A1 mutations
Yunjian Zhang, Yifeng Ding, Yi Wang, Shuizhen Zhou
252 Evaluation of MicroRNAs in Pediatric Epilepsy
Kursat Bora Carman, Hande Gazeteci Tekin, Dilek Cavusoglu, Coskun Yarar, Emre Kaplan, Cefa Nil Karademir, Didem Arslantas
363 A rare cause of autism and epilepsy combination: GRM7 gene mutation
Derya Guder, Emek uyur yalcin, nilufer eldes hacifazlioglu, Bilgihan Bikmazer, nuriye ayca gul
497 De novo mutation in setd1b is associ̇ated with intellectual disability, epilepsy, and autistic behavior
Sedef Terzioğlu Öztürk, Hande Dilber, Mehmet Ali Ekenel, Bahtiyar Şahinoğlu, Cengiz Dilber
514 Lafora disease: Case report of a 13 years old patient with cognitive decline, ataxia and seizures
Dilek Cebeci, Abdulkadir Tekgoz, Alpay Cetin, Mehmet Nur Talay, Berfin Burak Varanlar, Eşe Eda Turanlı
458 Progressive myoclonic epilepsy related to SEMA6B gene mutation
Hande Dilber, Sedef Terzioğlu Öztürk, Hamdi Kale, Cengiz Dilber
660 Study of clinical and genetic characteristics of limb-girdle muscular dystrophy in Iranian patients
Hossein Farshadmoghadam , Gholamreza Zamani, Mahmoud reza Ashrafi, Morteza Heidari, Ali Reza Tavasoli
460 Study of computerized cognitive training technique for treatment of children with attention deficit hyperactivity disorder. A new treatment modality experience.
Hussein AbdelDayem, Salma AbdelDayem
773 Wolf-Hirschhorn syndrome and Dup15q – review of the literature and case report.
Radu Perjoc, Oana Vladâcenco, Raluca Teleanu
83 A novel mutation in the RUNX2 gene; a rare cause of enlarged fontanel
Murat Özkale, Özlem Sangün, Atıl Bişgin, İbrahim Boğa, İlknıur Erol
236 First case of Bohring-Opitz syndrome inherited from the father
İlknur Erol , Murat Özkale, Atıl Bişgin
240 The First Turkish case with HIVEP2-related intellectual disability
İlknur Erol, Şeyda Beşen, Elif Perihan Öncel , Leman Tekin Orgun, Özge Sönmezler, Atıl Bişgin
244 Is pyridoxine effective in the treatment of hyperphosphatasia with mental retardation syndrome type 4: Single center experience
Şeyda Beşen, İlknur Erol , Özlem Sangün, Leman Tekin Orgun, Atıl Bişgin
245 The first siblings with TRAPPC6B mutation
İlknur Erol , Şeyda Beşen, Elif Perihan Öncel, Leman Tekin Orgun, Sevcan Tug Bozdoğan
247 Two Turkish siblings with intellectual disability associated with TUSC3 mutation
İlknur Erol , Gökçe Yegül Gülnar, Elif Perihan ÖNCEL, Şeyda Beşen, Leman Tekin Orgun, Yavuz Şahin
343 A Case of OTUD6B-Related Disorder
Gülbahar Kurt Bayir, Gökçen Öz Tunçer, Seren Aydin, Aslıhan Sanrı, Ayşe Aksoy
361 A report of a rare syndrom: Alazami Syndrom
Irmak Erdoğan, Nihal Olgaç Dündar, Pınar Gençpınar, Rabia Meral, Bumin Dündar
364 Sturge Weber Syndrome with phakomatosis pigmentovascularis: a case report
Aakanksha anand, Suvasini Sharma, dipti kapoor
435 Phenotypic diversity of 15q11.2 copy number variants: a case series and review of the literature
Gunce Basarir, Irmak Erdogan, Nihal Olgac Dundar, Berk Ozyilmaz, Pinar Gencpinar
98 Gene Panel Testing in children with Early Onset Epileptic Encephalopathies : A study in a Tertiary car center in Bangladesh
Kanij Fatema, Md Mizanur Rahman, Shaheen Akhter
100 A case report of sequential seizure semiology as a sign of genetic etiology
Thomas Murray, Jorge Vidaurre
167 COL4A1-related autosomal recessive encephalopathy in 2 Turkish children
Ahmet Yaramis
207 Case report: DOCK7 mutation as a rare cause of epileptic encephalopathy with cortical blindness, dysmorphic findings
Özlem Özsoy, Didem Soydemir, Çağatay Günay, Gamze Sarıkaya Uzan, Mehmet Can Yeşilmen, Ayşe Semra Hız, Uluç Yiş
230 Novel Mutations in AP3B2 Gene Cause an Early Onset Developmental and Epileptic Encephalopathy: A Rare Clinical Entity
Cengiz Dilber, Gül Yücel , Yavuz Şahin
267 Hypocalcemic Seizure in a Girl with FOXG1-Gene–Related Encephalopathy
Magdalena Bliznakova, Georgi Boshev, Zhivka Chuperkova, Miglena Georgieva
383 Early recurrent encephalopathy and subsequent hemiplegic migraine and intellectual disability caused by a de novo mutation in ATP2A2 gene
Ali Modaweb, Ahmed Abd Alwahab Nugud, Maha AlAli, Mohamed OE Babiker
387 TBC1D24 gene Mutations Presented with Familial Infantile Myoclonic Epilepsy
Nefise Arıbaş Öz, Nesrin Ceylan, Abdüllatif Bakır, Hamit Özyürek
389 A case of ‘Joubert Syndrome 31’ due to CEP120 homozygous mutation
Özgen Hür, Ayşe Nur Coşkun, Canan Üstün, Mutluay Arslan, Deniz Torun, Bülent Ünay
393 Clinical and genetic study of rare cases with coexistence of dual genetic diagnoses
Dandan Tan, Yidan Liu, Danyu Song, Hui Xiong
414 A Case of GRIN1 Mutation Presenting with Autistic Features
Özgen Hür, Mutluay Arslan, Deniz Torun, Bülent Ünay
419 A case of ‘Smith Magenis Syndrome’ with self-injurious behaviors and dysmorphic facial
Özgen Hür, Ayşe Nur Coşkun, Canan Üstün, Mutluay Arslan, Deniz Torun, Bülent Ünay
425 A rare cause of progressive myoclonic epilepsy: KCTD7 mutation
Özgen Hür, Canan Üstün, Ayşe Nur Coşkun, Mutluay Arslan, Deniz Torun
428 Clinical and genetic characteristics of PCDH19-related epilepsy syndromes：differences between East-Asians and European-Americans
Liu Liu, Yu Shen, Feng Gao
578 Clinical and genetic features of acute deterioration with resulting neurological regression in children with Dravet Syndrome
Neil Atkinson, Amy McTague, Elaine Hughes, Catherine Devile, Christin Eltze, Suresh Pujar
583 First Turkish case with UNC80 deficiency
İlknur Erol, Elif Perihan Öncel , Gökçe Yegül Gülnar, Şeyda Beşen, Leman Tekin, Özgür Kütük, Mehmet Oğuz Canan
592 A Cause of Severe Hypotonia in Infancy: Allan-Herndon-Dudley Syndrome
Sakir Genc, ozlem yayici koken, sait acik, Senay Haspolat
630 A Photosensitivite Trichothiodystrophy Patient With A Mutation in ERCC2 Gene
Fatma Hanci, Hande Özkalaycı, Ayşegül Daniş, Ömer Faruk Karaçorlu
745 Etiologies, Clinical profile and Yield of Genetic Evaluation in an Indian cohort of Neonatal and Early onset Developmental and Epileptic Encephalopathy
Vivek Jain, Pooja Agarwalaa, Thenral SG, Ramprasad V, Bhuvandeep Narang, Udita Mahadevia, Sakthivel Murugan
759 Evaluation of genetic, electrophysiological and clinical characteristics of patients followed up with the diagnosis of Developmental Epileptic Encephalopathy: A single center experience
Elif Perihan Öncel, İlknur Erol , Leman Tekin Orgun, Şeyda Beşen, Atıl Bişgin, Sevcan Tug Bozdoğan
114 The landscape of Lissencephaly among Egyptian Patients
Maha Zaki, Mahmoud Issa, Hasnaa Elbendary, Karima Rafat, Sherif Abdel-Ghafar, Ibrahim Hegazy, Ghada Abdel-Salam, Joseph Gleeson, Mohamed Abdel-Hamid
159 Prevention of Inherited Genetic Disease using WGS (whole genome sequencing)
Vinodh Narayanan, Keri Ramsey, Newell Belnap, Anna Abraham, Ashley Ryan, Sampath Rangasamy, Anna Bonfitto, Marcus Naymik, Matthew Huentelman, Denise Perry, Akila Subramaniam, Wayne Grody, Szabolcs Szelinger
200 Posterior fossa malformations in TASP1-related disorder (Suleiman-El-Hattab Syndrome)
Jehan Suleiman, Korbinian Riedhammer, Ayman El-Hattab
239 A pediatric case with primary familial brain calcification due to a homozygous variant on the JAM2 gene
İlknur Erol , Leman Tekin Orgun, Şeyda Beşen, Sevcan Tug Bozdoğan , Özlem Alkan
376 Filamin A associated periventricular nodular heterotopia presenting with mutism
Chew thye Choong, Saumya Shekhar Jamuar
427 The Yield of Genetic and Metabolic Testing in Epileptic Spasms
Mohammed AlQahtani, Ali Mir, Shahid Bashir, Wajd AlOtaibi, Fawzia Amer, Gregory Costain
430 PSEUDO-TORCH- A rare mutation causing global development delay, microcephaly and extensive band like brain calcification
Javeria Alvi, Tipu Sultan, Mahrukh Sultan, Saher Ahdi
501 Exploring the genetic basis of Leukodystrophies through an in-house targeted panel approach in resource-poor settings
Arushi Saini, Yashu Sharma, Prateek Bhatia, Naveen Sankhyan, Renu Suthar, Sameer Vyas, Vikas Bhatia, Savita Attri
532 Clinical Characteristics and Aetiology of Corpus Callosum Abnormalities: A single Centre Experience in Saudi Arabia.
Amal Kentab
606 A Dynamic Genetic Testing Approachment for Neurological Disorders in The Pediatric Neurogenetic Case-Management Councils
Cemile Busra Olculu, Durdugul Ayyildiz Emecen, Enise Avci Durmuslalioglu, Seda Kanmaz, Esra Isik, Tahir Atik, Erdem Simsek, Hepsen Mine Serin, Sanem Yilmaz, Gul Aktan, Sarenur Gokben, Ozgur Cogulu, Ferda Ozkinay, Hasan Tekgul
84 The first case of spastic ataxia type 4 associated with heterozygous mutations in MTPAP gene
İlknur Erol, Ruken Tekdemir, Şeyda Beşen, Elif Perihan Öncel , Leman Tekin , Sevcan Tuğ Bozdoğan, İbrahim Boğa
178 A case of a ADPRHL2 Mutation; Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy
Senem Ayça, Pelin Ozyavuz Çubuk
369 Alpha-fœtoproteine prognosis value in patients monitoring with ataxia-telangiectasia
Salma Zouari Mallouli, Sabrina Mejdoub, Olfa Jallouli , Sawssan Feki, Wafa Bouchaala, Hend Hachicha, Sihem Ben Nsir, Fatma Kamoun Feki, Hatem Masmoudi, Chahnez Charfi Triki
491 Hereditary spastic paraplegia type 26 with a novel mutation in B4GALNT1 gene and literature review of the clinical features
faruk incecik, ozlem m herguner
492 Homozygous mutation in CWF19L1 with recessive ataxia syndrome in a Turkish child
faruk incecik, ozlem m herguner, sevcan t bozdogan
272 The neuronal ceroid lipofuscinoses type 8 (CLN8) gene mutations: A new compound heterozygous case and the protein's bioinformatic analyses
Muhammad Mahajnah, Rajech Sharkia, Abdelnaser Zalan, Hazar Zahalkah
290 Neurodegeneration with brain iron accumulation in 18 Indian families: a case series highlighting phenotypic and genotypic diversity
Amita Moirangthem, Haseena Sait, Somya Srivastava, Manmohan Pandey, Deepak Ravichandran, Anju Shukla, Kausik Mandal, Deepti Saxena, Arya Shambhavi, Purvi Majethia, Lakshmi Priya Rao, Suvasini Sharma, Shubha Phadke
698 Ring Chromosome 18 Case With 18p Deletion
Olgay Bildik, Fatma Kusgoz, Berk Özyilmaz, Sener Arikan, Nihal Olgac Dundar, Pinar Gencpinar
726 Rare dual diagnoses in an infant: Aicardi-Goutieres and Moyamoya Syndromes
Süleyman Şahin, Yavuz Sayar, Miraç Yıldırım
765 Children with genetically confirmed Hereditary Spastic Paraplegia (HSP): A case series from Eastern Mediterranean Region of Turkey
Şeyda Beşen, Elif Perihan Öncel, Leman Tekin Orgun, Sevcan Tug Bozdoğan, İlknur Erol
54 Long-term prognosis of neurological system in tuberous sclerosis complex with neonatal onset epilepsy
Yan-Wen Shen, Yong Xu, Li-Ping Zou, Meng-Na Zhang, Jing He, Wen-Jing Zhou
331 Clinical and molecular spectrum of tuberous sclerosis complex in a regional cohort: an efficacy and outcome study with antiseizure medication plus mTOR inhibitor therapy
Meltem Orbay, Hepsen Mine Serin, Seda Kanmaz, Esra Isik, Tahir Atik, Ozgur Cogulu, Ferda Ozkinay, Sanem Yılmaz, Gul Aktan, Sarenur Gökben, Hasan Tekgül
354 Ketogenic Diet Therapy for Drug-resistant Epilepsy and Cognitive Impairment in Children with Tuberous Sclerosis Complex
Yu Fang, Dan Li, Man Wang, Hua Li, Lifei Yu, Xia Zhao, Jing Duan, Qiang Gu, Baomin Li, Jian Zha, Daoqi Mei, Guangbo Bian, Man Zhang, Huiting Zhang, Junjie Hu, Liu Yang, Jianxiang Liao
107 Neuroimaging characteristics of tuberous sclerosis complex in paediatric patients at a tertiary health facility in kenya: a case series
Maureen Njoroge, Sheila Waa, Jacqueline Mavuti, Pauline Samia
78 Thinning of the corpus callosum prominent in the splenium and colpocephaly: the AP-4 deficiency syndrome
Aydan Değerliyurt, Özlem Yayıcı Köken, Hanife Saat, Tülin Hakan Demirkan
125 Neurocutaneous melanosis: clinical and imaging characteristics in 7 patients
Angeles Schteinschnaider, Francina Belen Lombardi, Manuel Rivera, Romina Nelida Dominguez, Isaura Gonzalez, Paulina Yañez
597 Unravelling the diagnostic dilemma – A case series of radiologically diagnosed pontocerebellar hypoplasia.
Ami Shah, Shilpa Kulkarni, Foram Gala, Snehal Mallakmir
763 A prospective study of etiologies and phenotype of an Indian cohort of childhood onset (less than five years) epilepsies
Vivek Jain, Chitra Gupta, Rakhi Sharma, Thenral SG, Ramprasad V, Ravi Gupta, Bojamma Kalappa, Sandhya Nair
769 Clinical and genetic study of leukodystrophies in Tunisian cohort
Ichraf Kraoua, Thouraya Ben Younes, Imen Dorboz, Hanene Benrhouma, Hedia Klaa, Aida Rouissi, Sonia Abdelhak, Odile Boespflug –Tanguy, Ilhem Ben Youssef-Turki
63 S-adenosylhomocysteine hydrolase deficiency with associated masseter hypertrophy, bradykinesia, and cerebellar atrophy and alterations of creatine and choline homeostasis. Expansion of cerebrohepatomuscular phenotype
Judy Pipo-Deveza, Rebekah Jobling, Susan Blaser, Amanda Carnevale, Wayne Langburt, Grace Yoon, Ingrid Tein
136 Temporary Consciousness Disturbance in Van der Knaap disease after Minor Head Trauma
Arzu Ekici, Sevgi Yimenicioglu, Mehmet Ali EKİCİ
238 Intermediate severe Salla Disease in differential diagnosis of hypomyelinating leukodystrophy: the second and third case from Turkey
İlknur Erol , Yasemin Özkale, Özgür Kütük
292 A Rare Cause of Developmental Epileptic Encephalopathy: D-Bifunctional Protein Deficiency with a Novel Pathogenic Variant
Cemile Busra Olculu, Erdem Simsek, Sanem Yilmaz, Seda Kanmaz, Hepsen Mine Serin, Ayca Aykut, Asude Durmaz, Hasan Tekgul
328 Cystic Leukoencephalopathy; a confusing neuroimaging feature!
Zahra Rezaei, Mahmoud Mohammadi
334 Genotypic phenotypic charecteristics of galactosemia in postneonatal age in western India
Harshuti shah, Zachray Grinspan
586 MPS-like disease presumably caused by VPS16-associated impairment of intracellular trafficking
Jan-Christoph Schoene-Bake, Tobias Haack, Eva Bueltmann, Anibh Martin Das, Hans Hartmann
642 A Rare Case Of Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
Semra Saygi, Alev Arslan, Şenay Demi̇r
707 A Case Of Vanishing White Matter Disease With Atypical Neuroimaging Presentation
Olgay Bildik, Elif Didinmez Taskirdi, Melis Kose, Nihal Olgac Dundar, Pinar Gencpinar
753 Congenital Icthyosis and neurological manifestations, Sjogren Larsson and beyond: A study of seven children.
Sachendra Badal, Parvathi Parappil, Arjun Kurup, Ruchika Jha, Sweta Mukherjee, Vivek Gupta, Biju M John, Vishal Sondhi, Karthik Ram Mohan, KM Adhikari
72 The miracle of nucleoside treatment in thymidine kinase 2 deficiency
Gokce Eser, Ali Zeki Bedir, Haluk Topaloglu
147 A case of mitochondrial depletion syndrome type 13 due to a FBXL4 variant
Asburce Olgac, Halil İbrahim Aydın , Fatma Müjgan Sönmez
246 Two siblings with combined oxidative phosphorylation defect 11 with a novel mutation in the RMND1 gene
İlknur Erol, Leman Tekin Orgun, Şeyda Beşen, Elif Perihan Öncel, İbrahim Boğa, Atıl Bişgin, Özlem Alkan
318 Three Different Phenotypic Presentations of Leigh Syndrome
Seren Aydin, Gökçen Öz Tunçer, Özlem Sezer, Aslıhan Sanri, Gülbahar Kurt Bayir, Ayşe Aksoy
320 Ketamine: An effective and safe treatment for patients with MELAS and refractory status epilepticus
Ezgi Saylam, Jorge Vidaurre
323 Mitochondrial disorders: a descriptive study of a Tunisian pediatric series
Abir Zioudi, Ichraf Kraoua, Thouraya Ben Younes, Hedia Klaa, Hanene Benrhouma, Ilhem Ben Youssef-Turki
451 Progressive Mitochondrial Leukoencephalopathy in a one and half year-old boy: A Case Report
Anish Ainapure, Shilpa Kulkarni, Foram Gala, Shubham Kaudinya
480 A case of mitochondrial neuro-gastrointestinal encephalopathy or MNGIE syndrome, why not?
Seyfeddine Baouia
713 A case with mutation of Vps13D: Leigh syndrome or spinocerebellar ataxia?
Esra Ozpİnar, mehmet palaz, betul kilic, yasemin topcu, kursad aydin
93 Solving a puzzle: An infant with developmental delay, epileptic spasms, and petechiae
Ayse Yasemin Celik, Didem Ardicli, Burak Yürek, Ciğdem Seher Kasapkara, Halil Ibrahim Yakut, Nesrin Ceylan, Esra Kılıc, Aysegül Nese Cıtak Kurt
340 Mutations of The E3 Beta Subunit of The Pyruvate Dehydrogenase (PDH) Complex Gene: A Case Report
Gülbahar Kurt Bayir, Gökçen Öz Tunçer, Seren Aydin, Aslıhan Sanrı, Ayşe Aksoy
341 Two Different Phenotypes Caused by Mutation in the EARS2 Gene in Two Siblings
Gülbahar Kurt Bayir, Gökçen Öz Tunçer, Seren Aydin, Aslıhan Sanrı, Ayşe Aksoy
365 A Rare Mitochondrial disease; Naxe Gene Mutation
Hale Atalay Celik, Zeynelabidin Ozturk, Abdullah Sezer, Erhan Aksoy, Deniz Yuksel
439 High-dose Nicotinamide rescues from ‘Early-onset, progressive encephalopathy with brain edema and/or leukoencephalopathy-1 (PEBEL-1)’: All hope is not lost!
Surbhi Gupta, Ramya Bandi, Ramesh Konanki, Rose Mary Lawrence
463 Thiamine Pyrophosphokinase Deficiency in Indian origin Siblings - Expanding the phenotype
Ami Shah, Neeta Naik
715 Ventricular septation on MRI could be diagnostic clue for PDH: Two case reports
MEHMET PALAZ, Esra Ozpinar, yasemin topcu, Betul Kilic, Kursad Aydin
719 Can leukodystrophy be reversible? a LTBL case report
MEHMET PALAZ, Esra Ozpinar, Betul Kilic, Yasemin Topcu, Kursad Aydin
778 A CHALLENGING CASE: WERNICKE ENCEPAHALOPATHY AFTER GASTRIC SLEEVE SURGERY
İsmail Hakkı Akbeyaz, Burcu Karakayalı, Sermin Özcan, Gülten Öztürk, Fethi Gül, Burçin Doruk Oktay, Dericioğlu Volkan, Pınar Kahraman Koytak, Özge Yapıcı, Eda Almus, Naime Evrim Karadağ Saygı, Olcay Ünver, Dilşad Türkdoğan
152 Eladocagene Exuparvovec Gene Therapy Improves Motor Development in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency
Paul Wuh-Liang Hwu, Yin-Hsiu Chien, Ni-Chung Lee, Sheng-Hong Tseng, Antonia Wang, Panayiota Trifillis, Tuna Koca, Chun-Hwei Tai
153 Eladocagene Exuparvovec Improves Body Weight and Reduces Respiratory Infections in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency
Paul Wuh-Liang Hwu, Yin-Hsiu Chien, Ni-Chung Lee, Sheng-Hong Tseng, Antonia Wang, Panayiota Trifillis, Tuna Koca, Chun-Hwei Tai
154 Gene Therapy With Eladocagene Exuparvovec Improves Cognition and Language in Patients With Aromatic L-Amino Acid Decarboxylase Deficiency
Paul Wuh-Liang Hwu, Yin-Hsiu Chien, Ni-Chung Lee, Sheng-Hong Tseng, Antonia Wang, Panayiota Trifillis, Tuna Koca, Chun-Hwei Tai
212 Pyrimidine Metabolism Disorders as Rare Cause of Psycho-motor Retardation, Dysmorphism and Epilepsy
Defne Alikılıç, Deniz Sünnetçi, Adnan Deniz, Merve Öztürk, Ömer Karaca, Mesut Güngör, Bülent Kara
256 Efficacy and Safety of Cerliponase Alpha Therapy in Neuronal Ceroid Lipofuscinosis Type 2
Salih Akbaş, Tugba Hırfanoglu, Alp Özgün Börcek, Tuğba Atalay, Sebla Endürlük, Nazlı Balcan Karaca, İlknur Cankurt, Recep Kamil Kılıç, Deniz Menderes, Ayşe Serdaroğlu, Esra Serdaroğlu, Kıvılcım Gücüyener, Ercan Demir, Ebru Arhan
337 Study of 15 patients with early infantile neurometabolic epileptic encephalopathy-treatable etiologies
Rajvee shah, Harshuti Shah
508 Impact of COVID-19 on the care of children with neurometabolic disorders
Yashu Sharma, Arushi Saini, Gunjan Didwal, Rajdeep Kaur
543 Uridine-responsive epileptic encephalopathy: precision treatment across the age spectrum
Gurdeep Sekhon, Christin Eltze, Usha Kini, Sarah Hughes, Ana Pérez Caballero, James Davison, Martin Smith, Amy McTague
689 A case of asparagine synthetase deficiency successfully treated with ketogenic diet
Mert Altıntaş, Çiğdem İlter Uçar, Ömer Bektaş, Yavuz Sayar, Miraç Yıldırım, Serap Teber
298 A Mutation in Neurodegeneration with Brain Iron Accumulation – Two Brothers
Seren AYDIN, Gökçen ÖZ TUNÇER, Özlem YAYICI KÖKEN, Büşranur ÇAVDARLI, İnci GÜNGÖR, Ayşe AKSOY
324 Fatty Acid Hydroxylase associated Neurodegeneration (FAHN) – A case report from India highlighting its heterogenous nature.
Ami Shah, Neeta Naik
502 EEG and ONSD in management of hepatic encephalopathy: additional role of EEG in prognosis
Roshan Koul, Seema Alam
503 Congenital disorder of glycosylation : clinical case study of patients harboring pathogenic mutations in phosphomannomutase 2 gene (PMM2-CDG)
Prashant Utage, Aparna Prashant Utage, Nadir Aman, Krishnendu Menon, Umesh Bahmmarkar
505 Atypical presentation of PLAN-associated NBIA
Mahesh Kamate, Bhavana Koppad, Virupaxi Hattiholi
446 Metabolic Stroke; A Rare Clinical Condition of Glycerol Kinase Deficiency
HALE ATALAY CELİK, Ismail Solmaz, Erhan Aksoy, Mutlu Uysal Yazici, Kader Oguz
452 MRI pattern recognition of neuroceroid lipofuschinosis in children
Mahesh Kamate, Mayank Detroja, Bhavana Koppad, Virupaxi Hattilholi
596 Clarifying missense variants of uncertain significance in CLN6 Batten disease through the use of skin biopsy – a case report
Nicolas Abreu, Laura Biederman, Zarsha Khuhro, Kandamurugu Manickam, Emily de los Reyes
730 An Infant With Movement Disorder And Infantile Spasm: Attenuated NKH
Esra Ülgen Temel, Esra Serdaroğlu, Ebru Arhan
66 Clinical profile and outcome of 6 patients with Biotinidase deficeince: An experience from a tertiary care hospital of Pakistan
dr.IRAM JAVED
330 A RARE GLUT 1 DEFICIENCY SYNDROME PRESENTING WITH SPEECH DELAY
ESRA SARIGECILI, FATMA DERYA BULUT
353 SLC2A1 mutations associated Glucose Transport Type 1 Deficiency Syndrome: A Single Center Case Series
Elif Perihan Öncel , Talip Sayar, Şeyda Beşen, Leman Tekin Orgun, Neslihan Önenli Mungan, İlknur Erol
570 Clinical, Biochemical and Genetic analysis of 6 North Indian families: Biotinidase deficiency in 86% of the children
Gunjan Didwal, Arushi Gahlot Saini, Savita Verma Attri
593 Fuel for Thought – Case series of Beta-Ketothiolase patients presenting with metabolic encephalopathy
Swikaar Panchal, Ami Shah, Lakshmi Shobhavat, Rekha Solomon, Isha Bhagat
594 A rare cause of episodic vomiting: Late-onset multiple acyl-CoA dehydrogenase deficiency as a treatable metabolic myopathy
Ayse Yasemin Celik, Ciğdem Seher Kasapkara, Burcu Civelek Urey, Esra Kılıc, Nesrin Ceylan, Bekir Furkan Yalcın, Didem Ardicli
662 A rare metabolic disease causing infantile spasm: Argininosuccinate lyase deficiency
Nurşah Yeniay Süt, Miraç Yıldırım, Ömer Bektaş, Ayşe Tuğba Kartal, Serap Teber
711 Chylous blood in an infant with febrile encephalopathy: Clues to metabolic etiology (Very Long Chain Acyl CoA Dehydrogenase Deficiency)
Bishwo Kunwar, Sushant Ghimire, Prerna Guleria, Amit Devgan, Vishal Sondhi, Sachendra Badal
747 Phenotypic diversity of GLUT1 deficiency: A case report.
Pinar Edem, Esra Er, Pelin Teke Kisa, Hande Gazeteci Tekin, Berk Ozyilmaz
76 Diagnosis challenges of child abnormal movement in limited settings countries, the case of a little girl abandoned on the way to care
Dramane Coulibaly, Zeinab Kone, Mady Niakaté
243 Efficacy of zinc treatment in 2 cases with Arg209Cys mutation in GNAO1 gene
Ömer Karaca, Merve Öztürk, Defne Alikılıç, Adnan Deniz, Mesut Güngör, Bülent Kara
264 Hereditary Spastic Paraparesis Type 55: A Case Report
Seren AYDIN, Gokçen OZ TUNCER, Dilek AKTAS, Inci GUNGOR, Haydar Ali TASDEMIR
287 CLINICAL EVALUATION OF CHILDREN DIAGNOSED WITH SYDENHAM CHOREA, SINGLE CENTER EXPERIENCE
Hüseyin PÜR, Mehmet CANPOLAT, Ümmü Gülsüm ÖZGÜL GÜMÜŞ, Hüseyin PER, Süreyya Burcu GÖRKEM, Ali BAYKAN, Hakan GÜMÜŞ
300 Early-onset spontaneously relieved spasms of infancy in sleep: electroclinical characteristics and differential diagnoses
qiao hu, shuang liao
347 Caffeine significantly reduces frequency of Paroxysmal Dyskinesia in a child with an ADCY5 Mutation
SUKANYA VRUSHABHENDRA, MOHAMED BABIKER
422 An autosomal dominant familial dyskinesia gene: ADCY5 mutation
Özgen Hür, Canan Üstün, Ayşe Nur Coşkun, Mutluay Arslan
426 A novel psychological therapy approach for children with PNKD
Sara Sopena, Juliana Silva, Raj Bhatoa, Corin Whitfield, Tammy Hedderly
141 An Investigation of the relationship between dystonia severity and functional independence and quality of life in children with dystonia: A Preliminary Study
Kamile Uzun Akkaya, Pelin Atalan, Zekiye Başaran, Esra Serdaroglu, Bulent Elbasan
291 A novel combined heterozygous mutation in the PLA2G6 gene associated with early-onset Parkinson’s disease
İlknur Erol, Elif Perihan Öncel , Mehmet Fatih Dilen, Şeyda Beşen, Leman Tekin Orgun, Atıl Bişgin, Sevcan Tug Bozdoğan, Özlem Alkan
384 A case of dopa responsive dystonia due to compound heterozygous TH gene mutation in a Turkish Girl.
Serdar Saritas, Oguzhan Yarali, Nihal Aydin, Mustafa Onur Yildiz, Mehmet Burak Mutlu
441 A Case of Childhood Onset Dystonia Due to KMT2B Gene Mutation
Ayşe Nur Coşkun, Canan Üstün, Özgen Hür, Mutluay Arslan, Deniz Torun, Bülent Ünay
465 Profile of children with movement disorders (metabolic and genetic causes): single center study
ELSAYED ALI, ZAKIYAH DAAJANI, ABDULRAHIM KHUSHI
556 Novel mutation variant in GCH1 gene - a new cause for infantile-onset severe dystonic encephalopathy?
Eugenia Roza, Raluca Ioana Teleanu, Oana Aurelia Vladacenco, Daniela Dorina Vasile, Maria Lupu, Octavian Ioghen
565 Spectrum of genetically determined movement disorder in Indian Cohort
Suhani Shah , Shreya Gandhi, Tarishi Nemani, Nishant Rathod, Anaita Udwadia Hegde
676 Holmes tremor associated with two different etiologies
Çiğdem İlter Uçar, Ömer Bektaş, Yavuz Sayar, Miraç Yıldırım, Serap Teber
86 Neurological and immunological phenotypes in Ataxia Telangiectasia
Pinar Yavuz, İbrahim Oncel, Aysegül Akarsu, Deniz Ayvaz, Ilhan Tezcan, Banu ANLAR
411 COVID-19 vaccine induced opsoclonus-myoclonus-ataxia syndrome
Adnan Deniz, Defne Alikılıç, Merve Öztürk, Ömer Karaca, Mesut Güngör, Bülent Kara
454 Autosomal recessive spastic ataxia of Charlevoix–Saguenay : Two case reports
Anish Ainapure, Shilpa Kulkarni, Foram Gala, Konika Bansal
513 Ataxia oculomotor apraxia type 4 due to a pathogenic variant in PNKP gene
Aydan Değerliyurt, Özge Tanıdır Artan, Hanife Saat
528 Hereditary cerebellar ataxias: descriptive study of a hospital cohort
sihem Ben Nsir, Wafa Bouchaala, Olfa Jallouli, Salma Zouari, Fatma Kamoun, Chahnez Triki
574 CLINICO-EPIDEMIOLOGICAL PROFILE OF CHILDREN WITH OPSOCLONUS MYOCLONUS ATAXIA SYNDROME: A DECADE’S EXPERIENCE FROM A TERTIARY CARE CENTRE IN NORTH INDIA
Gautam Kamila, Sakshi Ojha, Sheffali Gulati, Prabhjot Kaur, Kaushik Raghunathan, Prashant Jauhari, Biswaroop Chakrabarty, Vishal Sondhi, Rachna Dubey, Prateek Kumar Panda, Rachana Seth, Sandeep Aggarwal
673 A study in a Turkish family with ataxia and points to MTCL1 as a candidate gene for autosomal dominant cerebellar ataxia
ÇİSİL ÇERÇİ KUBUR, Sibğatullah Ali ORAK, ASLI KÜBRA ATASEVER, Muzaffer POLAT
677 Acute cerebellitis associated with juvenile idiopathic arthritis
Çiğdem İlter Uçar, Yavuz Sayar, Miraç Yıldırım, Ömer Bektaş, Serap Teber
709 A rare neurodegenerative disorder mimicking autoimmune encephalitis induced by COVID-19: CONDSIAS
Esra Ozpinar, mehmet palaz, yasemin topcu, betul kilic, kursad aydin
75 The challenges of training in Child Neurology in West Africa countries
Zeinab Kone, Dramane Coulibaly, Mady Niakaté
91 Online paediatric EEG handbook: a survey on its usefulness
Veena Kander
692 A pilot study on the opinions of future doctors about child neurology
Ipek Tekcicek, Esra Serdaroglu
375 Construction of an introductory curriculum for new child neurology and neurodevelopmental disabilities trainees
Alexandra Santana Almansa, Christina Briscoe Abath, Agnieszka Kielian, Aristides Hadjinicolaou
469 Making it Home on Time: Improving Child Neurology Inpatient Discharge Timing
Ryan Sauer, Kimberly Jones, Sharoon Qaiser
477 Title: Measuring Transition Readiness in Adolescents with Epilepsy: Opportunities and Challenges
Tina Krysiak, Gogi Kumar, Sarah MacDonald, Shawnda Cates
638 Children’s Medical Home in China (CHMC) – Promoting Early Development of Chinese Children
Yingshan Shi , Tingyu Li, Haijun Li, Ting Zhang, Guoqiang Cheng, Jenny Chen, Michael E. Msall
688 Early Intervention app and Digital technology: Bridging the rehabilitation service gap in India
Franzina Coutinho, Dinesh Krishna, Marie Brien, gauri. saxena, Paramakalyani Rajeshwaran, Navamani V
88 Online Mother and Baby Yoga for Preterm-Born Infants and Their Mothers in the Time of COVID-19 Pandemic
Dilara Bozgan, Elmas Zeynep İnce, Gizem Tosun, Meliha Mine Çalışkan
